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A large brain is one of the most distinguishing features of humans compared to other 
members of the animal kingdom. During mammalian evolution there has been a 
disproportionate enlargement of the brain relative to body size and this expansion has 
been particularly prominent during the past 3 million years of human lineage. This 
must be the consequence of adaptive genetic alterations during mammalian 
evolution, but the genes and molecular processes altered are essentially unknown.  
One approach for identifying candidate genes for brain size regulation is through 
characterisation of Mendelian disorders of brain development. In particular, primary 
microcephaly has received considerable interest as a model disease for studying brain 
size regulators because patients present with a profoundly reduced brain size but 
have no other malformations. Genetic studies have identified mutations in seven 
genes that can cause primary microcephaly. All the primary microcephaly proteins 
localise to the centrosome at some stage during the cell cycle and have roles in a 
diverse range of functions including centrosome maturation, centriole formation and 
microtubule organisation at the spindle pole. The precise mechanism leading to 
primary microcephaly is not known but a prevalent hypothesis is that centrosome 
dysfunction disrupts mitosis of neural progenitor cells. Despite there being strong 
evidence in support of this hypothesis for most primary microcephaly genes, MCPH1 
(the first primary microcephaly gene to be identified) always appeared to be 
functionally distinct from other primary microcephaly proteins. Most work on 
MCPH1 has focussed on its role in the DNA damage response and cell cycle timing 
rather than on its mitotic role. As a result, the aim of this thesis is to perform a 
detailed analysis of MCPH1 function during mitosis. 
In this thesis, three isoforms of MCPH1 were characterised and their localisation, 
expression and stability examined. It was established that MCPH1 is highly regulated 
during mitosis. MCPH1 transcript and protein levels vary significantly throughout 
the cell cycle and MCPH1 protein is targeted for degradation late in mitosis. In 
addition, MCPH1 is hyperphosphorylated during mitosis (in prometaphase-arrested 
cells) suggesting that phosphorylation could potentially regulate MCPH1 mitotic 
function. Twelve mitotic phosphorylation sites were identified by phosphopeptide 
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mapping, many of which were CDK1 and PLK1 consensus sites. Both PLK1 and 
CDK1 also contribute to MCPH1 phosphorylation in vivo. Although MCPH1 non-
phosphorylatable mutants localise normally during mitosis, binding to interaction 
partners may be affected which may have functional consequences. 
During mitosis MCPH1 localises to the centrosomes and kinetochores. Consistent 
with this localisation, RNAi-mediated knockdown of MCPH1 leads to metaphase 
arrest with multipolar spindles, major defects in chromosome alignment and loss of 
chromatid cohesion. In addition, MCPH1 deficient mouse embryonic fibroblast cells 
also demonstrate similar chromosome alignment defects, strengthening this finding 
in an independent system. Live-imaging of MCPH1 depleted cells demonstrate that a 
normal bipolar spindle and metaphase plate are initially formed, but subsequently 
chromosomes and chromatids drop off the metaphase plate and eventually the 
spindle collapses. This suggests that the primary function of MCPH1 is to allow 
timely progression through metaphase, possibly by mediating kinetochore-
microtubule attachments to satisfy the spindle activated checkpoint. 
Therefore my work describes several roles for MCPH1 in mitosis (centrosome 
stability, chromosome alignment and metaphase progression) suggesting that its role 











Table of Contents 
 
Acknowledgements ..................................................................................................... 3 
Abstract ....................................................................................................................... 5 
Table of Contents ....................................................................................................... 7 
List of Figures ........................................................................................................... 13 
List of Tables ............................................................................................................ 15 
Abbreviations ........................................................................................................... 16 
1. Introduction .......................................................................................................... 19 
1.1. Brain development ........................................................................................ 19 
1.1.1. Evolution of the mammalian brain ........................................................... 19 
1.1.2. Evolution of the mammalian cerebral cortex ........................................... 20 
1.1.3. Cell biology of cerebral cortex expansion ............................................... 21 
1.1.4. Neural progenitor cells ............................................................................. 23 
1.1.5. Regulation of the number of neural progenitor cells ............................... 25 
1.1.5.1. Cell fate determination ...................................................................... 25 
1.1.5.2. Apoptosis .......................................................................................... 32 
1.1.6. Conclusion ............................................................................................... 33 
1.2. Autosomal recessive primary microcephaly ............................................... 33 
1.2.1. The clinical phenotype of primary microcephaly .................................... 33 
1.2.2. Primary microcephaly, Seckel and MOPD-II .......................................... 35 
1.2.3. The primary microcephaly genes ............................................................. 35 
1.2.4. Paralogues and orthologues of primary microcephaly proteins ............... 35 
1.2.5. The mutations in primary microcephaly genes ........................................ 36 
1.2.5.1. MCPH1 ............................................................................................. 37 
1.2.5.2. Other primary microcephaly genes ................................................... 39 
1.2.6. Adaptive evolution of the primary microcephaly genes .......................... 42 
1.3. Function of primary microcephaly proteins ............................................... 43 
1.3.1. STIL, CPAP and CEP152- regulators of centriole duplication................ 43 
1.3.1.1. Centriole duplication ......................................................................... 43 
1.3.1.2. STIL .................................................................................................. 45 
1.3.1.3. CPAP ................................................................................................. 46 
1.3.1.4. CEP152 ............................................................................................. 47 
1.3.1.5. Centrioles and PCM recruitment ....................................................... 48 
1.3.1.6. STIL, CPAP and CEP152 in primary microcephaly ......................... 48 
1.3.2. CDK5RAP2 maintains centrosome structure........................................... 49 
8 
 
1.3.2.1. CDK5RAP2 as a microtubule organiser ........................................... 49 
1.3.2.2. CDK5RAP2 in centrosome structure ................................................ 50 
1.3.3. ASPM in mitotic microtubule nucleation and organisation ..................... 51 
1.3.4. Summary .................................................................................................. 52 
1.3.5. Primary microcephaly proteins in cell cycle progression ........................ 53 
1.3.6. WDR62 .................................................................................................... 53 
1.4. The role of the primary microcephaly proteins in brain size 
determination ....................................................................................................... 54 
1.4.1. Spindle orientation and cell fate choice ................................................... 54 
1.4.2. Cilia and cell cycle length ........................................................................ 55 
1.4.3. Apoptosis ................................................................................................. 55 
1.5. MCPH1 .......................................................................................................... 56 
1.5.1 MCPH1 transcript expression ................................................................... 56 
1.5.2 MCPH1 protein and BRCT domains ........................................................ 57 
1.5.3 MCPH1 in chromosome condensation ..................................................... 57 
1.5.4. MCPH1 in the DNA damage response .................................................... 59 
1.5.4.1. ATM and ATR DNA damage response ............................................ 59 
1.5.4.2 MCPH1 in cell cycle checkpoints ...................................................... 60 
1.5.4.3. DNA damage repair .......................................................................... 62 
1.5.4.4. Genomic stability .............................................................................. 63 
1.5.4.5. Summary: MCPH1 in the DNA damage response ............................ 63 
1.5.5 Transcriptional regulation ......................................................................... 64 
1.5.6. Centrosomal role for microcephalin......................................................... 64 
1.5.7 Drosophila melanogaster model of microcephalin ................................... 65 
1.5.8. Summary of MCPH1 depletion phenotypes ............................................ 67 
1.5.9. Conclusion: the role of MCPH1 ............................................................... 68 
1.6. Thesis aims and objectives ........................................................................... 68 
1.6.1. Hypothesis: Primary microcephaly proteins function in a common 
pathway that regulates brain growth .................................................................. 68 
1.6.2. Thesis aims ............................................................................................... 70 
Chapter 2. Materials and Methods ......................................................................... 71 
2.1. General Reagents .......................................................................................... 71 
2.1.1. Sources of reagents .................................................................................. 71 
2.1.2. Preparation of buffer solutions ................................................................. 71 
2.1.3. Preparation of cell culture drug stock solutions ....................................... 72 
2.1.4. Plasmids ................................................................................................... 73 
2.2. Microbial methods ........................................................................................ 77 
2.2.1. Growth of bacteria.................................................................................... 77 
2.2.2. Preservation of bacteria ............................................................................ 77 
2.2.3. Transformation of E. coli ......................................................................... 77 
2.2.3.1. Preparation of chemically-competent cells for cloning .................... 77 
2.2.3.2. Transformation of chemically-competent cells ................................. 78 
2.3. Cell culture methods ..................................................................................... 78 
2.3.1. Preparation and growth of cell lines ........................................................ 78 
9 
 
2.3.1.1. Mammalian cell lines ........................................................................ 78 
2.3.1.2. Chicken cell lines .............................................................................. 79 
2.3.1.3. Preparation of primary mouse embryonic fibroblasts cell lines........ 79 
2.3.2. Preservation of mammalian and avian cells ............................................. 79 
2.3.3. Synchronization of mammalian cultured cells ......................................... 79 
2.3.3.1. G1/S cell arrest using thymidine block .............................................. 79 
2.3.3.2. Prometaphase arrest using nocodazole block .................................... 80 
2.3.4. Transfection of cultured mammalian cells ............................................... 80 
2.3.4.1. Short interfering RNA transfections ................................................. 80 
2.3.4.2. DNA Transfections ........................................................................... 81 
2.3.4.3. siRNA and DNA co-transfections ..................................................... 81 
2.3.4.4. Relative surface area of culture vessels ............................................ 81 
2.4. Nucleic Acid methods .................................................................................... 82 
2.4.1. General Methods ...................................................................................... 82 
2.4.1.1. Spectrophotometric quantification of nucleic acids .......................... 82 
2.4.1.2. Agarose gel electrophoresis .............................................................. 82 
2.4.2. DNA methods .......................................................................................... 83 
2.4.2.1. Purification of DNA from E.coli cells .............................................. 83 
2.4.2.2. Purification of DNA from human cells ............................................. 83 
2.4.2.3. DNA sequencing ............................................................................... 83 
2.4.2.4. Restriction digests ............................................................................. 83 
2.4.2.5. Purification of restriction digested DNA .......................................... 84 
2.4.2.6. Amplification of DNA by polymerase chain reaction ...................... 84 
2.4.2.7. Purification of PCR products ............................................................ 85 
2.4.2.8. Genotyping of mouse embryos ......................................................... 85 
2.4.2.9. Site directed mutagenesis .................................................................. 86 
2.4.2.10. Ligation of DNA molecules ............................................................ 87 
2.4.2.11. Site-specific recombination of DNA molecules ............................. 87 
2.4.3. RNA Methods .......................................................................................... 88 
2.4.3.1. Purification of RNA from human cells ............................................. 88 
2.4.3.2. Reverse transcription of RNA ........................................................... 88 
2.4.3.3. Quantitative real-time PCR (qRT-PCR) ........................................... 88 
2.5. Protein methods ............................................................................................. 90 
2.5.1. Protein preparation from cultured mammalian cells ................................ 90 
2.5.1.1. Whole cell protein preparations ........................................................ 90 
2.5.1.2. Nuclear and Cytoplasmic protein preparations ................................. 90 
2.5.2. Recombinant protein isolation from E. coli ............................................. 90 
2.5.3. Protein quantification ............................................................................... 91 
2.5.4. In-vitro protein phosphorylation assay .................................................... 91 
2.5.5. SDS-PAGE ............................................................................................... 92 
2.5.6. Staining of protein gels ............................................................................ 93 
2.5.6.1. Coomassie Blue staining ................................................................... 93 
2.5.6.2. Silver Staining of protein gels ........................................................... 93 
2.5.7. Western blotting ....................................................................................... 93 
2.5.8. Western blot image analysis .................................................................... 94 
2.5.9. Phosphorylation site mapping of proteins by mass spectrometry ............ 94 
2.6. Microscopy methods ..................................................................................... 95 
10 
 
2.6.1. Fixation of cells ........................................................................................ 95 
2.6.2. Immunostaining ....................................................................................... 95 
2.6.3. Microscopy ............................................................................................... 95 
2.6.3.1. Microscopy of fixed cell preparations............................................... 95 
2.6.3.2. Microscopy of live cells .................................................................... 96 
2.6.3.3. Processing of 3D datasets ................................................................. 96 
2.6.3.4. Quantification of fluorescent signals in 3D datasets ......................... 96 
2.6.4. Flourescence activated flow cytometry .................................................... 96 
Chapter 3. Characterisation of MCPH1 isoforms in the cell cycle ...................... 98 
3.1. MCPH1 is alternatively spliced .................................................................... 99 
3.2. MCPH1 is alternatively spliced in human fetal brain .............................. 100 
3.3. MCPH1 isoform protein expression .......................................................... 101 
3.4 siRNA can be used to specifically deplete MCPH1 isoforms ................... 102 
3.5. MCPH1 FL and S are absent in MCPH1 patient cells ............................ 105 
3.6. Tissue-specific differences in MCPH1 isoform expression ...................... 107 
3.7. Cell-cycle differences in MCPH1 isoform expression .............................. 109 
3.8. Discussion ..................................................................................................... 111 
3.8.1. Alternative splice isoforms of MCPH1 .................................................. 111 
3.8.2. Contribution of MCPH1 isoforms to primary microcephaly pathogenesis
 .......................................................................................................................... 112 
3.8.3. Potential roles of MCPH1 isoforms ....................................................... 113 
Chapter 4. Localisation studies of MCPH1 isoforms .......................................... 115 
4.1. MCPH1 isoforms exhibit distinct localisations during interphase ......... 115 
4.2. MCPH1(Δ8) localises to the centrosome during interphase .................... 117 
4.3. MCPH1 isoforms exhibit distinct subcellular localisation during mitosis
 .............................................................................................................................. 118 
4.3.1. Inducible regulation of MCPH1 expression ........................................... 118 
4.3.2. MCPH1 isoform localisation during mitosis.......................................... 120 
4.4. MCPH1(FL) and Δ8 localise to the kinetochores ..................................... 124 
4.5. MCPH1(FL) localises to the centrosomes in a microtubule-dependent 
manner ................................................................................................................ 126 
4.6. MCPH1 N-terminus is sufficient for centrosomal localisation ............... 127 
4.7. The BRCT1 domain of MCPH1 interacts with centrosomal component 
PCNT ................................................................................................................... 129 
4.8. Discussion ..................................................................................................... 131 
4.8.1. Validation of epitope-tagged localisation studies .................................. 131 
4.8.2. MCPH1 kinetochore localisation ........................................................... 132 
4.8.3. MCPH1 centrosomal localisation .......................................................... 134 
11 
 
Chapter 5. The characterisation of MCPH1-deficient cells ............................... 137 
5.1. RNAi mediated depletion of MCPH1 ........................................................ 137 
5.1.1. Knockdown of MCPH1 isoforms by RNAi ........................................... 137 
5.1.2. MCPH1 depletion leads to multipolar spindle formation ...................... 138 
5.1.3. MCPH1 depletion leads to chromosome alignment defects .................. 141 
5.1.4. Live-imaging of MCPH1-deficient cells ................................................ 143 
5.1.5. Spindle checkpoint appears to be active in MCPH1-deficient cells ...... 145 
5.1.6. Multipolar spindle phenotype is due to fragmentation of PCM ............. 146 
5.1.7. MCPH1 deficiency compromises chromatid cohesion .......................... 148 
5.2. Mcph1
-/-
 MEFs ............................................................................................. 149 
5.2.1. Generation and characterisation of Mcph1
-/- 
MEFs ............................... 149 
5.3. MCPH1 patient lymphoblastoid cells ........................................................ 153 
5.3.1. CDK5RAP2, ASPM and γ-tubulin protein abundance is unaffected in 
MCPH1 LBCs .................................................................................................. 154 
5.3.2. CPAP localisation and centriole duplication is unaffected in MCPH1 
LBCs ................................................................................................................ 155 
5.3.3. Centrosome maturation is unaffected in MCPH1 LBCs ........................ 157 
5.3.4. Microtubule focussing and ASPM localisation is unperturbed in MCPH1 
LBCs ................................................................................................................ 159 
5.4. Discussion ..................................................................................................... 161 
5.4.1. MCPH1 is required for chromosome alignment .................................... 161 
5.4.2. Chromatid cohesion is lost in MCPH1-RNAi cells ............................... 162 
5.4.3. MCPH1 is required for spindle bipolarity .............................................. 163 
5.4.4. What is the primary function of MCPH1 at mitosis? ............................. 164 
5.4.5. MCPH1 does not appear to be required for centrosome maturation ...... 167 
Chapter 6. Post-translational modifications of MCPH1 .................................... 169 
6.1. GFP-MCPH1 is cleaved by caspases ......................................................... 169 
6.1.1. MCPH1 FL and Δ8 proteins demonstrate cleavage ............................... 169 
6.1.2. MCPH1 FL and Δ8 are cleaved by a caspase-dependent mechanism ... 171 
6.1.3. MCPH1 FL and Δ8 are cleaved at aspartate 625 ................................... 172 
6.2. MCPH1 is degraded in late mitosis and early G1 phase .......................... 175 
6.3. MCPH1 is phosphorylated during mitosis ................................................ 178 
6.4. Identification of MCPH1 phosphorylation sites ....................................... 178 
6.5. CDK1 and PLK1 contribute to MCPH1 mitotic phosphorylation ......... 180 
6.5.1. CDK1 mediated phosphorylation of MCPH1 ........................................ 180 
6.5.2. PLK1 mediated phosphorylation of MCPH1 ......................................... 182 
6.6. PLK1 or CDK1 phosphorylation does not appear to be required for 
MCPH1 kinetochore localisation ...................................................................... 184 
6.6.1. Mutation of PLK1 or CDK1 phosphosites did not affect MCPH1 
localisation ....................................................................................................... 184 
6.6.2. MCPH1 localisation appears to be independent of CDK1 phosphorylation 
of PLK1 binding sites ...................................................................................... 186 
12 
 
6.7. Discussion ..................................................................................................... 189 
6.7.1. MCPH1 is proteolytically cleaved by caspases ..................................... 189 
6.7.2. Degradation of MCPH1 during mitotic exit .......................................... 191 
6.7.3. Phosphorylation of MCPH1 during mitosis ........................................... 193 
Chapter 7. Discussion ............................................................................................ 197 
7.1. Summary of the main findings from this thesis ....................................... 197 
7.1.1. Model of the functional role of MCPH1 at mitosis................................ 198 
7.2. Are the primary microcephaly proteins in a shared pathway? .............. 198 
7.2.1. Cilia function .......................................................................................... 199 
7.2.2. Spindle orientation ................................................................................. 200 
7.2.3. Chromosome segregation and apoptosis ................................................ 201 
7.3. Summary ...................................................................................................... 203 
7.4. Future work ................................................................................................. 203 
7.4.1. MCPH1 isoform function ....................................................................... 203 
7.4.2. The role of MCPH1 at the kinetochores ................................................ 204 
7.4.3. MCPH1 function in neuronal progenitor cells ....................................... 205 
7.4.3.1. Human neuronal progenitor cells as models of primary microcephaly
 ...................................................................................................................... 205 
7.4.3.2. MCPH1 function in neuronal progenitor cells in Drosophila and 
rodents .......................................................................................................... 207 
Appendices .......................................................................................................... 208 
Appendix 1. Oligonucleotides ............................................................................ 208 
(a) Site-directed mutagenesis ........................................................................... 208 
(b) Gateway recombination .............................................................................. 211 
(c) Sequencing .................................................................................................. 212 
(d) PCR and qPCR ........................................................................................... 213 
(e) siRNA ......................................................................................................... 214 
Appendix 2. Antisera ......................................................................................... 215 
(a) Primary antibodies ...................................................................................... 215 
(b) Secondary antibodies .................................................................................. 216 
Appendix 3. Cell cycle regulation of MCPH1 is independent of caspases .... 216 
Appendix 4. Conservation of microcephalin phosphorylation sites between 
human and mouse .............................................................................................. 217 





List of Figures 
 
Figure 1.1 Comparison of the brain of a mouse, a macaque monkey and a human. . 20 
Figure 1.2. The model of radial neuronal migration. ................................................. 22 
Figure 1.3. Enlargement of the cortex surface area by decrease in apoptosis or 
increase in proliferative divisions. ............................................................................. 23 
Figure 1.4. Symmetric versus asymmetric divisions during mouse neurogenesis. .... 24 
Figure 1.5. Asymmetric neuroblast divisions in Drosophila. .................................... 26 
Figure 1.6. Symmetric and asymmetric cell divisions of mouse neuronal progenitors.
 .................................................................................................................................... 28 
Figure 1.7. The cell-cycle length hypothesis ............................................................. 31 
Figure 1.8. Effect of apoptosis on progenitor cell population and final brain size. ... 32 
Figure 1.9. Neuroimaging of primary microcephaly patient...................................... 34 
Figure 1.10. Primary microcephaly mutations in MCPH1. ....................................... 37 
Figure 1.11. Primary microcephaly mutations within ASPM, CDK5RAP2, CPAP, 
STIL, WDR62 and CEP152. ....................................................................................... 39 
Figure 1.11. Primary microcephaly mutations within ASPM, CDK5RAP2, CPAP, 
STIL, WDR62 and CEP152. ....................................................................................... 40 
Figure 1.12 Centriole duplication in C. elegans and higher organisms. .................... 44 
Figure 1.13. Functional conservation of proteins essential for procentriole formation.
 .................................................................................................................................... 45 
Figure 1.14. CDK5RAP2 in centriole linkage. .......................................................... 51 
Figure 1.15. Primary microcephaly proteins at the centrosome................................. 53 
Figure 1.16. PCC in blood cells of MCPH1 primary microcephaly patients. ............ 58 
Figure 1.17. Model of MCPH1 function .................................................................... 68 
Figure 3.1. Human microcephalin. ............................................................................. 99 
Figure 3.2. Expression of human MCPH1 FL, S and Δ8 transcripts. ...................... 100 
Figure 3.3. Immunoblot detection of MCPH1 FL and S isoforms. ......................... 102 
Figure 3.4. Targeted knockdown of MCPH1 isoforms by siRNA. .......................... 104 
Figure 3.5. Immunoblot detection of MCPH1 isoforms in MCPH1 patient-derived 
LBC. ......................................................................................................................... 106 
Figure 3.6. Expression patterns of MCPH1 isoforms in human tissue. ................... 108 
Figure 3.7. MCPH1 isoform levels during the cell cycle. ........................................ 110 
Figure 4.1. Localisation of MCPH1 isoforms during interphase. ............................ 116 
Figure 4.2. Centrosomal localisation of MCPH1 Δ8 during interphase. ................. 117 
Figure 4.3. Tetracycline-inducible gene expression system. ................................... 119 
Figure 4.4. Localisation of GFP-tagged MCPH1 FL during mitosis. ...................... 121 
Figure 4.5. Localisation of GFP-tagged MCPH1 isoforms during metaphase. ....... 123 
Figure 4.6. Analysis of kinetochore localisation of MCPH1. .................................. 125 
Figure 4.7. Localisation of GFP-MCPH1 FL to the centrosome during mitosis. .... 127 
Figure 4.8. Analysis of centrosomal localisation of MCPH1 fragments. ................ 128 
Figure 4.9. MCPH1-BRCT1 interacts with pericentrin and ϒ-tubulin. ................... 130 
Figure 4.10. Cell-cycle regulated localisation of kinetochore components. ............ 134 
Figure 5.1. MCPH1 isoform depletion by RNAi. .................................................... 138 
Figure 5.2 MCPH1 depletion by RNAi leads to mitotic spindle multipolarity. ...... 140 
Figure 5.3. MCPH1 depletion by RNAi leads to chromosome alignment defects. . 142 
14 
 
Figure 5.4. Live-imaging of MCPH1 depleted cells. ............................................... 144 
Figure 5.5. High cyclin-B1 levels are present in MCPH1 depleted cells. ............... 145 
Figure 5.6. Multipolar spindles arise due to fragmentation of PCM. ...................... 147 
Figure 5.7 Chromatids prematurely separate in MCPH1 deficient cells. ................ 148 
Figure 5.8. Characterisation of the Mcph1 gene-trap allele. .................................... 150 
Figure 5.9. MCPH1-deficient MEFs show chromosome alignment defects. .......... 152 
Figure 5.10. Hypothesis: primary microcephaly genes act in a centrosome maturation 
pathway. ................................................................................................................... 154 
Figure 5.11. Protein levels of PCNT, CDK5RAP2, ASPM and γ-tubulin are 
unaffected in MCPH1 and PCNT patient LBC. ....................................................... 155 
Figure 5.12. CPAP localisation and centriole number is not affected in MCPH1 
patient derived LBC. ................................................................................................ 156 
Figure 5.13. Recruitment of CDK5RAP2, PCNT and γ-tubulin are unaffected in 
MCPH1 patient derived LBCs. ................................................................................ 158 
Figure 5.14. Microtubule nucleation and focusing is not affected in MCPH1 patient 
derived LBC. ............................................................................................................ 160 
Figure 6.1. GFP-MCPH1 FL and Δ8 are cleaved. ................................................... 170 
Figure 6.2. GFP-MCPH1 FL and Δ8 are cleaved by a caspase dependent-mechanism.
 .................................................................................................................................. 172 
Figure 6.3. GFP-MCPH1 is cleaved after residue aspartate 625. ............................ 174 
Figure 6.4. MCPH1 is degraded in late mitosis and early G1 phase. ....................... 177 
Figure 6.5. MCPH1 is hyperphosphorylated during a prometaphase arrest. ........... 178 
Figure 6.6. Identification of MCPH1 phosphorylation sites by phosphopeptide 
mapping. ................................................................................................................... 179 
Figure 6.7. MCPH1 is phosphorylated by CDK1 during mitosis. ........................... 181 
Figure 6.8. MCPH1 is phosphorylated by PLK1 during mitosis. ............................ 183 
Figure 6.9. MCPH1 PLK1 and CDK1 phospho-dead and constitutively active 
mutants localise to the kinetochores. ....................................................................... 185 
Figure 6.10. MPH1 and PLK1 co-localise at the centrosomes and kinetochores 
during mitosis. .......................................................................................................... 186 
Figure 6.11. MCPH1 kinetochore localisation may be independent of CDK1 
phosphorylation. ....................................................................................................... 188 
Figure 7.1. Model of MCPH1 function in mitosis ................................................... 198 
Figure 7.2. Primary microcephaly proteins are required for accurate chromosome 
segregation. .............................................................................................................. 202 
Figure 7.3. Differentiation of immortalised human neural stem cells. .................... 206 








List of Tables 
 
Table 1.1. Relative brain size in selected animals ..................................................... 19 
Table 1.2. Primary microcephaly genes paralogues and orthologues ........................ 36 
Table 1.3. Summary of MCPH1 mutations ................................................................ 38 
Table 2.1.  Commonly used buffers ........................................................................... 71 
Table 2.2. Drug stock solutions ................................................................................. 72 
Table 2.3. Plasmids used in this thesis ....................................................................... 73 
Table 2.4. Gateway entry vectors created for this thesis............................................ 74 
Table 2.5 a. Gateway destination vectors created for this thesis ............................... 75 
Table 2.5 b. Gateway destination vectors created for this thesis ............................... 76 





















 ampicillin resistance 
APC/C anaphase  promoting complex or cyclosome 
bp base pair  
BRCT BRCA1 C-terminal 
BSA bovine serum albumin 
cDNA complementary DNA 
Cm
R
 chloramphenicol resistance 
CMV cytomegalovirus 
CT cycle threshold 
CHX cyclohexamide 
CNN1 centrosomin motif 1 
CNN2 centrosomin motif 2 
DAPI 4',6-diamidino-2-phenylindole 
DDR DNA damage response 
d.p.c days post coitum 
dH2O distilled water 
DMEM dulbecco's modified Eagle medium 
DMSO dimethyl sulfoxide 
DNA deoxyribonucleic acid 
DNAase deoxyribonuclease 
dNTP deoxyribonucleotide triphosphate 
DSB double strand break 
DTT dithiothreitol 
E embryonic day 
ECACC European cell culture collection 
EDTA ethylenediaminetetraacetic acid 
EGTA ethylene glycol tetraacetic acid 
EtOH ethanol 
EUCOMM European conditional mouse mutagenesis program 
17 
 
FCS fetal calve serum 
FL full-length 
kMT kinetochore-microtubule 
GFP green fluorescent protein 
HFB human fetal brain 
HR homologous recombination 
IR irradiation 
IRIF irradiation induced foci 
Kan
R




LBC lymphoblastoid cells 
M molar 
MEF mouse embryonic fibroblast 
mRNA messenger ribonucleic acid 
MOPD microcephalic osteodysplastic primordial dwarfism 
MOPS 3-(N-morpholino)propanesulfonic acid 
MRI magnetic resonance imaging 
MTOC microtubule organising centre 
NHEJ non-homologous end joining 
NMD nonsense mediated decay 
Noc nocodazole 
PTC premature termination codon 
NMD nonsense mediated decay 
OD optical density 
ORF open reading frame 
PBS phosphate buffered saline 
PCC premature chromosome condensation 
PCM pericentriolar material 




PIPES piperazine-N,N′-bis(2-ethanesulfonic acid) 
Purv A purvalanol A 
RNA ribonucleic acid 
RNase ribonuclease 
Rosc roscovitine 
RPMI Roswell park memorial institute medium 
RT reverse transcriptase 
qRT-PCR quantitative real time PCR 
S short 
SAC spindle assembly checkpoint 
s.d. standard deviation 
SDS sodium dodecyl sulphate 
s.e.m. standard error of the mean 
siRNA small interfering RNA 
ss single stranded 
SNP single nucleotide polymorphisms 




Tm melting temperature 
Tris tris(hydroxymethyl)aminomethane 
TuRC tubulin ring complex 
UB ubiquitin 












1.1. Brain development 
1.1.1. Evolution of the mammalian brain 
Most variation in brain size can be accounted for by differences in body weight 
(Jerison, 1973); as a general rule larger animals need larger brains to run their bodies. 
However, throughout mammalian and primate evolution there has been a 
disproportionate enlargement of the brain relative to body size (Northcutt and Kaas, 
1995). For example, there is a 15-fold increase in relative brain size between mouse 
and man (Table 1.1). Although brain size has increased during primate evolution, 
expansion of the brain has been most prominent in the human lineage, with a tripling 
in brain size in the 3 million years after humans diverged from apes (Jerison, 1973). 
This expansion of the brain reflects an increase in the total cell number rather than 
cell size (Table 1.1) but does not result from a uniform increase in cell number in all 
areas of the brain; instead different areas of the brain have expanded at different 
rates.  
 
Table 1.1. Relative brain size in selected animals 
Species Relative brain size (EQ) Neurons in brain 
Mouse             0.5 10
7
  
Monkey             2.09  10
9
 




Relative brain size data is given as encephalization quotient (EQ) and taken from (MacPhail, 
1982). Estimates of neuron number in the brain are taken from (Braitenberg, 2001). (Table 




1.1.2. Evolution of the mammalian cerebral cortex 
During mammalian evolution, it is the outer portion of the cerebrum, the cerebral 
cortex, which has expanded more in size than other areas of the brain (Finlay and 
Darlington, 1995; Northcutt and Kaas, 1995). This expansion has been through an 
increase in cortical surface area rather than cortical thickness (Rakic, 1995).  For 
example, the 1000-fold increase in cortical surface area from mouse to man is only 
accompanied by a 2-fold increase in cortical thickness (Rakic, 1995). This huge 
increase in cortical surface area has not been accompanied by a proportional increase 
in skull size; instead the surface of the brain forms a series of folds and convolutions, 
called gyri and sulci, to accommodate it within the skull. This has led to the 
progression of the smooth brains (lissencephalic) of rodents to one of multiple folds 
and convolutions in humans (gyrencephalic) (Figure 1.1). 
 
 
Figure 1.1 Comparison of the brain of a mouse, a macaque monkey and a human. The 
pictures are drawn to scale to demonstrate the actual difference in size. From mouse, 
macaque monkey to human brain there is a small increase in the thickness of the cortex 
(dark purple outline), a large expansion in surface area (1: 100: 1000 X respectively) and an 





1.1.3. Cell biology of cerebral cortex expansion  
The cell-biological basis of the enormous expansion of the cerebral cortex surface 
area without a comparable increase in thickness has been addressed by the radial unit 
hypothesis (Rakic, 1988; Rakic, 1995). To understand the radial-unit hypothesis we 
need to understand how the cerebral cortex develops (reviewed by Bystron et al., 
2008; Nowakovski and Hayes, 2005). The cerebral cortex forms from the neural 
progenitors present in the ventricular and sub-ventricular zone that line the lateral 
ventricles of the brain. It is within this zone that neurons are generated and migrate 
outwards to form the six different layers of the cerebral cortex 
(The_Bloulder_Committee, 1970). The earliest neurons generated populate one of 
the inner-most layers whereas the neurons generated later pass the earlier neurons to 
form the outer-most layer of the developing cortex (Angevine and Sidman, 1961; 
Rakic, 1974). The radial unit hypothesis states that each neuron generated by a single 
founder neural progenitor cell follows the same migratory path and so these cells 
stack radially contributing to the thickness of the brain. Each neuron generated by a 
different founder neural progenitor cell will follow a different migratory path and 
will arrange tangentially across the cortical plate leading to lateral brain expansion 
(Figure 1.2) (Rakic, 1988; Rakic, 1995). Thus, during evolution only an increase in 
the number of the founder neural progenitor cells could lead to expansion of the 






Figure 1.2. The model of radial neuronal migration. 
The neurons (MN) generated at the ventricular zone (VZ) migrate through the intermediate 
zone (IZ) to the cortical plate (CP). The neurons generated from the same site of origin but 
at different times form a radial stack of cells (E40-E100). Neurons generated from a 




The principles of the radial unit hypothesis have been tested experimentally by 
expanding the neuronal progenitor population in the rodent brain through either 
decreasing the rate of apoptosis or increasing the rate of neuronal proliferation. The 
rate of apoptosis was decreased by inactivating the components of programmed cell 
death, caspase 3 and 9 (Kuida et al., 1998; Kuida et al., 1996). The rate of 
proliferation was increased by overexpression of an active form of β-catenin which 
can influence the decision of neuronal precursor cells to re-enter the cell cycle 
instead of differentiating (Chenn and Walsh, 2002).  In all cases there was an 
increase in the number of precursor cells in the ventricular zone accompanied with 
lateral expansion of the cerebral cortex leading to the formation of an enlarged, 
folded cerebral cortex (Figure 1.3) (Chenn and Walsh, 2002; Kuida et al., 1998; 






Figure 1.3. Enlargement of the cortex surface area by decrease in apoptosis or increase in 
proliferative divisions. 
(A & B) Brain sections of a wild type mouse embryo (panel 1), an embryo deficient in 
caspase 9 (A, panel 2) or a transgenic mouse embryo expressing an activated form of β-
catenin (B, panel 2). (C) Diagrams showing how the increased number of progenitor cells 
can equate to an increase in cortical surface area and folding rather than cortical thickness. 





1.1.4. Neural progenitor cells  
The initial population of neuronal progenitor cells in the developing brain form the 
ventricular zone (The_Bloulder_Committee, 1970). These cells are initially thought 
to undergo rounds of symmetric cell divisions to produce two daughter cells also 
with neural progenitor cell fate thereby increasing the surface area and thickness of 
the ventricular zone (Caviness et al., 1995). At a particular developmental stage, E33 
in humans (Bystron et al., 2006) and E10 in mice (Garcia-Moreno et al., 2007), the 
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neural progenitor cells begin to switch to an asymmetric mode of division to produce 
one daughter cell that continues to proliferate and another which migrates out of the 
ventricular zone to become a neuronal cell or basal progenitor committed to neuronal 
cell fate (Chenn and McConnell, 1995; Iacopetti et al., 1999; Takahashi et al., 1995a; 
Takahashi et al., 1996). This switch from symmetric to asymmetric divisions is 
gradual and as cells progress through the period of neurogenesis the number of 
asymmetric divisions to symmetric divisions increases (Figure 1.4) (Takahashi et al., 
1996). Changes in the proportions of these divisions, especially during the early 
rounds of symmetric divisions, are likely to have a significant impact on final 
neuronal output and cortical surface area (Caviness et al., 1995). For example, seven 
extra symmetric divisions during this time could lead to a 1,000 fold increase in 
cortical surface area (Rakic, 2009).  
 
 
Figure 1.4. Symmetric versus asymmetric divisions during mouse neurogenesis.  
The ratio of symmetric proliferative divisions (red) and asymmetric neurogenic divisions 
(green) is altered over the course of mouse neurogenesis (embryonic day 11-17). 








1.1.5. Regulation of the number of neural progenitor cells 
The final number of neural progenitor cells is affected by changes to cell fate choice 
and cell survival. Each of these factors is described in detail below. 
1.1.5.1. Cell fate determination 
1.1.5.1.1. Apical and basal polarity 
The neuroepithelial cells and radial glia that populate the ventricular zone are 
polarised at the apical and basal axis, maintaining contact with the ventricular surface 
and basal lamina throughout the cell cycle (Gal et al., 2006; Hartfuss et al., 2003; 
Noctor et al., 2002). Neuroepithelial cells and radial glial can undergo symmetric or 
asymmetric divisions (reviewed by Huttner and Kosodo, 2005) and their apical and 
basal polarity is thought to impact on the mode of division of these cells (reviewed 
by Fietz and Huttner, 2010; Gotz and Huttner, 2005). The plasma membrane and 
associated cell cortex at the apical and basal poles are unique in composition 
(reviewed by Gotz and Huttner, 2005) and recently a number of associated proteins 
have been demonstrated to promote cell renewal and influence cell fate choice 
(reviewed by Fietz and Huttner, 2010). For example in mice, inheritance of the Par3 
constituent of the apical cell cortex (Bultje et al., 2009; Marthiens and ffrench-
Constant, 2009) has been shown to influence daughter cell fate choice, with 
overexpression of Par3 promoting proliferation and Par3 depletion leading to 
neurogenesis (Bultje et al., 2009; Costa et al., 2008). In addition, some of the 
receptors important in mediating attachment to the basal lamina, such as integrin β1 
and laminin α2 and α4 also promote progenitor cell fate (Radakovits et al., 2009).  
1.1.5.1.2. Spindle orientation and the segregation of cell fate 
determinants 
The distribution of the apical and basal membranes to the daughter cells is ultimately 
determined by the alignment of the mitotic spindle in relation to the apical-basal axis. 
The final spindle orientation is established during metaphase (Haydar et al., 2003); 
this specifies the position of the cytokinesis furrow (Rappaport, 1996) and the 
segregation of cell fate determinants to the daughter cells. Both the centrosome, 
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which nucleates microtubule asters, and some polarity determinants, that link the 
astral microtubules to the cell cortex, are required to correctly orientate the mitotic 
spindle (reviewed by Buchman and Tsai, 2007). 
 In Drosophila neuroblasts spindle pole orientation is important to actively control 
asymmetric cell divisions (reviewed by Gonczy, 2008; Knoblich, 2010). Early in the 
cell cycle one centrosome accumulates significant levels of pericentriolar material 
which enables it to nucleate a robust microtubule network and position the 
centrosome at the apical membrane (Figure 1.5). The second centrosome is devoid of 
PCM and moves through the cytoplasm until mitosis when it accumulates PCM and 
aligns at the basal membrane (Conduit and Raff, 2010; Januschke et al., 2011; 
Rebollo et al., 2007; Rusan and Peifer, 2007). In Drosophila, centrosome 
dysfunction (Basto et al., 2006; Giansanti et al., 2001; Lucas and Raff, 2007) or 
disruption of astral microtubules (Siller and Doe, 2008) leads to errors in the 




Figure 1.5. Asymmetric neuroblast divisions in Drosophila. 
(a) Normal asymmetric neuroblast division. One centrosome, with a significantly expanded 
PCM, nucleates a robust array of microtubules to position the centrosome at the apical 
cortex (green). The other centrosome with less PCM moves through the cell, until 
prometaphase when it accumulates PCM and becomes positioned at the basal cortex (red). 
Correct spindle orientation in relation to apical and basal cortex can be lost by (b) 
centrosome amplification (Basto et al., 2008), (c) loss of centrosomes (Basto et al., 2006) or 
disruption of astral microtubules (Siller and Doe, 2008) which can often lead to a symmetric 






In rodents, the centrosome and polarity determinants are thought to play a crucial 
role in the control of spindle pole orientation during symmetric divisions (Fietz and 
Huttner, 2010; Fish et al., 2008; Gotz and Huttner, 2005). In many invertebrate 
systems such as Drosophila embryonic neuroblasts the mitotic spindle oscillates by 
90° between symmetric and asymmetric divisions (Kaltschmidt et al., 2000). 
However in the mammalian cerebral cortex, horizontal cleavages have not been 
widely reported (Estivill-Torrus et al., 2002; Landrieu and Goffinet, 1979; Silva et 
al., 2002; Smart, 1973). The mitotic spindle is usually vertical or nearly vertical and 
it is subtle changes in its orientation that is required to shift the plane of cell division 
from bisecting to bypassing the apical and basal membrane (Attardo et al., 2008; 
Fish et al., 2006; Kosodo et al., 2004). The apical and basal membrane comprise of 
only 1-2% of the total cell membrane (Kosodo et al., 2004) and so to ensure their 
equal segregation the positioning of the mitotic spindle has to be very precise. Loss 
of accuracy could lead to an increase in asymmetric divisions (Figure 1.6). Indeed in 
some cases disruption of the centrosome or microtubules did alter spindle orientation 
in neuronal progenitor cells correlating with a decrease in the progenitor cell 
population and increase in neuronal cell population thought to reflect an increase in 
asymmetric divisions (Feng and Walsh, 2004; Fish et al., 2006; Lizarraga et al., 
2010). In addition, a reduction in brain size was often reported (Feng and Walsh, 
2004; Lizarraga et al., 2010). However in contrast to these results, spindle orientation 
and plane of cytokinesis was altered in mouse neuronal progenitor cells depleted of 
polarity determinant LGN without affecting the progenitor population. Cells were 
displaced from the ventricular zone but continued to proliferate maintaining a normal 
rate of neuronal production and unperturbed brain size (Konno et al., 2008). Similar 
results were observed following depletion of LGN in neuroepithelium of chick 
embryo (Morin et al., 2007). These findings suggest that cell fate choice is set 
regardless of spindle positioning and apical basal membrane inheritance. Thus, 
further work is required to examine the precise role spindle orientation and 





Figure 1.6. Symmetric and asymmetric cell divisions of mouse neuronal progenitors.  
(a) During normal symmetric divisions the cleavage plane bisects the apical domain and 
basal process. (b) During asymmetric divisions the plane of division bypasses the apical or 
basal process leading to asymmetric inheritance of cell fate determinants into daughter 
cells. (c & d) Spindle orientation is affected if the centrosomes or microtubules are 
disrupted, in some cases leading to asymmetric cell divisions. (Figure adapted from Megraw 
et al., 2011) 
 
 
1.1.5.1.3. Centrosome asymmetry 
The centrosome pair that coordinate mitotic spindle pole orientation are not 
morphologically identical. Each centrosome consists of a pair of centrioles 
surrounded by PCM (reviewed by Azimzadeh and Bornens, 2007). One centrosome 
contains the mother centriole which is older than the other centrioles and contains 
unique structural appendages (Vorobjev and Chentsov Yu, 1982). Centrosome 
asymmetry is linked to cell fate choice in rodent radial glia. The centrosome, 
containing the oldest mother centriole is inherited by the radial progenitor cells 
whereas the centrosome containing the younger mother centriole is inherited by the 
differentiating cell (Wang et al., 2009). Disrupting the unique appendages required 
for the mother centriole to mature, led to a reduction of the progenitor cell population 
linking centriole maturation to cell fate choice (Wang et al., 2009). 
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Mechanistically it is unclear how centriole age could specify cell fate and a number 
of hypotheses have been proposed (Stearns, 2009). One possibility is that the 
appendages of the oldest mother centriole enable this centrosome to nucleate a more 
robust network of microtubules allowing accumulation of proteins that influence cell 
fate (Fuentealba et al., 2008; Jakobsen et al., 2011). Alternatively, the oldest mother 
centriole may be mediating an effect via the primary cilium; a microtubule based 
hair-like structure that emanates from most mammalian cell‟s surface. Primary cilia 
are also present in apical domains of neural progenitors and can act as a sensory 
organelle to transduce signals from the environment into the cell to regulate the 
proliferation and specification of these cells (reviewed by Lee and Gleeson, 2011; 
Louvi and Grove, 2011). The age of the mother centriole determines the timing of 
cilia formation in the two daughter cells following cell division (Anderson and 
Stearns, 2009). The cell that harbours the older mother centriole generates its 
primary cilium before its sister cell and as a result the two cells may differ in their 
response to extrinsic signals which may influence cell fate choice.  
Centrosome asymmetry has also been reported in Drosophila stem cells. In the 
germline cells of male Drosophila the mother centrosome is always retained in the 
stem cell (Yamashita et al., 2007). In Drosophila neuroblasts it is the younger 
daughter centrosome that is maintained in the stem cell and the mother centrosome is 
inherited into the neuroblast (Conduit and Raff, 2010; Januschke et al., 2011). Thus, 
centrosome asymmetry may be a conserved feature of polarised stem cells. 
1.1.5.1.4. Cell cycle length hypothesis 
In the developing cerebral cortex the transition from proliferative to neurogenic cell 
divisions is accompanied by an increase in cell cycle length (Takahashi et al., 
1995b). Specifically, this is due to a lengthening of G1 phase, all other cell cycle 
phases remain unchanged (Takahashi et al., 1995b). Rather than a uniform change in 
cell cycle length of all cortical progenitor cells undergoing proliferative or 
neurogenic divisions (Cai et al., 1997) it was established that it was the neurogenic 
subpopulation that had a significantly longer cell cycle than the proliferative 
population (Calegari et al., 2005).  
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There are concerted mechanisms that control G1 length and cell fate choice. 
Mitogenic factors such as bFGF can lead to a decrease in G1 length whereas 
differentiation promoting factors such as NT3 can lead to an increase in G1 length 
(Lukaszewicz et al., 2002). Recent evidence has now convincingly demonstrated a 
causal relationship between cell cycle length and cell fate choice. Overexpression of 
CDK4/cyclin D1 or forced expression of cyclin D1 or E1 can shorten the length of 
G1 phase, increasing the proportion of proliferative divisions during neurogenesis 
(Lange et al., 2009; Pilaz et al., 2009). In addition knockout of cyclin D2 in mouse 
could lengthen G1 phase leading to the opposite effect with a reduction in the 
progenitor population (Glickstein et al., 2009)  
How could an increase in the length of G1 phase promote neurogenic divisions? One 
possible answer to this question has been addressed by the cell cycle length 
hypothesis (Calegari and Huttner, 2003). This hypothesis is based on the idea that 
cell fate is influenced by extrinsic and intrinsic factors, such as mitogenic and 
differentiating signals, that often exert their influence during G1 phase of the cell 
cycle (Baek et al., 2003). The length of the cell cycle corresponds to a window of 
increased sensitivity to these factors and they may only induce a certain cell fate if 
allowed to function for a sufficient length of time. In a short G1 phase, cell fate 
determinants do not have sufficient time to induce differentiation and so both 
daughter cells maintain progenitor cell fate. If the G1 phase is longer, cell fate 
determinants may be able to induce differentiation in one but not the other daughter 
cell. The unequal exposure to cell fate determinants may depend on cell intrinsic 





Figure 1.7. The cell-cycle length hypothesis.   
A neurogenic cell-fate determinant is distributed unequally to daughter cells A and B (60% 
and 40% respectively). In a short G1 phase length (time unit 1) both daughter cells will 
proliferate. An intermediate time in G1 phase (time unit 2), daughter cell A will become a 
neuron and B will become a progenitor cell. At the longest G1 length (time unit 3) both cell 
A and B will become neurons. (Figure reproduced from Gotz and Huttner, 2005) 
 
1.1.5.1.5. Cilia and cell cycle length 
Recently a link between cilia and the control of cell cycle length has been 
established. Cilia formation is cell cycle regulated process that occurs in quiescent 
(G0) cells and is reabsorbed as cells re-enter the cell cycle (reviewed by Pan and 
Snell, 2007). Recently it has been demonstrated that the cilia can actually influence 
the timing of cell cycle entry. Two interacting proteins of the microtubule motor 
protein dynein, NDE1 and TCTEX-1, that control cilia length and reabsorption 
respectively also influence the timing of progression into S-phase of the cell cycle in 
a cilia dependent manner (Kim et al., 2011; Li et al., 2011). The cell cycle-length 
hypothesis (Section 1.5) predicts changes to the length of G1 phase would affect cell 
fate choice during neuronal development. Indeed, Tctex-1 knockdown in mouse 
(which led to increased time in G1 phase) induced premature neuronal differentiation 
and overexpression of T94E variant TCTEX-1 (which led to an increase in S-phase) 
induced loss of neuronal differentiation (Li et al., 2011). 
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1.1.5.2. Apoptosis  
In addition to the mode and rate of cell divisions, the survival of the neuronal 
progenitor cells is also an important factor determining the size of the progenitor 
population. Widespread neuronal cell death does occur during fetal development 
(Haydar et al., 1999; Thomaidou et al., 1997) and perturbation of this process can 
greatly increase brain size. For example, inactivation of caspase 3 or caspase 9 (two 
of the effectors of apoptosis) decreases apoptosis of the progenitor cell population 
resulting in an enlarged cerebral cortex with an increased surface area (Kuida et al., 
1998; Kuida et al., 1996). Conversely, activation of Notch and Ephrin A signalling 
leads to an increase in apoptosis, a reduction in the progenitor population and cortical 
size (Depaepe et al., 2005; Yang et al., 2004). The dramatic changes in cortical 
surface area observed by increasing or decreasing the rate of apoptosis is consistent 
with the principles of the radial-unit hypothesis (Figure 1.8) (Rakic, 1988) 
implicating apoptosis as a potential evolutionary regulator of cerebral cortex size.   
 
Figure 1.8. Effect of apoptosis on progenitor cell population and final brain size. 
This model illustrates how changes to the rate of programmed cell death during the 
symmetric divisions of the neuronal progenitor cell population in the ventricular zone (VZ) 
can have a dramatic effect on the number of radial columns at the cerebral cortex (CC). This 
results in surface expansion of the cerebral cortex without changes in thickness (panel 2). In 
contrast, changes to the rate of programmed cell death during asymmetric divisions would 
affect the number of neurons within a radial column changing the thickness but not surface 





During human evolution there has been expansion of the cerebral cortex. This 
reflects lateral expansion of the cerebral cortex likely to be caused by an increase in 
the neuronal progenitor cell population. Expansion of the neuronal progenitor 
population could be accomplished by changes to cell survival or cell fate choice. 
Some of the proteins that play a role in these processes have been identified through 
mouse models or evolutionary studies but many of the proteins that play a role in 
brain size are unknown. Another way to identify candidate regulators of brain size is 
through the study of genetic neurodevelopmental disorders of brain size. 
 
1.2. Autosomal recessive primary microcephaly 
1.2.1. The clinical phenotype of primary microcephaly  
Microcephaly is characterised by a reduced head circumference, at least 3 standard 
deviations below the age and sex-related mean (Ross and Frias 1977). Head 
circumference is used as a proxy measurement of brain size as the skull also enlarges 
concomitantly with brain growth. Thus the underlying cause of microcephaly is 
reduced growth of the brain. 
 Microcephaly can be caused by environmental and maternal factors such as maternal 
alcohol consumption during pregnancy or congenital toxoplasmosis (Cowie, 1960). 
In the absence of environmental and maternal factors genetic factors are considered 
(Bundey, 1992; Qazi and Reed, 1973).  Primary microcephaly is a genetic disorder in 
which microcephaly occurs in isolation without any other malformations (Ross, 
1977).  
Primary microcephaly patients present with a significantly reduced head 
circumference at birth (Roberts et al., 2002). Neuroimaging shows that there is a 
significant reduction in brain volume with size of the cerebral cortex most 
significantly affected (Figure 1.9)(Bond et al., 2002). Consistent with the small size 
of the brain, some reduction in the volume of white matter and simplification of the 
gyral patterning is evident (McCreary et al., 1996). In most cases, the architecture of 
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the brain is normal suggesting that defects in neuronal migration are unlikely (Bond 




Figure 1.9. Neuroimaging of primary microcephaly patient.  
Axial (A & B) and sagittal (C & D) magnetic resonance images (MRI) of primary microcephaly 
patient (A & C) and an unaffected individual of similar age and sex (B & D). The primary 
microcephaly patient shows significant reduction in the size of the cerebral cortex and 
simplification of the cerebral cortex gyral patterning. (Figure reproduced from Bond et al., 
2002). 
 
All patients with primary microcephaly present with mental retardation (mild to 
severe) but do not show progressive decline in cognitive abilities or significant 
neurological deficits (Roberts et al., 2002). Mild seizures have been reported in 
several cases (Darvish et al., 2010; Passemard et al., 2009; Shen et al., 2005). 
Primary microcephaly is considered primarily a disorder of brain growth and usually 
normal height and weight are reported. However in some cases a reduction in height 
can occur but it is not as marked at the degree of microcephaly (Darvish et al., 2010; 
Passemard et al., 2009; Trimborn et al., 2004).  
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1.2.2. Primary microcephaly, Seckel and MOPD-II 
The extensive characterisation of primary microcephaly patients in recent years has 
broadened the phenotypic spectrum and it has become clear that there is overlap with 
primordial dwarfism disorders such as Seckel syndrome and microcephalic 
osteodysplastic primordial dwarfism-type II (MOPD-II) (Majewski and Goecke, 
1982). Both Seckel syndrome and MOPD-II have microcephaly of similar severity to 
primary microcephaly but are accompanied with substantially, usually proportionate, 
short stature. Patients diagnosed with MOPD-II additionally present with distinct 
skeletal abnormalities which differentiate it from Seckel syndrome (Hall et al., 
2004). The molecular genetics of these disorders has highlighted the phenotypic 
relationship as Seckel syndrome and primary microcephaly share some disease 
causing genes (Section 1.2.5.2).  
1.2.3. The primary microcephaly genes 
Primary microcephaly is a rare autosomal recessive genetic disorder with incidence 
estimates ranging from 1/30,000 to 1/250,000 in different populations (Komai et al., 
1955; Van Den Bosch, 1959). It is genetically heterogeneous and currently seven 
causative genes have been identified: encoding MCPH1 (Jackson et al., 2002), 
WDR62 (Bilguvar et al., 2010; Nicholas et al., 2010; Yu et al., 2010), CDK5RAP2 
(Bond et al., 2005), CEP152 (Guernsey et al., 2010), ASPM (Bond et al., 2002), 
CPAP (Bond et al., 2005) and STIL (Kumar et al., 2009). Further genetic 
heterogeneity is likely to exist since at least 30% of primary microcephaly families of 
Pakistan, Indian and Iranian ethnicity do not show linkage to any of the seven loci 
identified (Darvish et al., 2010; Gul et al., 2006; Kumar et al., 2004; Roberts et al., 
2002) . 
1.2.4. Paralogues and orthologues of primary microcephaly 
proteins 
Orthologues and paralogues of the primary microcephaly genes have been identified 
(Table 1.2). One potential explanation to account for brain specific phenotype in 
primary microcephaly patients is the existence of paralogues in humans that can 
supply functional redundancy in all tissues except the brain (first proposed in (Bond 
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and Woods, 2006). Indeed characterised paralogues exist for CDK5RAP2, WDR62 
and CPAP, namely myomegalin, MAPKBP1 and TCP10 respectively (Hung et al., 
2000; Nicholas et al., 2010; Verde et al., 2001). In addition potential paralogues for 
CEP152, ASPM and CPAP have also recently been identified (Megraw et al., 2011). 
Further work to determine if there are differences in tissue expression and functional 
redundancy between primary microcephaly proteins will substantiate this hypothesis.  
 
Table 1.2. Primary microcephaly genes paralogues and orthologues 
Gene Other names Paralogues                     Orthologues 
   D. melanogaster C. elegans 
MCPH1 BRIT1 None Mcph1 W04A8.1? 
WDR62     - MAPKBP1 CG7337 H24G06.1 
CDK5RAP2 CEP215 Myomegalin Centrosomin (Cnn) SPD-5? 
CEP152     - C10orf118 Asterless (Asl) None 
ASPM     -                hSif1 Abnormal spindle (Asp) ASPM-1 
CPAP CENPJ TCP10 dSas4 SAS-4 
STIL SIL None Ana2 SAS-5 
     
 
1.2.5. The mutations in primary microcephaly genes 
In this section I describe the mutation spectrum for each primary microcephaly gene 
and make predictions on the potential effect these mutations have on the proteins 
they encode (Section 1.2.5). I then address the evolution of these genes (Section 
1.2.6) and describe the function of each of the primary microcephaly proteins 







Microcephalin (MCPH1) is the focus of this thesis and so the MCPH1 mutations 
causative of primary microcephaly is described in detail. MCPH1 is a 14 exon gene 
that encodes an 835 amino acid protein with 3 BRCA1 C-terminal domains (BRCT) 
(Jackson et al., 1998). The 13 reported MCPH1 mutations comprise of nonsense 
mutations, large deletions and missense mutations (Summarised in Figure 1.10 and 
Table 1.3) (Alderton et al., 2006; Darvish et al., 2010; Jackson et al., 2002; Leung et 




Figure 1.10. Primary microcephaly mutations in MCPH1.  
The type and location of MCPH1 mutations are represented on a schematic of the MCPH1 
gene and protein. Exons are depicted as blue boxes and BRCT protein domains are 
represented by the purple boxes. (Original data from Alderton et al., 2006; Darvish et al., 













Table 1.3. Summary of MCPH1 mutations 
Gene mutation Predicted protein effect Reference 
c. 74C>G                 S25X (Jackson et al., 2002) 
c. 80C>G                 T27R (Trimborn et al., 2005) 
c. 147C>G                 H49E (Darvish et al., 2010) 
c. 149T>G/151A>G            V50G/ I51V (Leung et al., 2011) 
c. 215C>T                 S72L (Darvish et al., 2010) 
c. 427InsA                 143fs (Alderton et al., 2006) 
c. 436+1G>T               splicing (Darvish et al., 2010) 
c. 566InsA                N189fs (Darvish et al., 2010) 
c. del exon 3       Truncated protein (Darvish et al., 2010) 
c. del exon 2-3       Truncated protein (Darvish et al., 2010) 
c. del exon 4       Truncated protein (Darvish et al., 2010) 
c. del exon 1-6      No protein product (Darvish et al., 2010) 
c. del exon 1-8      No protein product (Leung et al., 2011) 
 
 
The presence of large homozygous genomic deletions in conjunction with multiple 
frameshift mutations suggest that complete loss of function of MCPH1 can cause 







 mutations lacked 
detectable MCPH1 protein (Alderton et al., 2006; Leung et al., 2011; Tibelius et al., 
2009).  
The highly conserved BRCT1 domain may be a functionally critical domain since all 
four missense mutations are clustered here and a truncated MCPH1 protein missing 
some of this domain has been reported in a primary microcephaly patient (Figure 
1.10) (Darvish et al., 2010; Leung et al., 2011; Trimborn et al., 2005). Further 
investigation into the consequences of these missense mutations on the protein they 







1.2.5.2. Other primary microcephaly genes 
The mutations identified in the other primary microcephaly genes are summarised in 
Figure 1.11. 
 
    
Figure 1.11. Primary microcephaly mutations within ASPM, CDK5RAP2, CPAP, STIL, 
WDR62 and CEP152.  
Schematic representation of primary microcephaly genes (A) ASPM (B) CDK5RAP2 (C) CPAP 
(D) STIL (E) WDR62 (F) CEP152. The exons are depicted by blue boxes with substantially 
larger exons expanded. Protein domains are represented by the purple boxes. The position 
and type of mutation causative of primary microcephaly are shown next to the gene and 
protein. Mutations leading to severe cortical malformations (E) and Seckel syndrome (F) are 
also represented. (Original data from Bhat et al., 2011; Bilguvar et al., 2010; Bond et al., 
2002; Bond et al., 2005; Bond et al., 2003; Darvish et al., 2010; Guernsey et al., 2010; Gul et 
al., 2006; Kaindl et al., 2010; Kalay et al., 2010; Kumar et al., 2004; Kumar et al., 2009; 
Muhammad et al., 2009; Nicholas et al., 2010; Nicholas et al., 2009; Saadi et al., 2009; Shen 
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From investigating the primary microcephaly mutation spectrum (Figure 1.11) and 
that of allelic disorders a number of interesting observations can be made.  
1) The presence of a large number of homozygous frameshift mutations dispersed 
throughout the ASPM gene and a homozygous genomic deletion of exon 2-13 
(Nicholas et al., 2009) suggests primary microcephaly can be caused by complete 
loss of ASPM protein (Figure 1.11A)(Bond et al., 2002; Bond et al., 2003; Darvish 
et al., 2010; Gul et al., 2006; Kumar et al., 2004; Muhammad et al., 2009; Nicholas 
et al., 2009; Saadi et al., 2009; Shen et al., 2005).  
2) The frameshift mutations identified in CDK5RAP2 and CPAP are also likely to 
lead to be null alleles; however only a few mutations have been reported per gene 
and identification of more mutations would substantiate this hypothesis (Bond et al., 
2005) (Figures 1.11B & C).  
3) The frameshift mutations identified in STIL may encode a truncated protein as 
STIL mutant transcripts would contain a premature terminating codon (PTC) in the 
last exon of the gene which may not be targeted for nonsense mediated decay (NMD) 
(Figure 1.11D)(Kumar et al., 2009). In addition the splicing mutation reported for 
STIL may also be hypomorphic through a combination of exon skipping which is 
common for this type of mutation (Al-Dosari et al., 2010).  
4) The mutation spectrum of WDR62 reveals a general correlation between missense 
mutations, possibly causing partial loss of protein function, resulting in primary 
microcephaly and frameshift mutations, leading to complete loss of protein function, 
resulting in a more severe phenotype with cortical malformations (Figure 1.11E) 
(Bhat et al., 2011; Bilguvar et al., 2010; Nicholas et al., 2010; Yu et al., 2010). 
Similarly there may be some association between hypomorphic CEP152 missense 
mutations and primary microcephaly (Guernsey et al., 2010) and more severe 
frameshift mutations with Seckel syndrome (Figure 1.11F)(Kalay et al., 2010).  
5) Homozygous missense mutations have been identified in ASPM and CPAP which 
may pinpoint functionally critical domains (Figure 1.11A and C) (Bond et al., 2005; 
Darvish et al., 2010). 
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1.2.6. Adaptive evolution of the primary microcephaly genes 
Primary microcephaly leads to a brain volume comparable in size to early hominids 
(Wood and Collard, 1999). Thus, through the primary microcephaly phenotype, loss 
of function of any of the primary microcephaly proteins has been implicated in the 
determination of brain size. It is tempting to speculate that gain of function 
evolutionary changes to the primary microcephaly genes may partly underlie changes 
in brain size during evolution.  
Significantly, evolutionary studies of MCPH1, ASPM, CDK5RAP2 and CPAP genes 
have demonstrated that they have undergone a period of positive selection during 
primate evolution (Evans a et al., 2004; Evans b et al., 2004; Evans et al., 2006; 
Wang and Su, 2004). MCPH1 and ASPM genes have been suggested to have 
continually responded to positive selection during the evolution of modern humans 
(Evans et al., 2005; Mekel-Bobrov et al., 2005). However these findings have been 
widely disputed (Currat et al., 2006; Timpson et al., 2007; Yu et al., 2007) and it was 
argued that demographic effects of population growth could also explain these 
observations (Currat et al., 2006). In addition numerous studies had not found a 
meaningful association between the human MCPH1 and ASPM haplotypes, 
reportedly associated with evolutionary selection, brain size or IQ (Dobson-Stone et 
al., 2007; Mekel-Bobrov et al., 2007; Rushton et al., 2007; Timpson et al., 2007; 
Woods et al., 2006).  
However, recently it has been demonstrated that some of the MCPH loci can 
contribute to variation in brain size and structure adding weight to these evolutionary 
findings.  Two studies found an association between single nucleotide 
polymorphisms (SNPs) in MCPH1, ASPM or CDK5RAP2 loci and variation in brain 
size (Rimol et al., 2010; Wang et al., 2008). The studies of Rimol et al. (2010) and 
Wang et al. (2008) considered a larger number of SNPs, many of which were located 




1.3. Function of primary microcephaly proteins  
The primary microcephaly proteins play a role in a diverse range of functions. Here 
we focus on describing the functions of the primary microcephaly proteins in 
processes such as mitosis, cell cycle progression and checkpoint control that could 
impact neurogenesis. The focus of this thesis, MCPH1, is described in Section 1.5. 
1.3.1. STIL, CPAP and CEP152- regulators of centriole 
duplication  
1.3.1.1. Centriole duplication 
The centrosome is composed of two cylindrical structures called centrioles 
surrounded by pericentriolar material (PCM) (reviewed by Azimzadeh and Bornens, 
2007). The walls of centrioles are constructed of nine sets of microtubules arranged 
in a radially symmetric manner highly conserved among all species (reviewed by 
Azimzadeh and Marshall, 2010; Marshall, 2009). The centrioles are essential for the 
duplication of the centrosome, which occurs mainly during S phase of the cell cycle. 
At this stage, the two centrioles separate and a daughter centriole assembles at the 
proximal ends of each centriole (Chretien et al., 1997; Kuriyama and Borisy, 1981; 
Vorobjev and Chentsov Yu, 1982). The initial structure used to build the daughter 
centriole can vary between species.  In C. elegans, the earliest detectable structure is 
a central tube; microtubules assemble around its circumference to form the mature 
centriole (Figure 1.12A) (Pelletier et al., 2006). In higher organisms, such as 
Drosophila and vertebrates, a cartwheel structure comprised of nine radial spokes 
projecting from a central hub is initially formed and microtubules assemble around 
this (Figure 1.12B) (Anderson and Brenner, 1971; Cavalier-Smith, 1974; Guichard et 






Figure 1.12 Centriole duplication in C. elegans and higher organisms. 
(A) Schematic of procentriole formation in C. elegans. A central tube is formed 
perpendicular to the wall of the mother centriole. Nine microtubules assemble around the 
central tube as it increases in length. The central tube remains part of the daughter 
centriole. (B) Schematic of procentriole formation in higher organisms. A cartwheel 
structure is formed consisting of nine radial spokes emanating from a central hub. 
Microtubules assemble around the cartwheel and it increases in length. The cartwheel 
structure can be lost or remain in the daughter centriole depending on the species. (Figure 
reproduced from Loncarek and Khodjakov, 2009). 
 
The process of centriole duplication is a highly ordered and well conserved sequence 
of events. The core components were initially identified in C. elegans by siRNA and 
mutation screens, this includes SPD-2 (Kemp et al., 2004; Pelletier et al., 2004), 
ZYG1 (O'Connell et al., 2001), SAS-5 (Delattre et al., 2004), SAS-6 (Leidel et al., 
2005) and SAS-4 (Leidel and Gonczy, 2003). These proteins are recruited in a 
specific order to assemble a procentriole (Figure 1.13A). SPD-2 and ZYG-1 are 
recruited prior to central tube formation and play a regulatory role in procentriole 
formation (Pelletier et al., 2006). SPD-2 and ZYG-1 recruit SAS-5 and SAS-6 which 
are required for central tube formation. Finally SAS-4 is recruited and is required for 
the addition of microtubules to the perimeter of the central tube (Pelletier et al., 
2006).  
Counterparts of all these proteins have been identified in other species such as 
Drosophila and humans and in most cases there is some functional conservation 
between species (Figure 1.13B). The only exception is SPD-2, although human and 
Drosophila orthologues exist they do not play an essential role in centriole 
duplication  (Dix and Raff, 2007; Giansanti et al., 2008; Gomez-Ferreria et al., 2007; 
Zhu et al., 2008). In Drosophila and humans there are also a few additional proteins 
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that play a role in procentriole formation that have not been identified in C. elegans 
(Dobbelaere et al., 2008; Goshima et al., 2007; Kleylein-Sohn et al., 2007). Very 
significantly, three primary microcephaly proteins are orthologues of these C. 
elegans proteins with conserved roles in centriole duplication.  
 
 
Figure 1.13. Functional conservation of proteins essential for procentriole formation.  
Proteins required for centriole duplication in C. elegans (A), Drosophila and humans (B). The 
proteins highlighted in red have functional orthologues in C. elegans, Drosophila and 




It has recently been demonstrated that the primary microcephaly protein STIL is 
orthologous to the C. elegans SAS-5 protein and Drosophila Ana2 protein (Stevens 
et al., 2010a). In C. elegans embryos SAS-5 is essential for centriole duplication 
(Delattre et al., 2004) and with SAS-6 is required to form the central tube, the first 
step in C. elegans procentriole formation (Pelletier et al., 2006). In Drosophila, Ana2 
plays a similar role in the early steps of centriole formation required with dSas6 to 
form the building blocks of the procentriole cartwheel structure (Stevens et al., 
2010b). In fact, overexpression of Ana2, Sak and dSas-6 in Drosophila 
spermatocytes is sufficient to drive formation of highly ordered structures resembling 
the inner cartwheel (Stevens et al., 2010b). The role of Ana2 in centriole duplication 
has been established from RNAi screens of S2 cells (Dobbelaere et al., 2008; 
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Goshima et al., 2007). Drosophila ana2 mutant flies have not been reported and so 
the role of Ana2 in fly development has not been established.  
It has not been definitively confirmed that STIL plays a role in centriole duplication 
in vertebrates but it appears likely that it is required for this process. In zebrafish loss 
of function of Stil is embryonic lethal. Embryos show evidence of a mitotic defect 
with disorganised mitotic spindles often lacking one or both centrosomes (Pfaff et 
al., 2007). It was also reported that Stil
-/-
 mouse embryonic fibroblast (MEF) cells 
often lacked detectable centrioles (Castiel et al., 2010). In addition, Stil mutant mice 
showed defects characteristic of aberrant cilia function, such as randomized left–right 
asymmetry and neural tube abnormalities which may be caused by a centriolar defect 
(Izraeli et al., 1999). In contrast, primary microcephaly patients with STIL mutations 
do not present with phenotypes characteristic of cilia defects (reviewed by Cardenas-
Rodriguez and Badano, 2009) consistent with our hypothesis that STIL mutations 
lead to a C-terminal truncation in humans rather than loss of function (Section 1.2.5). 
 
1.3.1.3. CPAP 
The primary microcephaly protein CPAP and its orthologues in Drosophila and C. 
elegans are required for centriole duplication (Basto et al., 2006; Kohlmaier et al., 
2009; Leidel and Gonczy, 2003). In humans, overexpression of CPAP leads to 
excessive lengthening of the parental and daughter centrioles (Kohlmaier et al., 
2009; Schmidt et al., 2009; Tang et al., 2009). Despite the extended centriolar 
structure, immunofluorescence and electron microscopy analysis demonstrated a 
morphology similar to genuine centrioles (Schmidt et al., 2009; Tang et al., 2009). 
Thus it was proposed that CPAP may be required to promote centriole elongation.  
In C. elegans SAS-4 plays a role in the later stage of procentriole formation required 
for the addition of microtubules around the periphery of the central tube (Pelletier et 
al., 2006). During human procentriole formation, the cartwheel structure is formed, 
microtubules are assembled and elongate (Figure 1.10). The first microtubule of the 
triplet is thought be nucleated from the γ-tubulin ring complex (γTuRC) assembled at 
the prximal end of the centriole (Guichard et al., 2010). Echoing the findings in 
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worm, CPAP may play a role in procentriole elongation by promoting recruitment 
and/or attachment of microtubules to the centriole. Indeed CPAP can interact with α 
and β tubulin dimers and possesses microtubule depolymerisation activity (Hung et 
al., 2004) which are essential for its role in centriole elongation (Tang et al., 2009). 
1.3.1.4. CEP152 
CEP152 has been identified as an additional centriole duplication factor in humans 
and Drosophila which has not been identified in worms. It is required early in the 
procentriole formation pathway and may play a similar regulatory role to SDP2 in C. 
elegans. 
In Drosophila the CEP152 orthologue, asterless (Asl), is required for centriolar 
duplication. Loss of Asl in Drosophila caused failure of centriole duplication with a 
reduction in the number of centrioles and centrosomes observed in mutant flies 
(Blachon et al., 2008; Dobbelaere et al., 2008). Asl functions early in the centriole 
duplication pathway where it appears to be acting as a molecular scaffold for Sak 
(ZYG-1 in C. elegans), necessary for its recruitment to the centriole and function in 
centriole duplication (Dzhindzhev et al., 2010). Similar to dSas4 flies, asl knockout 
flies do survive into adulthood but they exhibit characteristics of a cilia defect 
including uncoordinated movement (due to loss of mechanosensory function in 
neurons) and immotile sperm (Basto et al., 2006; Blachon et al., 2008).  
In vertebrates CEP152 also appears to be a critical component of the centriole 
assembly pathway. CEP152 morphilino depletion in zebrafish led to reduced cilia 
formation (Blachon et al., 2008). In humans, depletion of CEP152 by RNAi prevents 
normal centriole duplication and PLK4 (ZYG-1 in C. elegans and Sak in Drosophila) 
overexpression mediated centrosome amplification (Cizmecioglu et al., 2010; 
Dzhindzhev et al., 2010; Hatch et al., 2010). CEP152 functions early in the centriole 
assembly pathway, acting with PLK4 to initiate centriole formation and is required 
for CPAP and hSAS6 localisation to the centriole (Cizmecioglu et al., 2010; 
Dzhindzhev et al., 2010; Hatch et al., 2010). 
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1.3.1.5. Centrioles and PCM recruitment 
The centrioles act as a scaffold for the recruitment of PCM (Basto et al., 2006; 
Bobinnec et al., 1998; Conduit et al., 2010; Kirkham et al., 2003; Salisbury, 2003). 
Thus, the centriolar proteins such as CPAP, CEP152 and STIL may also play a role 
in establishing the size of PCM. Indeed a correlation between SAS-4 levels, centriole 
length and PCM size has been established in C. elegans (Kirkham et al., 2003) and a 
relationship between Asl (CEP152) and PCM incorporation into centrosomes has 
also been established in Drosophila (Conduit et al., 2010).  
1.3.1.6. STIL, CPAP and CEP152 in primary microcephaly 
STIL, CPAP and CEP152 or their orthologues play a key role in centriole biogenesis 
and it is likely that in their absence, centrioles and cilia would not be formed. Indeed, 
this is the case in dsas4 and asl Drosophila models (Basto et al., 2006; Dzhindzhev 
et al., 2010). It seems to be very unlikely that humans lacking centrioles and cilia 
would only present with a small brain and be otherwise phenotypically normal, 
especially considering the key role cilia plays in human development (Goetz and 
Anderson, 2010). Thus, it could be hypothesised that primary microcephaly patient 
mutations in STIL, CPAP and CEP152 only lead to partial loss of protein function. 
This possibility is consistent with the mutation spectrum of STIL and CEP152 
(Section 1.2.5.2.) and although complete loss of CPAP protein function was 









1.3.2. CDK5RAP2 maintains centrosome structure  
CDK5RAP2 appears to play a different role at the centrosome to CPAP, CEP152 and 
STIL. Whereas CPAP and CEP152 localise to the centrioles (Hatch et al., 2010; 
Kleylein-Sohn et al., 2007), CDK5RAP2 localises to the PCM surrounding the 
centrioles (Barrera et al., 2010; Fong et al., 2008) where it plays a key role in 
maintaining centrosome structure with a plethora of cellular phenotypes arising with 
its loss.  
1.3.2.1. CDK5RAP2 as a microtubule organiser 
CD5RAP2 belongs to the centrosomin family of proteins which are conserved from 
yeast to humans (Megraw et al., 2011). Centrosomin proteins are composed of two 
highly conserved domains, called centrosomin motifs 1 and 2 (CNN1 and CNN2) 
(Barr et al., 2010; Sawin et al., 2004; Zhang and Megraw, 2007). The CNN1 domain 
is required for γ-tubulin recruitment and/or tethering in S. pombe, Drosophila and 
humans (Fong et al., 2008; Sawin et al., 2004; Venkatram et al., 2004; Zhang and 
Megraw, 2007)  which is important to confer microtubule nucleation capacity and 
organisation (reviewed by Luders and Stearns, 2007). In humans, the CNN1 region 
of CDK5RAP2 is sufficient to interact with members of the γ-TuRC playing a direct 
role in its recruitment to the PCM (Fong et al., 2008). Independent of a role in γ-
TuRC tethering, the CNN1 domain of CDK5RAP2 can also act as a regulator of 
microtubule nucleation, required to stimulate microtubule nucleation of purified γ-
TURC (Choi et al., 2010).  
In Drosophila, Cnn plays a key role in assembling the PCM and is required for the 
recruitment of most PCM proteins tested during mitosis (Lucas and Raff, 2007; 
Megraw et al., 1999; Vaizel-Ohayon and Schejter, 1999). In fact, only the depletion 
of Plk1 could equally perturb PCM protein recruitment and it is thought these two 
proteins could function together to initiate PCM maturation (Dobbelaere et al., 
2008).  
CDK5RAP2 does not appear to play such a key role in assembling the PCM. Modest 
decreases in levels of PCM proteins, such as pericentrin, CEP192 and NEDD1 were 
reported following CDK5RAP2 RNAi in HeLa cells (Haren et al., 2009) and a 
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reduction in AKAP450 was reported in chicken DT40 cells with loss of CNN1 or 
CNN2 domain (Barr et al., 2010). This difference in phenotype between Drosophila 
and mammals may be due to the CDK5RAP2 mammalian paralogue myomegalin 
which also localises to the centrosome (Shimada et al., 2007; Verde et al., 2001) and 
may function redundantly with CDK5RAP2 partially compensating for its loss (Bond 
and Woods, 2006). It would be interesting to establish if depletion of CDK5RAP2 
and myomegalin would lead to a similar phenotype as loss of Cnn.  
1.3.2.2. CDK5RAP2 in centrosome structure 
During the cell cycle, the centrosomes and centrioles undergo a number of 
conformational changes (reviewed by Azimzadeh and Bornens, 2007); CDK5RAP2 
appears to play an important role in maintaining appropriate structure in accordance 
with cell cycle stage.  In vertebrates, CDK5RAP2 plays a conserved role in 
maintaining cohesion between the two centrosomes until G2 phase of cell cycle. This 
finding was established in an RNAi screen of HeLa cells, Cdk5rap2
-/-
 MEFs and 
chicken DT40 cells, where loss of the CNN1 motif was sufficient to cause this 
phenotype (Barr et al., 2010; Barrera et al., 2010; Graser et al., 2007b). The primary 
cause of loss of cohesion is unclear. A fibrous protein linker, consisting of proteins 
such as rootletin and C-NAP1 (Bahe et al., 2005; Yang et al., 2006), is thought to 
link two parent centrioles to maintain centrosome cohesion (Figure 1.14) and may be 
disrupted due to loss of  CDK5RAP2 since parental centrioles were separated and 
displacement of rootletin was reported (Barrera et al., 2010). 
In addition to playing a role in centrosome cohesion, the CDK5RAP2 orthologue in 
mouse is also required to maintain centriole engagement between parent and 
daughter centriole (Barrera et al., 2010) (Figure 1.14). This premature centriole 
disengagement appears to licence further centriole duplication which leads to 
formation of excess centrioles and multipolar mitosis in Cdk5rap2
-/-
 MEFs (Barrera 
et al., 2010). Centriole engagement usually persists until anaphase of mitosis, a 
process regulated by the separase protein and PLK1 (Tsou and Stearns, 2006; Tsou et 




Figure 1.14. CDK5RAP2 in centriole linkage.  
The centriole parent (blue) and daughter (pink) are tightly bound in an engaged state. Each 
centriole pair is connected by protein linker (dotted line) which runs between the parental 
centrioles and maintains centrosome cohesion. Loss of cohesion and engagement occurs at 
G2 phase and anaphase respectively but can occur prematurely when CDK5RAP2 is 
depleted.  
 
CDK5RAP2 and Cnn also play a conserved role in tethering the centrosomes to the 
spindle pole during mitosis in chicken DT40 cells and Drosophila embryos (Barr et 
al., 2010; Lucas and Raff, 2007). In chicken, both the CNN1 and CNN2 are required 
for this function (Barr et al., 2010). It has been proposed that CDK5RAP2 may 
function in this process through its role in recruitment of AKAP450 (Barr et al., 
2010). AKAP450 interacts with p150
glued
 (Kim et al., 2007): part of the NuMA-
dynein-dynactin complex required to link the centrosome to spindle pole (Merdes et 
al., 1996; Silk et al., 2009).  
 
1.3.3. ASPM in mitotic microtubule nucleation and 
organisation  
ASPM plays a similar role to CDK5RAP2 in nucleation and organisation of the 
spindle microtubules. ASPM localises to the centrosome and minus end of 
microtubules during mitosis in Drosophila, C. elegans, rodents and humans (do 
Carmo Avides and Glover, 1999; Fish et al., 2006; van der Voet et al., 2009; Zhong 
et al., 2005). Drosophila asp mutants (ASPM orthologue) have unfocused mitotic 
spindle morphology causing metaphase arrest in larval neuroblasts and maternal 
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effect lethal phenotype in syncytial embryo (Casal et al., 1990; Gonzalez et al., 
1990). Asp appears to be required for the organisation and aggregation of 
microtubules into spindle poles which it can achieve even in the absence of the 
centrosome (Morales-Mulia and Scholey, 2005; Wakefield et al., 2001).  In addition, 
Asp is required with γ-TuRC to restore microtubule nucleation capacity of salt 
stripped centrosomes in vitro, a function that requires Plk1 dependent 
phosphorylation (do Carmo Avides and Glover, 1999; do Carmo Avides et al., 
2001). It is likely that Asp performs this function by organizing the γ-TURC within 
the PCM to form a nucleating centre for microtubules but it is possible it could play a 
regulatory role in nucleation similar to CDK5RAP2 (Choi et al., 2010).  
In mice neuroepithelial cells, Aspm is required to promote symmetric cell divisions 
by maintaining spindle orientation in the correct position relative to the apical-basal 
axis (Fish et al., 2008; Fish et al., 2006). Interestingly Aspm is not required for the 
initial alignment of the spindle established during metaphase but it is required to 
maintain the orientation during anaphase and telophase (Fish et al., 2008; Fish et al., 
2006). A function in spindle positioning has also been reported for the ASPM 
orthologue in C. elegans, ASPM-1. ASPM-1 forms a complex with LIN-5 and CMD-
1 at the spindle pole which is required with the motor protein dynein to maintain the 
correct spindle rotation and positioning during C. elegans meiotic divisions (van der 
Voet et al., 2009).  
1.3.4. Summary 
The primary microcephaly proteins are required for a diverse range of functions at 
the centrosome. CPAP, CEP152 and STIL and orthologues belong to a conserved 
pathway of proteins required to initiate centriole duplication during G1 to S phase of 
the cell cycle. CDK5RAP2 plays an important structural role at the centrosome 
throughout the cell cycle and ASPM is required during mitosis to focus and nucleate 




Figure 1.15. Primary microcephaly proteins at the centrosome. 
Schematic of the centrosome cycle and stages each of the primary microcephaly proteins or 
orthologues play a functional role. 
 
1.3.5. Primary microcephaly proteins in cell cycle progression 
Some of primary microcephaly proteins also function in cell cycle progression. For 
example, ASPM and STIL appear to function as tumour promoters in certain cellular 
contexts. Proliferation of glioblastoma cells was associated with increased expression 
of ASPM (Hagemann et al., 2008). Increased expression of STIL was found in 
multiple cancers correlating with an increase in proliferation and metastatic potential 
(Erez et al., 2004; Ramaswamy et al., 2003). Consistent with this finding MEF cells 
lacking Stil are characterised by decreased proliferation showing slow growth and a 
low mitotic index (Castiel et al., 2010). Stil may be required for G2/M phase 
progression as it negatively regulates Chfr, an E3 ligase (Castiel et al., 2010), which 
can delay mitotic entry in response to stress (Matsusaka and Pines, 2004).  
1.3.6. WDR62 
WDR62 is the most recently identified primary microcephaly protein and so far little 
is known about its function. Wdr62 mRNA is expressed in the ventricular and 
subventricular zone of mouse neuroepithelium consistent with a role in proliferation 
(Bilguvar et al., 2010; Nicholas et al., 2010). Expression is high in the mouse 
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neuroepithelium during the period of neurogenesis then subsequently decreases as 
neurogenesis recedes. Consistent with wdr62 transcript levels WDR62 protein in 
mouse fetal brain showed similar expression patterns (Bilguvar et al., 2010).  
Similar to the other primary microcephaly proteins, WDR62 localises to the 
centrosome and spindle poles during mitosis. Indeed, WDR62 was identified as an 
interactant of the centrosomal protein CEP170 (Hutchins et al., 2010). At interphase 
WDR62 is cytoplasmic localising to the golgi apparatus (Nicholas et al., 2010; Yu et 
al., 2010). The spindle pole localisation of green fluorescent protein (GFP) tagged 
WDR62 was abrogated by recapitulating a patient missense mutation suggesting the 
pathogenicity of these mutations could be due to the absence of WDR62 from the 
spindle poles (Nicholas et al., 2010). Further studies of WDR62 will hopefully 
provide further insight into its function. 
1.4. The role of the primary microcephaly proteins in 
brain size determination 
1.4.1. Spindle orientation and cell fate choice  
The orientation of the mitotic spindle during neuronal progenitor cell divisions can 
affect the distribution of cell fate determinants to daughter cells and possibly their 
cell fate choice (Sections 1.1.5.1-2). Most of the primary microcephaly proteins 
function at the centrosome which has a conserved role in setting up spindle 
orientation relative to polarity cues (reviewed by Buchman and Tsai, 2007). Thus, 
through disruption of various centrosomal functions it is very possible that all of the 
primary microcephaly proteins could disrupt spindle orientation in neuronal 
progenitor cells. For instance, Drosophila, dsas-4 (CPAP), asl (CEP152) or cnn 
(CDK5RAP2) mutant flies show an increase in spindle misalignment with respect to 
cortical cues during asymmetric neuroblast divisions (Basto et al., 2006; Blachon et 
al., 2008; Giansanti et al., 2001). This caused increase in abnormal asymmetric larval 
neuroblast divisions resulting in failed cytokinesis or a symmetric division but did 




Likewise, in mouse neuronal progenitor cells acute depletion of Aspm or expression 
of a truncated form of CDK5RAP2 (Cdk5rap2
an
), lacking most of CNN1 domain, 
leads to an improperly aligned spindle with respect to the apical-basal axis (Fish et 
al., 2008; Fish et al., 2006; Lizarraga et al., 2010). This phenotype correlated with an 
expanded neuronal layer and decrease in progenitor pool which may be due to loss of 
symmetric divisions (Fish et al., 2006; Lizarraga et al., 2010).  
In addition the Cdk5rap2
an
 mouse has microcephaly of equivalent severity to primary 
microcephaly patients in certain genetic backgrounds (Lizarraga et al., 2010). A 
reduced brain size was not observed in a subsequent Cdk5rap2
-/-
 mouse published by 
Barrera et al. which led to the production of a truncated CDK5RAP2 protein most 
equivalent to that predicted for primary microcephaly patients (Barrera et al., 2010), 
a microcephaly phenotype could be strain dependent. Aspm mutant mice expressing 
truncated forms of Aspm also displayed mild microcephaly (Pulvers et al., 2010). 
However, in contrast to acute Aspm knockdown, this phenotype does not appear to 
be caused by changes to cell fate choice (Pulvers et al., 2010)  and may have 
alternative basis. 
1.4.2. Cilia and cell cycle length 
The primary microcephaly proteins localise to the centrosome and it is possible that 
they are required for the formation/ proper functioning of cilia. Depletion of many 
centrosomal proteins is sufficient to disrupt cilia and indeed asl, and dsas4 
Drosophila mutants or Sil knockout mice exhibited characteristics of a cilia defect 
(Basto et al., 2006; Blachon et al., 2008; Izraeli et al., 1999). Disruption of cilia may 
affect the cells response to environmental signals or change cell cycle length, both of 
which could lead to cell fate choice changes (Han and Alvarez-Buylla, 2010; Kim et 
al., 2011; Lee and Gleeson, 2011; Li et al., 2011; Louvi and Grove, 2011).  
1.4.3. Apoptosis  
In addition to cell fate choice, changes to cell survival could also affect final brain 
size (Section 1.1.5.2). One possibility is that the primary microcephaly proteins 
might be required to ensure proper chromosome segregation (first proposed by 
(Kouprina et al., 2004)). In rodents and humans, a surprising number of cerebral 
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cortical neurons are aneuploid arising due to defects in chromosome segregation 
(Kaushal et al., 2003; McConnell et al., 2004; Rehen et al., 2001; Rehen et al., 2005; 
Yang et al., 2003). Absence of any of the primary microcephaly proteins may reduce 
the fidelity of chromosome segregation causing a higher incidence of chromosome 
aneuploidy (Thompson and Compton, 2008) and possibly a decrease in cell fitness 
(Torres et al., 2008; Weaver et al., 2007). Consistent with this some of the primary 
microcephaly proteins or their orthologues, such as ASPM, CPAP and CDK5RAP2, 
are required for normal chromosome segregation and often cell survival (Cho et al., 
2006; Eppig and Barker, 1984; Higgins et al., 2010; Lizarraga et al., 2010; van der 
Voet et al., 2009). In addition, neuroblasts of asl Drosophila mutants also show 
increase in aneuploidy (Giansanti et al., 2001). The reduction in neuronal progenitor 
population reported in Cdk5rap2
an
 mouse embryos is also associated with an increase 
in chromosome missegregation and cell death which may also be a contributing 
factor to the microcephaly observed in these mice (Lizarraga et al., 2010).  
 
1.5. MCPH1 
MCPH1 was the first primary microcephaly protein to be identified in 2002 (Jackson 
et al., 2002). Of the seven primary microcephaly proteins now identified, MCPH1 
appears to play the most distinct role. Whereas functional studies of other primary 
microcephaly proteins have focused on characterising a centrosomal role, MCPH1 
functional studies have concentrated on other areas. Given this protein is the subject 
of this thesis, a comprehensive overview of all the functions of MCPH1 is provided.  
1.5.1 MCPH1 transcript expression 
MCPH1 transcript expression is consistent with a function in brain development. In 
situ hybridisation of Mcph1 in the fetal mouse brain demonstrated that Mcph1 is 
expressed during neurogenesis with high levels in the lateral ventricles (Jackson et 
al., 2002). In humans, RT-PCR detected MCPH1 expression in the fetal brain as well 
as other tissues such as liver and kidneys (Jackson et al., 2002).   
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Although MCPH1 expression is associated with cell proliferation during 
development, it is down-regulated in several types of human cancer such as ovarian 
and breast cancer (Rai et al., 2006; Rai et al., 2008) and it has been therefore 
suggested that MCPH1 could function as a tumour suppressor.  
1.5.2 MCPH1 protein and BRCT domains 
Microcephalin (MCPH1) is predicted to contain 3 BRCT domains one at the N-
terminus and two at the C-terminus (Figure 1.10) (Jackson et al., 2002). BRCT 
domains are common to many of the proteins involved in transducing DNA damage 
and cell cycle signals (Huyton et al., 2000). Members of this family include proteins 
that are required for DNA damage signal transduction such as BRCA1, 53BP1 and 
MDC1 and those directly involved DNA repair, such as XRCC1 and DNA ligase IV. 
Several studies have shown that the BRCT domains mediate protein–protein 
interactions, between BRCT domains in different proteins or more often between 
BRCT domain and proteins with a different structure (Glover et al., 2004). In 
particular, tandem BRCT domains contain a phospho-protein recognition domain 
(Manke et al., 2003; Yu et al., 2003) that may specifically result in the protein 
binding phosphorylation targets of the cell cycle and DNA damage pathway kinases. 
Roles for MCPH1 in cell cycle regulation and DNA repair have now been 
established by functional studies. 
1.5.3 MCPH1 in chromosome condensation 
Microcephalin plays a role in cell cycle timing by regulating the onset of 
chromosome condensation during mitosis. This function was initially identified when 
it was demonstrated that MCPH1 primary microcephaly is allelic to premature 
chromosome condensation (PCC) syndrome (Trimborn et al., 2004). Patients with 
PCC syndrome have the same clinical phenotype as primary microcephaly but also 
presented with abnormally condensed chromosomes (Neitzel et al., 2002). 
Cytogenetic analysis of primary microcephaly patients with MCPH1 mutations 






Figure 1.16. PCC in blood cells of MCPH1 primary microcephaly patients. 
Prophase like cells in peripheral blood lymphocytes of MCPH1 primary microcephaly 
patients (a) and patients with PCC syndrome (b) that also have mutations in MCPH1. (Figure 
reproduced from Trimborn et al., 2004). 
These prophase-like cells result from the early onset of chromosome condensation in 
G2 and late decondensation post mitosis (Neitzel et al., 2002; Trimborn et al., 2004). 
This PCC phenotype can also be recapitulated by RNAi mediated depletion of 
MCPH1 (Trimborn et al., 2004; Trimborn et al., 2006). The role of MCPH1 in 
chromosome condensation appears to be mediated through the condensin II complex 
which is required for mitotic chromosome assembly (reviewed by Nasmyth and 
Haering, 2005). RNAi-mediated depletion of condensin II subunits rescues the PCC 
phenotype in MCPH1 patient LBC or MCPH1 RNAi cells (Trimborn et al., 2006). 
MCPH1 interacts with condensin II subunit CAPG2 via residues 376–485 suggesting 
it may play a direct role in condensin II regulation. However, this interacting region 
is not required for the rescue of the PCC phenotype in Mcph1
-/-
 MEFs (Wood et al., 
2008). Instead the N-terminal BRCT1 domain is required to prevent PCC (Wood et 
al., 2008) and following the identification of the X-ray crystal structure of the N-
terminus of MCPH1 a hydrophobic pocket on the surface of the BRCT1 domain was 
identified as essential to this function (Richards et al., 2010). The MCPH1 BRCT 
domain does interact with the SET nuclear oncogene which has also been recently 
implicated in regulation of condensin II mediated chromosome condensation (Leung 




MCPH1 could also regulate condensin II function indirectly. The action of condensin 
II in prophase chromosome condensation is regulated during the cell cycle by CDK1 
mediated phosphorylation (Abe et al., 2011). CDK1 kinase activity is regulated 
during the cell cycle by post-translational modifications, for example interphase 
CDK1 is phosphorylated on T14 and Y15 resulting in inhibition of kinase activity 
(Mueller et al., 1995; Parker and Piwnica-Worms, 1992). MCPH1 LBC and Mcph1 
mutant Drosophila have reduced inhibitory tyrosine phosphorylation of CDK1 
(Alderton et al., 2006; Brunk et al., 2007) which could lead to aberrant activation. 
Indeed in MCPH1 LBC the level of pY15-CDK1 is nearly normal in G1 phase but 
drops in S and G2 phase temporally correlating with an increase in cells with PCC 
(Alderton et al., 2006). Thus it appears that through perturbing cell cycle timing 
MCPH1 can also affect condensin II-mediated chromosome condensation.  
It has been hypothesised that the role of MCPH1 in chromosome condensation may 
contribute to MCPH1 disease pathogenesis (Leung et al., 2011) since missense 
mutations affecting the BRCT1 domain (which is required for chromosome 
condensation) can lead to primary microcephaly (Darvish et al., 2010; Leung et al., 
2011; Trimborn et al., 2005). However, there have been no reports of abnormal 
chromosome condensation due to mutations of other primary microcephaly genes 
and so this is unlikely to be a shared pathway contributing to pathogenesis.  
1.5.4. MCPH1 in the DNA damage response 
1.5.4.1. ATM and ATR DNA damage response 
The ATM pathway primarily responds to double strand breaks in DNA caused by 
ionising radiation (Canman et al., 1998). Following DNA damage, the MRN 
complex, consisting of MRE11, RAD50 and NBS1, and ATM are rapidly recruited 
to sites of damage (reviewed by Lavin, 2007).The ATM protein then becomes fully 
activated and can phosphorylate downstream targets such as H2AX, BRCA1, 53BP1 
and CHK2 to coordinate cell cycle arrest and DNA repair (reviewed by Derheimer 
and Kastan, 2010; Li and Zou, 2005). 
Upon exposure to irradiation (IR), MCPH1 co-localizes with numerous proteins 
associated with the ATM damage response pathway such as NBS1, p-ATM, γH2AX, 
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MDC1 and 53BP1 (Jeffers et al., 2008; Lin et al., 2005; Rai et al., 2006; Xu et al., 
2004). MCPH1 is recruited to irradiation induced foci (IRIF) early in the ATM DNA 
damage response (DDR) depending only on H2AX for foci formation and 
independent of NBS1, ATM, MDC1, BRCA1 and 53BP1 (Jeffers et al., 2008; Wood 
et al., 2007).  H2AX may be directly required for MCPH1 recruitment to IRIF since 
both proteins can interact in vitro (Wood et al., 2007) possibly via the C-terminal 
tandem BRCT domains which are required for MCPH1 recruitment to sites of DNA 
damage (Jeffers et al., 2008; Wood et al., 2007). Depletion of MCPH1 in U20S cells 
impairs the recruitment of NBS1, ATM, MDC1 and 53BP1 to sites of irradiation (IR) 
induced DNA damage (Lin et al., 2005; Rai et al., 2006). However, contradictory 
results were published in MCPH1 patient LBC which do not show defective 
recruitment of NBS1 and 53BP1 in response to IR (Gavvovidis et al., 2010).  
 
MCPH1 is also implicated early in the ATR response after UV. Three complexes, 
RPA, ATR-ATRIP and 9-1-1 (RAD9, RAD1 and HUS1) are among the earliest 
response elements in this pathway (reviewed by Cimprich and Cortez, 2008; Flynn 
and Zou, 2011). UV results in an increase in single stranded DNA which is coated by 
replication protein A (RPA). The RPA coated ssDNA then recruits the ATR-ATRIP 
(Zou and Elledge, 2003) and plays an important role in localising the 9-1-1 complex 
(Ellison and Stillman, 2003; Majka et al., 2006; Zou et al., 2003). ATR can then 
phosphorylate downstream targets such as TOPBP1 and CHK1 to coordinate DNA 
repair and cell cycle arrest (reviewed by Li and Zou, 2005). Upon exposure to UV, 
MCPH1 localises to UV-induced foci and is required for the recruitment of ATR and 
RPA suggesting that MCPH1 may regulate the binding of RPA to damaged ssDNA 
(Rai et al., 2006).  
1.5.4.2 MCPH1 in cell cycle checkpoints 
Following DNA damage it is important to stall cell cycle progression until the 
damage is repaired. Checkpoints exist to delay cell cycle progression at the G1/S, S 
and G2/M phases of the cell cycle and these can be activated by the ATR and ATM 
pathway. The primary effector kinases of the ATR and ATM pathways are CHK1 
and CHK2 respectively which inactivate the CDC25 family of phosphatases 
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(CDC25A, B and C in humans) to prevent the removal of inhibitory CDK 
phosphorylations until the DNA damage is repaired (reviewed by Boutros et al., 
2006).   
The role of MCPH1 in the downstream integrity of the cell cycle checkpoints in 
response to ATM pathway activation is controversial. Knockdown of MCPH1 by 
siRNA in U2OS cells leads to a significant increase in cells showing failed S-phase 
and G2/M checkpoint arrest following IR (Lin et al., 2005; Xu et al., 2004). However 
LBC with truncating MCPH1 mutations (Gavvovidis et al., 2010), Mcph1
-/-
 chicken 
DT40 cells (Brown et al., 2010) and mcph1 mutant Drosophila larvae (Rickmyre et 
al., 2007) do not show deficient G2/M phase arrest following IR.  
These differences may be attributable to CHK1 and BRCA1 transcript and protein 
levels in the cell, which are decreased following MCPH1 RNAi (Lin et al., 2005; Xu 
et al., 2004; Yang et al., 2008) but unperturbed in MCPH1 LBC (Alderton et al., 
2006; Gavvovidis et al., 2010). CHK1 and BRCA1 are important regulators of S and 
G2/M checkpoint arrest (Liu et al., 2000; Sorensen et al., 2003; Xu et al., 2001) and 
so differences in protein levels may account for the discrepancies between RNAi and 
patient cells. It is possible that a decrease in CHK1 and BRCA1 levels only occur as 
an immediate response to acute MCPH1 depletion whereas cells adapt to genetic 
ablation of MCPH1 by upregulating redundant pathways to compensate for reduction 
in CHK1 and BRCA1 levels. 
Although the G2/M checkpoint was intact, the MCPH1 LBC and Mcph1
-/-
 DT40 cells 
did exhibit a delay in resolving H2AX foci and re-entering mitosis following IR 
(Brown et al., 2010; Gavvovidis et al., 2010). However rather than defective DDR, 
chromosome hypercondensation was proposed to account for both of these 
observations.  
MCPH1 does appear to be required for G2/M phase arrest in response to activation of 
ATR DDR by UV and replication interference. In LBC MCPH1 function was placed 
downstream of CHK1 regulating CDC25A stability (Alderton et al., 2006). DNA 
damage leads to CHK1 mediated phosphorylation of CDC25A targeting it for 
ubiquitination and subsequent degradation (Busino et al., 2003; Jin et al., 2003; Xiao 
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et al., 2003). CDC25A levels can trigger the G2/M phase checkpoints through 
regulation of CDK1-cyclin B activity (Boutros et al., 2006). In MCPH1 LBC 
CDC25A was aberrantly stabilised leading to a reduction of inhibitory 
phosphorylation of CDK1 and defective G2/M phase arrest (Alderton et al., 2006).  
1.5.4.3. DNA damage repair 
In addition to sensing DNA damage, MCPH1 is also involved in the repair process of 
double strand breaks (DSB). DSB can be repaired by two conserved pathways, 
homologous recombination (HR) and non-homologous end joining (NHEJ) 
(reviewed by Pardo et al., 2009). MCPH1 appears to play a role in both of these 
pathways. Using an HR repair analysis system, a defect in homologous 
recombination efficiency was demonstrated in Mcph1
-/-
 MEFS (Wood et al., 2008). 
Defective HR and NHEJ are also evident on RNAi depletion of MCPH1 (Peng et al., 
2009). The function of MCPH1 is also physiologically important playing a role in 
meiotic homologous recombination DNA repair in mice spermatocytes (Liang et al., 
2010). 
How does MCPH1 function in both these repair processes? It appears that MCPH1 
has a direct and indirect role in DSB repair. MCPH1 directly interacts with BRCA2 
and RAD51, two central components of HR. This binding is required for recruitment 
and/or retention of BRCA2/RAD51 complex at sites of DNA damage (Liang et al., 
2010; Wu et al., 2009). MCPH1 also plays an indirect role in the DSB repair 
processes via the regulation of chromatin structure, which is important to allow DDR 
proteins access to sites of DNA damage (Morrison et al., 2004; Tsukuda et al., 2005; 
van Attikum et al., 2004).  MCPH1 can modulate HR repair through Condensin II. 
MCPH1 interacts with condensin II and it is the condensin II binding region that can 
is required for MCPH1 HR function (Wood et al., 2008). It also plays a role as a 
regulator of the SWI/SNF chromatin remodelling complex. Following DNA damage, 
MCPH1 interaction with the SWI/SNF component BAF170 is increased due to 
ATR/ATM dependent phosphorylation of BAF170. This interaction appears to be 
required for relaxation of chromatin structure in MCPH1 deficient cells and access of 
repair proteins such as RAD51, phospho-RPA and KU70 to sites of DNA damage 
(Peng et al., 2009). Additional studies are required to establish if the role of MCPH1 
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in chromatin remodelling affects the recruitment of other DDR proteins such as 
ATM, ATR and NBS. 
1.5.4.4. Genomic stability 
MCPH1 is also required for genomic stability as expected from its functions in DDR 
and repair. Mcph1
-/-
 mice are hypersensitive to irradiation with a significantly 
reduced survival rate compared to wild-type animals. In addition MEFs and T 
lymphocytes isolated from Mcph1
-/- 
mice also showed an increase in chromosomal 
breaks in response to irradiation (Liang et al., 2010). Moderate radiosensitivity was 
also reported for Mcph1 null DT40 (Brown et al., 2010) and MCPH1-RNAi cells 
(Lin et al., 2005). 
1.5.4.5. Summary: MCPH1 in the DNA damage response 
In summary, multiple roles have been suggested for MCPH1 in the ATM and ATR 
DDR including sensing DNA damage, controlling cell cycle checkpoints and HR and 
NHEJ repair. Unfortunately, there is no unifying model of MCPH1 function in the 
DDR pathway and some conflicting data exists. In particular the role of MCPH1 in 
ATM response is unclear and results differ between chronic versus acute MCPH1 
depletion and type of mutation. The role of MCPH1 in chromatin remodelling does 
appear to account for some of the functions of MCPH1 in DDR detection and repair. 
It is also worth noting that the role of MCPH1 in the ATR response is consistent with 
the clinical phenotype of primary microcephaly patients which shows some 
phenotypic overlap with Seckel syndrome, a disorder associated with defective ATR 
signalling (Alderton et al., 2004; O'Driscoll et al., 2003). Defects in the ATM DDR, 
such as mutations in NBS1 and ATM result in Nijmegen breakage syndrome and 
ataxia teleangiectasia respectively (Savitsky et al., 1995; Varon et al., 1998). These 
disorders are characterised by defective response to IR, unusual sensitivity to X-rays 
and predisposition for malignancies (reviewed by Shiloh, 1997)  which have not been 
reported in MCPH1 primary microcephaly patients.  
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1.5.5 Transcriptional regulation  
As discussed in section 1.5.4.2, there is evidence to suggest that MCPH1 regulates 
the transcription of DDR genes, CHK1 and BRCA1, when acutely depleted (Lin et 
al., 2005; Xu et al., 2004; Yang et al., 2008). MCPH1 positive regulation of CHK1 
and BRCA1 is mediated through an interaction with the transcription factor E2F1 
(Yang et al., 2008). MCPH1 interacts with E2F1 via the BRCT2/3 domain; 
overexpression of this domain alone prevents MCPH1-E2F1 interaction and inhibits 
the role of MCPH1 in transcriptional induction in some E2F1 promoters. MCPH1 
also regulated the expression of a subset of other E2F target genes such as DDR 
genes RAD51, TOPBP1 and DDB2 as well as pro-apoptotic genes such as p73, 
caspase 3 and 7 (Yang et al., 2008). It is unclear if the role of MCPH1 in the 
transcriptional regulation of these genes is also only an acute response to MCPH1 
depletion similar to BRCA1 and CHK1.   
1.5.6. Centrosomal role for microcephalin 
Since centrosomal function is shared between all of the MCPH proteins, a role for 
MCPH1 at the centrosome has been investigated. MCPH1 localises to the 
centrosome at various stages of the cell cycle depending on the organism. In human 
cell lines a centrosomal localisation has been demonstrated at interphase and mitosis 
(Rai et al., 2008; Tibelius et al., 2009). In chicken DT40 cells GFP-tagged MCPH1 
localises to the centrosome throughout the cell cycle, the N-terminus BRCT1 domain 
is implicated in recognition of a centrosome component for this localisation (Jeffers 
et al., 2008). In Drosophila embryos, MCPH1 has a nuclear localisation during 
interphase and it is a short isoform comprising of only one N-terminal BRCT domain 
that localises to the centrosome during mitosis (Brunk et al., 2007).  
A study of MCPH1 LBC showed MCPH1 together with PCNT is required for the 
recruitment of CHK1 to interphase centrosomes (Tibelius et al., 2009). CHK1 is 
required during an unperturbed cell cycle to maintain inhibitory phosphorylation of 
CDK1 and CDC25B at the centrosome thereby controlling entry into mitosis 
(Kramer et al., 2004). MCPH1 LBC also presented with reduced inhibitory 
phosphorylation of centrosomal CDK1 and CDC25B (Tibelius et al., 2009). This 
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correlated with the reduction in CHK1 centrosome levels and premature entry into 
mitosis demonstrated by premature chromosome condensation (Neitzel et al., 2002; 
Tibelius et al., 2009; Trimborn et al., 2004). Thus, MCPH1 function was placed 
upstream of CHK1, and PCNT, in preventing initial activation of CDK1 at the 
centrosome. However recently the localisation of CHK1 to the centrosome has been 
disputed and it has been proposed that it is nuclear CHK1 preventing premature 
activation of nuclear CDK1 that affects entry into mitosis (Enomoto et al., 2009; 
Matsuyama et al., 2011). Thus, MCPH1 may play a role in CDK1 activation at the 
centrosome by a CHK1 independent mechanism. MCPH1 localises to the nucleus 
during interphase (Lin et al., 2005) and could also play a role in preventing 
premature activation of CDK1 through a nuclear pathway.  
During mitosis centrosome defects were also reported in MCPH1-deficient cells. 
RNAi mediated depletion of MCPH1 in U2OS cells induced loss of spindle integrity, 
spindle disorganisation, chromosome congression defects and cytokinesis failure 
(Rai et al., 2008). It is unclear from this study the underlying mechanism of these 
phenotypes. The authors proposed that elevated Aurora A and PLK1 protein levels 
may in part play a role in these phenotypes (Rai et al., 2008).  
1.5.7 Drosophila melanogaster model of microcephalin 
Recently the developmental role of microcephalin in cell cycle regulation has been 
studied in a Drosophila model. The Drosophila orthologue of MCPH1, mcph1, is 
expressed in Drosophila larval brains (Brunk et al., 2007; Rickmyre et al., 2007) and 
homozygous mutations in mcph1 males leads to low penetrance defects in adult brain 
structure (Rickmyre, Dasgupta et al. 2007). 
Mcph1 is cyclically localised during the embryonic cell cycle and is essential for 
early embryonic cell cycles (Brunk et al., 2007; Rickmyre et al., 2007). Similarly to 
ASPM and CDK5RAP2 orthologues, asp and cnn, homozygous null mutations in 
mcph1 leads to a maternal effect lethal phenotype due to mitotic arrest occurring in 
the early syncytial cell cycles, when mcph1 expression is highest (Brunk et al., 2007; 
Rickmyre et al., 2007). Nuclei in such embryos rapidly arrest in a metaphase-like 
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state with fragmented, misaligned DNA, broad mitotic spindles and detachment of 
centrosomes from spindle poles.  
Further analysis of the early cell cycles demonstrated that from the first mitotic 
division the centrosome and nuclear cycles were uncoordinated (Brunk et al., 2007). 
This phenotype is either a consequence of Chk2-mediated mitotic arrest or triggers 
such an arrest as mutation of chk2 supresses the defects in mcph1 embryos allowing 




















1.5.8. Summary of MCPH1 depletion phenotypes 
Table 1.4. MCPH1 deletion phenotypes  
Mutation System Knockdown or mutant phenotype reference 
mutation human LBC Defective G2/M arrest, impaired CDC25A degradation 
and low levels of Tyr 15-CDK1. Also failure to inhibit 
CDC45 loading onto chromatin after DNA damage 







Premature chromosome condensation in early G2 
phase and delayed decondensation post mitosis. 
(Trimborn et 
al., 2004) 
mutation human Failure to recruitment CHK1 and PCNT to interphase 




mutation human Proficient G2/M checkpoint in response to IR. Delay in 
resolving H2AX foci and re-entering mitosis following 
IR. 
(Gavvovidis 
et al., 2010) 
mutation Chicken 
(DT40) 
Proficient G2/M checkpoint following IR. Moderate 
radiosensitivity. IR induced centrosome amplification. 
Sustained CHK1 phosphorylation after IR. 
(Brown et al., 
2010) 
Mutation Mouse Mice severely radiosensitive and infertile due to 
defective meiotic homologous recombination. MEFs 
and lymphocytes showed increased chromosomal 
breakage following IR. 
(Liang et al., 
2010) 
Mutation Mouse Gene-trap in intron 12 of Mcph1 deleting BRCT3 
domain. Normal brain and body size but reduced 
survival rate. Misregulated chromosome condensation. 
Normal DDR to IR. 
(Trimborn et 
al., 2010) 
Mutation Mouse Defective HR repair and misregulated chromosome 
condensation. 
(Wood et al., 
2008) 
mutation Drosophila Uncoordinated centrosome and nuclear cycles 
followed by mitotic arrest during early syncytial 
divisions. 
(Brunk et al., 
2007) 
mutation Drosophila Homozygous adult males have defective mushroom 
body structure. Mitotic arrest during syncytial divisions 
which can be supressed by Chk2 mutation. Genomic 




RNAi U2OS Decrease in CHK1 and BRCA1 expression levels. Failure 
of S phase and G2/M checkpoint in response to IR. 
Increased sensitivity to DNA damage. 






Decrease in transcript levels of some E2F1 target genes 
such as BRCA1, CHK1, p107, APAF1, p73, caspase 3 & 7 
and other E2F target genes such as TOPBP1, RAD51 
and DDB2. 
(Yang et al., 
2008) 
RNAi U2OS Increased chromosomal aberrations. Failure to recruit 
NBS1, 53BP1, MDC1, p-ATM to IRIF and ATR, RPA to 
UV-induced foci.  
(Rai et al., 
2006) 
RNAi U2OS Impaired S phase and G2/M checkpoint. Decreased 
expression of CHK1 and BRCA1 
(Xu et al., 
2004) 
RNAi HTC75 Inhibition of foci formation in response to DNA 
damage at telomeres. 
(Kim et al., 
2009) 
    




Table 1.4. MCPH1 deletion phenotypes  
Mutation System Knockdown or mutant phenotype reference 
RNAi U2OS Defective HR and NHEJ repair. Decreased association of 
SWI SNF with chromatin and decreased chromatin 
relaxation. 
(Peng et al., 
2009) 
RNAi U2OS Loss of spindle integrity, spindle disorganisation, 
chromosome congression defects and cytokinesis 
failure 
(Rai et al., 
2008) 
    
 
1.5.9. Conclusion: the role of MCPH1 
MCPH1 plays an important role in a number of signal transduction pathways 
including the DDR and cell cycle timing. To achieve these functions MCPH1 BRCT 
domains may be particularly important possibly enabling it to act as a scaffold for a 
range of phosphorylated proteins during signal transduction. 
 
Figure 1.17. Model of MCPH1 function  
MCPH1 may play a role in multiple signal transduction pathways by acting as a scaffold for 
multiple proteins 
 
1.6. Thesis aims and objectives 
1.6.1. Hypothesis: Primary microcephaly proteins function in 
a common pathway that regulates brain growth 
Seven genes have been identified as being mutated in primary microcephaly patients 
(Section 1.2.4). A variety of types of mutations have been reported that are likely to 
lead to loss of protein, a single amino acid change or a truncated protein product 
(Section 1.2.5). All mutations lead to a significant decrease in prenatal brain size 
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which is likely to be attributed to a decrease in neuronal progenitor population 
(Section 1.1.3). The reduced population of progenitor cells could be due to an 
increase in cell death, changes to cell fate choice or alterations in the timing of the 
cell cycle (Section 1.1.5).  
It is possible that mutation of primary microcephaly genes leads to the same 
phenotype through one common pathway (Cox et al., 2006). Given that all of these 
proteins localise to the centrosome such a common pathway may well act at the 
centrosome. 
The centrosomal function of all the proteins have not yet been characterised but those 
that have, play a role in centriole duplication (CEP152, CPAP and STIL), 
centrosome stability (CDK5RAP2) or spindle pole focusing (ASPM and 
CDK5RAP2) (Section 1.3). These are diverse centrosomal functions but could all 
affect centrosomal function at mitosis and impact neurogenic proliferations. One 
possibility is that the primary microcephaly proteins impair microtubule 
nucleation/organisation which could consequently affect spindle pole positioning, the 
orientation of cleavage plane and segregation of cell fate determinants (Section 
1.1.5.1.2). Impaired centrosome function can also cause defects in chromosome 
segregation leading to aneuploidy (Ganem et al., 2009) and possibly decreased cell 
fitness (Thompson and Compton, 2008; Torres et al., 2008; Weaver et al., 2007). 
Alternatively it may be that the primary microcephaly proteins perturb cilia function 
which could lead to changes in cell fate choice (Section 1.1.5.1.5). 
Currently it is unclear what pathways are shared by the primary microcephaly 
proteins. To provide further insights the function of MCPH1 was explored in this 
thesis. This protein has always appeared to be functionally distinct from other 
primary microcephaly proteins and so any shared function could be highly 
informative. Since a potential mechanism leading to primary microcephaly is likely 
to perturb cell divisions (Sections 1.1.3 & 1.1.4) MCPH1 role in mitosis in a 




1.6.2. Thesis aims 
A greater understanding of the role of MCPH1 in mitosis could provide important 
clues to identifying a single pathway that explains how primary microcephaly 
proteins regulate brain growth. Thus, the main aim of this thesis is to characterise 
MCPH1 function in mitosis. To address this, my main aims are to:  
1) Characterise MCPH1 isoforms and cell cycle regulation of expression. 
2) Establish localisation of human MCPH1 during the cell cycle. 
3) Define mitotic functions of MCPH1. 
4) Investigate post-translation regulation of MCPH1 during mitosis. 
In addition mechanistic characterisation of MCPH1 function in mitosis may offer 















Chapter 2. Materials and Methods 
 
2.1. General Reagents 
2.1.1. Sources of reagents 
Chemicals were purchased from Sigma Aldrich, BDH Laboratory Supplies (AnalaR, 
VWR), Fisher Chemicals, and Amersham Biosciences (GE Healthcare). Enzymes 
were obtained from New England Biolabs, Promega and Roche. Cell culture material 
was purchased from Gibco (Invitrogen) or Sigma-Aldrich unless otherwise stated.  
2.1.2. Preparation of buffer solutions 
All commonly used buffers were made using dH2O. Solutions were sterilised by 
autoclaving at 121°C for 15 min. Solutions that could not be autoclaved were passed 
through a 0.22 μm filter (Millipore).  
Table 2.1.  Commonly used buffers 
Drug Final Concentration 
10 X TBE 0.89 M Tris base, 0.89 M boric acid, 20 mM EDTA 
10 X TBS 0.5 M Tris base, 1.5 M NaCl, (pH adjusted to 7.5 with HCl) 
10 X Tris-glycine running 
buffer 
250 mM Tris base, 1.92 M glycine, 1% (w/v) SDS 
 
1 X Western transfer buffer 25 mM Tris base, 192 mM glycine, 0.1% (w/v) SDS, 20% (v/v) 
methanol 
NETN 20 mM Tris-HCl pH 8, 100 mM NaCl, 1 mM EDTA, 0.5% NP40 
WCE buffer 50 mM Tris-HCl pH 8, 280 mM NaCl, 0.5% NP40, 0.2 mM 
EDTA, 0.2 mM EGTA, 10% Glycerol 
PHEM 
 
25 mM Hepes-NaOH pH 6.8, 100 mM EGTA, 60 mM PIPES, 2 
mM MgCl2 
4 X protein sample loading 
buffer 
0. 5 M Tris-HCl pH 6.8, 50% (v/v) Glycerol, 2% (w/v) SDS, 
0.1% (w/v) Bromophenol blue 
PreScission cleavage buffer 50 mM Tris-HCl pH 7.5, 150 mM NaCl, 1 mM EDTA, 1 mM 
DTT 
Kinase reaction buffer 50 mM Tris-HCl pH 7.5, 10 mM MgCl2, 2 mM EGTA 
TE 10 mM Tris-HCl pH 8, 1 mM EDTA 
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2.1.3. Preparation of cell culture drug stock solutions 
Drugs were added to tissue culture media immediately prior to use and used at the 
working concentrations indicated in Table 2.1.3. Stock solutions were made in tissue 
culture hoods in dimethyl sulfoxide (DMSO) or autoclaved dH2O before aliquoting 
and storing them at -20˚C. 
 
Table 2.2. Drug stock solutions   
Drug Solvent Stock concentration Working 
concentration 
MG132 DMSO 20 mM 10 µM 
Purvalanol A     DMSO 10 mM 20 µM 
Roscovitine DMSO 12.5 mM 50 µM 
B12536 DMSO 10 mM 100 nM 
Z-VAD-FMK DMSO 10 mM 10 µM 
Nocodazole DMSO 200 μg/ml 200 ng/ml 
Taxol DMSO 10 mM 10 nM-10µM 
Thymidine H2O 200 mM 2 µM 
Colcemid DMSO 1 mg/ml 0.1 µg/ml 
Doxycycline 
 
H2O 50 mg/ml 10-1000 ng/ml 










Plasmids used throughout this study are listed in Tables 2.3-2.5. Those that were 
created for this work were constructed using standard cloning techniques and 
oligonucleotides described in Appendix 1 b. 
 
Table 2.3. Plasmids used in this thesis 
Plasmid Description Source 
pTRE_tight AmpR mammalian expression vector 
controlled by a tetracycline inducible 
promoter 
Clontech 
pDEST_EGFP KanR and CmR mammalian expression vector 
with a gateway cassette and a N-terminal 
EGFP tag controlled by CMV promoter 
LMBP 
pDONR221 KanR  E. coli expression vector with a 
Gateway entry cassette and T7 promoter 
Invitrogen 
pCDNA3.1_DEST_MYCHIS AmpR and CmR mammalian expression vector 
with a gateway cassette and a C-terminal 
MYCHis tag controlled by CMV promoter  
A. Jackson 
lab created 
by A .Jackson 
pMT107 AmpR mammalian expression vector with 
Ubiquitin cloned in frame with N-terminal 




pTRE_EGFP_DEST Tetracycline inducible mammalian expression 
vector engineered with an N-terminal EGFP 





pGEX4T3_GST_DEST_STREP AmpR and CmR mammalian expression vector 
with a gateway cassette and a C-terminal 
MYCHis tag controlled by CMV promoter 
A. Jackson 
lab created 
by M. Reijns 












Table 2.4. Gateway entry vectors created for this thesis 
Plasmid                                             Description 
pDEST221_FL attB-FL without stop codon recombined in frame with pDEST221 
expression vector 
pDEST221_FLX attB-FL recombined in frame with pDEST221 expression vector 
pDEST221_S attB-S without stop codon recombined in frame with pDEST221 
expression vector 
pDEST221_SX attB-S recombined in frame with pDEST221 expression vector 
pDEST221_∆8 attB-∆8 without stop codon recombined in frame with pDEST221 
expression vector 
pDEST221_∆8X attB-∆8 recombined in frame with pDEST221 expression vector 
pDEST221_1-223X attB-MCPH1 nt. 1-669 with stop codon recombined in frame with 
pDEST221 expression vector 
pDEST221_BRCT1 attB-MCPH1 nt. 1-267 recombined in frame with pDEST221 
expression vector 
pDEST221_BRCT1X attB-MCPH1 nt. 1-267 with stop codon recombined in frame with 
pDEST221 expression vector 
pDEST221_NBX attB-MCPH1 nt. 246-1923 with stop codon recombined in frame 
with pDEST221 expression vector 




FL = full-length isoform of MCPH1, S = short isoform of MCPH1, Δ8 = MCPH1 isoform 
















Table 2.5 a. Gateway destination vectors created for this thesis 
Plasmid                                                      Description 
pTRE_EGFP_FL MCPH1(FL) recombined in frame with N-
terminal EGFP-tag of pTRE_EGFP_DEST 
expression vector 
pTRE_EGFP_FLT1877G T1877G mutation in FL in pTRE_EGFP 




A360G mutation in  FL in pTRE_EGFP, 
pTRE_EGFP_FLA360G_C361A_A362T A360G, C361A and A362T mutations in FL in 
pTRE_EGFP 
pTRE_EGFP_FL T573G T573G mutation in FL in pTRE_EGFP. 
pTRE_EGFP_FLT573G_C574A T573G and C574A mutations in FL in pTRE_EGFP 
pTRE_EGFP_FLT762G T762G mutation in FL in pTRE_EGFP 
pTRE_EGFP_FLT762G_C763A T762G and C763A mutations in FL in pTRE_EGFP 
pTRE_EGFP_FLT831G T831G mutation in FL in pTRE_EGFP 
pTRE_EGFP_FLT831G_C832A_A833T T831G, C832A and A833T mutations in FL in 
pTRE_EGFP 
pTRE_EGFP_FLA861G_G862C A861G and G862C mutations in FL in 
pTRE_EGFP 
pTRE_EGFP_FLA861G_G862A A861G and G862A mutations in FL in 
pTRE_EGFP 
pTRE_EGFP_FLT999G T999G mutation in FL in pTRE_EGFP 
pTRE_EGFP_FLT999G_C1000A T999G and C1000A mutations in FL in 
pTRE_EGFP 
pTRE_EGFP_FLT1095G T1095G mutation in FL in pTRE_EGFP 
pTRE_EGFP_FLT1095G_C1096A_A1097T T1095G, C1096A and A1097T mutations in FL in 
pTRE_EGFP 
pTRE_EGFP_FLT1251G T1251G mutation in FL in pTRE_EGFP 
pTRE_EGFP_FLT1251G_C1252A_A1253T T1251G, C1252A and A1253T mutations in FL in  
pTRE_EGFP 
pTRE_EGFP_FLA1449G_G1450C A1449G and G1450C mutations in FL in 
pTRE_EGFP 
pTRE_EGFP_FLA1449G_G1450A A1449G and G1450A mutations in FL in 
pTRE_EGFP 






Table 2.5 b. Gateway destination vectors created for this thesis 
Plasmid                                                      Description 
pTRE_EGFP_FLA1644G_G1645A A1644G and G1645A mutations in FL in pTRE_EGFP 
pTRE_EGFP_FLA2307G_G2308C A2307G and G2308C mutations in FL in pTRE_EGFP 
pTRE_EGFP_FLA2307G_G2308A A2307G and G2308A mutations in FL in pTRE_EGFP 
pTRE_EGFP_FLS89A,S254A,S548A S89A,S254A, S548 in FL in pTRE_EGFP 
pTRE_EGFP_FLS277A,S287A,S417A,S769A S277A, S287A, S417A, S483A, S769A in FL in 
pTRE_EGFP 
pTRE_EGFP_S Short isoform of MCPH1 recombined in frame with 
N-terminal EGFP-tag of pTRE_EGFP 
pTRE_EGFP_∆8 ∆8 isoform ofMCPH1 recombined in frame with N-
terminal EGFP-tag of pTRE_EGFP 
pTRE_EGFP_∆8D621E D621E in Δ8 in pTRE_EGFP 
pTRE_EGFP_∆8D625E D625E in Δ8 in pTRE_EGFP 
pTRE_EGFP_BRCT1 BRCT1 domain of  MCPH1(aa 1-89) recombined in 
frame with N-terminal EGFP-tag of pTRE_EGFP 
pTRE_EGFP_NTERM N-terminal of MCPH1 (aa 1-223) recombined in 
frame with N-terminal EGFP-tag of pTRE_EGFP 
pCDNA3.1_FL_MYCHIS Full-length MCPH1 recombined in frame with C-
terminal MYCHIS-tag of pCDNA3.1_MYCHIS 
pCDNA3.1_S_MYCHIS Short isoform of MCPH1 recombined in frame with 
C-terminal MYCHIS-tag of pCDNA3.1_MYCHIS 
pCDNA3.1_Δ8_MYCHIS Δ8 isoform of MCPH1 recombined in frame with C-
terminal MYCHIS-tag of pCDNA3.1_MYCHIS 
pGEX_GST_BRCT1_STREP BRCT1domain of MCPH1 (aa 1-89) recombined in 
frame with N-terminal GST-tag and C-terminal 
STREP-tag of pGEX_GST_STREP 
pGEX_GST_NB_STREP NB domain of MCPH1 (aa 83-835) recombined in 
frame with N-terminal GST-tag and C-terminal 
STREP-tag of pGEX_GST_STREP 
pGEX_GST_BRCT2/3_STREP BRCT2_BRCT3 domains of MCPH1 (aa 644-835) 
recombined in frame with N-terminal EGFP-tag of 






2.2. Microbial methods 
2.2.1. Growth of bacteria 
E. coli strains were grown at 37˚C in/on Luria-Bertani (LB) broth medium. To 
maintain selection for plasmid DNA in transformed cells the relevant antibiotic(s) 
(Table 2.3) were added to LB at the required concentration. 
2.2.2. Preservation of bacteria 
For storage of E. coli, 500 µl of stationary phase cell culture was mixed with 500 µl 
of 50% glycerol and stored in 2 ml Cryo-screw capped tubes (Greiner) at -80°C.  
2.2.3. Transformation of E. coli 
2.2.3.1. Preparation of chemically-competent cells for cloning 
Preparation of chemically-competent E. coli was performed in-house by Martin 
Reijns. “E. coli DH5 or DB3.1 cells were grown overnight on LB-agar. The next 
day, a single colony was taken and 5 ml of rich LB with 20 mM MgSO4 was 
inoculated and grown overnight to stationary phase. Following this, 250 ml of LB 
with 20 mM MgSO4 was inoculated with 2 ml of the stationary-phase culture and 
incubated at 23˚C in a shaking incubator at a minimum of 200 rpm until OD600 
reached 0.4-0.6 (usually 8-10 h). The culture was then cooled on ice for about 15 min 
and cells were kept on ice for all subsequent steps. Cells were sedimented (10 min, 
3,000 rpm, 4˚C) and gently resuspended in 80 ml of ice-cold sterilised TB buffer (10 
mM Pipes-HCl pH 6.7, 15 mM CaCl2, 0.25 M KCl, 55 mM MnCl2). Cells were left 
on ice for 10 minutes, centrifuged for 10 minutes at 3,000 rpm at 4˚C, and gently 
resuspended in 20 ml of ice-cold TB buffer. After adding 1.5 ml of DMSO followed 
by a final 10 min incubation on ice, cells were dispensed into 200 l aliquots in cold, 
sterile tubes and snap-frozen in liquid nitrogen. Aliquots were stored at –80˚C until 
required for transformation” (Martin Reijns, „An analysis of Lsm protein complexes‟ 
University of Edinburgh). 
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2.2.3.2. Transformation of chemically-competent cells 
For transformation of chemically-competent E. coli, approximately 1 ng of plasmid 
DNA, or 4 l of a ligation reaction was added to 50 l of competent cells. Cells and 
DNA were incubated on ice for 30 min before 45 sec heat-shock at 42˚C. Following 
2 min recovery on ice, the cells were resuspended in 1 ml of LB and incubated at 
37˚C for 60 min with shaking. 300 l of cells were spread on to LB-agar plates 
containing the appropriate antibiotic(s). The plates were incubated overnight at 37˚C 
to achieve discrete colonies. 
 
2.3. Cell culture methods 
2.3.1. Preparation and growth of cell lines  
2.3.1.1. Mammalian cell lines 
HeLa, U20S, Cos7and HEK293 cell lines were obtained from the European 
collection of cell cultures (ECACC). U2OS cells stably expressing GFP tagged α-
tubulin and RFP tagged histone 2B is an unpublished reagent kindly provided by 
W.E Earnshaw lab, University of Edinburgh.  
Cells were cultured in Dulbecco's Modified Eagle Medium (DMEM) (Gibco) and 
maintained in a 37 °C incubator with 5 % CO2. Cells were trypsinised in 
trypsin:versene (1:1, v:v) at 37°C for 5 min and passaged at 1:6-1:9. 
Lymphoblastoid cells (LBCs) were obtained from human primary microcephaly 
patients and were transformed with Epstein Barr virus in house by Sean O‟Neil. The 
LBCs were cultured in Roswell park memorial institute medium (RPMI) 1640 




All media was supplemented with 10 % fetal calve serum (FCS, HyClone, Thermo 




2.3.1.2. Chicken cell lines 
Chicken DT40 cells stably expressing GFP tagged MCPH1 Short (created by Paola 
Vagnarelli) were cultured in RPMI-1640 supplemented with 10% FCS, 1 % Chicken 
Serum (Gibco), 200 mM L-Glutamine, 100 U/ml penicillin, 100 μg/ml streptomycin 
and 2 mg/ml G418. Cells were maintained between 5-10x10
5
cells/ml in a 37°C 
incubator with 5% CO2. Large volumes up to 250 ml were maintained in 850 cm
2
 
roller bottles (BD) rotating at 20 rpm on a miniPERM Universal Turning Device 
(Greiner Bio One). 
2.3.1.3. Preparation of primary mouse embryonic fibroblasts cell 
lines 
Mouse embryonic fibroblasts were prepared from embryos collected at 13.5 days 
post coitum (E13.5). Each embryo was isolated from the decidua and placed in 
DMEM culture media. The tails were collected for genotyping and the heads and 
abdominal cavities removed. Each embryo was minced using a clean scalpel, 
transferred into a T25cm
2
 tissue culture flask and maintained in DMEM, 10% FCS, 
0.1 mM βME, 100 U/ml penicillin and 100 μg/ml streptomycin.  Fibroblast colonies 
were visible following culture for 48 hours at 37° C in 5% CO2 and 10% O2. Cells 
were trypsinised in trypsin:versene (1:1, v:v) at 37°C for 5 min and passaged at 1:3. 
MEFs were maintained up to passage 6, after which cells become senescent and 
begin to display centrosome abnormalities (Borel et al., 2002). 
2.3.2. Preservation of mammalian and avian cells 
For storage of tissue culture cells, 2-7 x10
6
 adherent cells or 1-3 x10
6
 of non-
adherent cells were harvested and resuspended in 1 ml of FCS, 10 % DMSO. The 
cells were stored in 2 ml cryostat tubes in liquid nitrogen. 
2.3.3. Synchronization of mammalian cultured cells 
2.3.3.1. G1/S cell arrest using thymidine block 
HeLa cells were synchronised at the G1/S border by a double thymidine block. 
Thymidine was added to the media of HeLa cells that were 30-40% confluent to give 
2 mM final concentration. The cells were incubated at 37 °C for 19 hr, then washed 3 
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times in PBS and incubated in fresh media for 9 hr at 37 °C. The second thymidine 
treatment was then performed for 15 hr. The cells were released from G1/S arrest by 
removal of thymidine and allowed to progress through the cell cycle during which 
cells were harvested at various time points. To synchronise transfected cells usually a 
single thymidine block of 2 mM for 19 hr was performed immediately following 
transfection. 
2.3.3.2. Prometaphase arrest using nocodazole block  
Mammalian cultured cells were synchronised at prometaphase by a nocodazole 
block. When cells were 80-90% confluent, nocodazole was added to the media at a 
final concentration of 200 ng/ml and cells were incubated at 37°C for 16 hr.  Mitotic 
cells were then collected by mitotic shake off and either used immediately for cell 
extracts or washed in PBS and released into fresh media. Cells were collected at 
various time points following release from nocodazole block. 
2.3.4. Transfection of cultured mammalian cells 
2.3.4.1. Short interfering RNA transfections 
Short interfering RNA (siRNA) oligonucleotides were transfected into monolayer 
cells using Oligofectamine™ (Invitrogen).  HeLa or U2OS cells were 30-50% 
confluent at time of transfection. For each transfection of a 6-well plate, two 
complexes were prepared. The first contained 200 pmol of siRNA in 175μl of Opti-
MEM I Medium (Invitrogen) and the second contained 3μl Oligofectamine in 12μl 
Opti-MEM. After 5-10 min incubation the solutions were combined for 15-20 min 
and then added to the cells. The cells were incubated in 800 μl Opti-MEM with the 
transfection mixture for 4-6 hr after which the complexes were replaced with media. 
To efficiently deplete some target mRNAs, two consecutive transfections were 
performed 24 hr apart.   
2.3.4.1.1. siRNA oligonucleotide design 
siRNA oligos for RNA interference in cultured mammalian cells were designed 
using a siRNA design tool from the Whitehead Institute (available online at 
http://jura.wi.mit.edu/bioc/siRNA). The Whitehead siRNA design algorithm (Yuan et 
al., 2004) was used to identify potential target sequences that satisfied the following 
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criteria. First, the siRNA targeted sequence is 19 nucleotides in length. Second, the 
target sequence had a GC content of 30-50%. Third, target sequences had less than 
15-16 contiguous base pairs of homology to other coding sequences.  
2.3.4.2. DNA Transfections 
DNA was transfected into monolayer cells using Lipofectamine™ 2000 (Invitrogen).  
HeLa, U2OS, Cos-7 or HEK293 cells were 90% confluent at time of transfection. 
For each transfection of a well of a 6-well plate two complexes were prepared. The 
first contained 1-2 μg of DNA in 250 μl of Opti-MEM I Medium (Invitrogen) and 
the second contained 2 μl Lipofectamine in 250 μl Opti-MEM. After 5 min 
incubation the solutions were mixed for 20 min and then added to the cells. The cells 
were incubated in 1.5 ml Opti-MEM with the transfection mixture for 4-6 hr after 
which the complexes were replaced with media.  
2.3.4.3. siRNA and DNA co-transfections 
siRNA oligonucleotides and DNA was co-transfected in to monolayer cells using 
Lipofectamine™ 2000 (Invitrogen) . HeLa or U2OS cells were 60% confluent at 
time of transfection. For each transfection of a well of a 6-well plate two complexes 
were prepared. The first contained 1 μg of DNA and 200 pmol of siRNA oligo in 250 
μl of Opti-MEM I Medium (Invitrogen) and the second contained 2 μl Lipofectamine 
in 250 μl Opti-MEM. After 5 min incubation the solutions were combined for 20 min 
and then added to the cells. The cells were incubated in 1.5 ml Opti-MEM with the 
transfection mixture for 4-6 hr after which the complexes were replaced with media.  
2.3.4.4. Relative surface area of culture vessels 
The volumes of reagent stated for mammalian cell transfections describe 6-well plate 
formats. Often 12-well format or 100-mm dishes were used. The equivalent volumes 




2.4. Nucleic Acid methods 
2.4.1. General Methods 
2.4.1.1. Spectrophotometric quantification of nucleic acids 
The concentration of nucleic acids was determined by measuring the optical density 
at 260 nM using a NanoDrop 1000 UV-Vis Spectrophotometer (Thermo 
FisherScientific). 1 µl of each sample was used for each measurement. The purity of 
the nucleic acid sample was determined by measuring the absorbance at 230 nM, 260 
nM and 280 nM. The 260/280 ratio of a sample free of protein contamination should 
be 1.8-2.2 and a 230/260 ratio ≥1.7 indicates a sample free of carbohydrates and 
lipids. 
2.4.1.2. Agarose gel electrophoresis 
Nucleic acid samples were analysed in agarose gels ranging from 0.8% to 2% 
agarose/TBE (w:v). Gels were prepared by dissolving agarose (Hi-Pure Low EEO 
agarose, Biogene) in 60 ml of 1x TBE buffer by boiling and adding ethidium 
bromide to a final concentration of 0.5 g/ml. The samples were mixed with 6 X 
DNA loading buffer (6 X DNA loading buffer: 30% (v/v) glycerol, 0.4% (w/v) 
Orange G), loaded on to the gel and 80-150 volts applied to resolve the nucleic acid 
fragments by size. The nucleic acids were visualised using a UV transilluminator 
(BioDoc-It System,UVP). For reference, markers containing DNA fragments of 
known sizes were included (1kb DNA Ladder (Invitrogen) or 100bp DNA Ladder 
(Promega). 




















2  4  10  10  20  60  140  25  75  
Ratio to 24-
well plate  
1  2  5  5  10  30  70  12.5  37.5  
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2.4.2. DNA methods 
2.4.2.1. Purification of DNA from E.coli cells 
2.4.2.1.1. Small scale preparation of plasmid DNA 
Plasmid DNA was prepared using the QIAprep Spin Miniprep Kit (Qiagen), 
following the manufacturers‟ instructions. DNA was extracted from 5 ml of 
stationary phase E. coli culture and eluted in 50 l of elution buffer (10mM Tris-HCl 
pH 8.5).  
2.4.2.1.2. Large scale preparation of plasmid DNA 
Depending on required yield and quality, plasmid DNA was isolated using the 
Endofree Plasmid Maxi Kit, QIAGEN Plasmid Maxi Kit or the QIAGEN Plasmid 
Midi Kit (Qiagen).  DNA was extracted from 150-250 ml of stationary phase E. coli 
following the manufacturers‟ instructions and eluted in 500 l of TE.  
2.4.2.2. Purification of DNA from human cells 
DNA was isolated from human cells using the Qiamp DNA extraction kit (Qiagen) 
following the manufacturers‟ instructions. DNA was extracted from approximately 1 
x10
6 
LBCs and eluted in 50 µl elution buffer.  
2.4.2.3. DNA sequencing 
Dye terminator sequencing reactions (ABI) were performed and processed by the 
Institute of Genetics and Molecular Medicine (IGMM) sequencing service on a 
3130/3730 genetic analyser (Applied Biosystems). The DNA sequencing data was 
analysed using Sequencher 4.10.1 (Gene Codes Corp.). 
2.4.2.4. Restriction digests 
Plasmid DNA was digested with the appropriate restriction endonuclease in the 
buffer supplied by the manufacturer (NEB or Roche). To ensure complete restriction 
digestion before subsequent cloning steps the digest was performed in 20 l with 2 – 
5 g of DNA and 20 U of the appropriate enzyme(s) and incubated overnight at 
84 
 
37°C. For double digests the optimal buffer conditions were selected for both 
enzymes using the manufacturers‟ guidelines.  
2.4.2.5. Purification of restriction digested DNA  
DNA fragments produced by restriction digestion were resolved by agarose gel 
electrophoresis. The desired DNA fragment was excised from the gel using a scalpel 
and purified using the QiaQuick Gel Extraction kit (Qiagen) according to the 
manufacturers‟ instructions. DNA was eluted in 30 μl elution buffer and stored 
indefinitely at -20˚C. 
2.4.2.6. Amplification of DNA by polymerase chain reaction 
2.4.2.6.1. Primer Design to amplify DNA for cloning  
Primers to amplify DNA were designed using the primer design program Primer3 
(available online at http://frodo.wi.mit.edu/primer3/ eye). The primers selected 
usually had a melting temperature (Tm) of around 55˚C (45-65˚C) which did not 
differ by more than 4°C between the forward and reverse primers in a pair. The 
nearest neighbour formula was used to predict the Tm (˚C) of primers (SantaLucia, 
1998).  
2.4.2.6.2. Polymerase chain reaction 
Specific regions of DNA were amplified using the polymerase chain reaction (PCR). 
Specifically designed oligonucleotide primers (Appendix 1 d) were annealed to 
denatured template DNA and extended by a thermostable DNA polymerase. 
Different taq polymerases were utilised: FastStartTaq (Roche) for standard PCR, 
ExpandTaq (Roche) and PhusionFlashTaq (Finnzymes) for when a high level of 
polymerase accuracy is required. 
A typical PCR mixture contained: 1-100 ng template DNA (plasmid or genomic),  1 
X PCR buffer (provided by manufacturer), 0.2 mM dNTP (Roche), 0.1-0.5 µM 
forward primer, 0.1-0.5 µM reverse primer, 0.5 U taq polymerase and H2O up to a 
total reaction volume of 25 µl.  
PCRs were performed on a DNA Engine Tetrad 2 thermal cycler (MJ Research). A 




  Denaturation  94˚C 2 min 
  Denaturation  94˚C             15 sec 
  Annealing  45-65˚C 30 sec 
  Extension  72˚C             45 sec per kb 
 Extension  72˚C 7 min 
*Annealing temperature is based on the melting temperature of primer set used in 
each PCR. 
2.4.2.7. Purification of PCR products  
To purify PCR products the QiaQuick PCR Purification kit (Qiagen) was used 
according to the manufacturers‟ instructions. DNA was eluted in 30 l of elution 
buffer and stored indefinitely at -20˚C.  
2.4.2.8. Genotyping of mouse embryos  
To genotype mice for the insertion of the Mcph1 gene trap cassette a PCR was 
performed using DNA isolated from mouse embryonic tail. Each embyo tail was 
lysed in 50 µl of 25 mM NaOH and 0.2 mM EDTA by boiling at 95°C for 30 min. 
After boiling, the mixture was cooled at room temperature for 5 min and then 50 µl 
of 40 mM Tris-HCl pH 4 was added to neutralise the base. The PCR consisted of 1 
µl of template, 1 X ReddyMix PCR master mix (Thermo Scientific) and 1 M of 
each oligonucleotide (Appendix 1 d) in a 25 µl final volume. Thermal cycling 
conditions were as follows:  
 Denaturation  94˚C 2 min 
  Denaturation  95˚C 45 sec 
  Annealing  58˚C 45 sec 
  Extension  72˚C 45 sec 














2.4.2.9. Site directed mutagenesis 
2.4.2.9.1. Primers for site-directed mutagenesis 
Mutagenic primers for use in site-directed mutagenesis were designed using the 
Quickchange Primer Design Program (available online at 
http://www.genomics.agilent.com). The design algorithm adhered to a number of 
rules. The primers were between 25 and 55 bases in length, with a melting 
temperature (Tm) of ≥78˚C (see below) and the desired mutation was located near the 
middle of the primer with a minimum of ~10–15 bases of correct sequence on either 
side. The Tm of primers was calculated using the following formula: 
 
Tm = 81.5 + 0.41(%GC) – 675/N - % mismatch 
 
in which N is the primer length in bases and the values for %GC and % mismatch are 
whole numbers. 
 
2.4.2.9.2. Site directed mutagenesis 
Point mutations were introduced into plasmid vectors using the PCR based 
QuikChange method (Stratagene). In brief, primers containing the desired 
mutation(s) (Appendix 1a) were designed to anneal to the same sequence on opposite 
strands of the plasmid. The primers are extended by PCR generating a mutated 
plasmid. The PCR product is treated with DpnI to digest the methylated parental 
DNA template and thereby select for the mutation-containing synthesized DNA.  
The PCR was composed as follows: 50 ng plasmid, 0.25 mM dNTPs, 0.2 µM 
mutagenic primers (forward and reverse), 1 X DNA polymerase buffer with MgCl2 
(provided by Stratagene) and 1.25U of PfuTurbo DNA polymerase (Stratagene). 
Cycling parameters for site directed mutagenesis were as follows: 
 Denaturation  95˚C 1 min 
  Denaturation  95˚C 30 sec 
  Annealing  55˚C 1 min  
  Extension  68˚C 1 min per kb 








The PCR product was incubated with 10 U of DpnI (NEB) at 37˚C overnight to 
digest parental vector DNA. Following incubation, 0.5-1 l of the DpnI treated DNA 
was used for transformation into DH5α E. coli (Section 2.2.3.2). Resulting colonies 
were miniprepped and screened by sequencing (Section 2.4.2.3).  
2.4.2.10. Ligation of DNA molecules 
Ligations were performed using T4 DNA ligase (Roche). Briefly, 100-200 ng of 
vector DNA, 2 to 3 times this molar amount of insert DNA, 1 U T4 DNA Ligase and 
1x Ligation Buffer (provided by Roche) were incubated for 4 hr at room temperature. 
Following incubation, 1 μl ligation mixture was used to transform E. coli 
2.4.2.11. Site-specific recombination of DNA molecules  
Recombination cloning was performed using Gateway Technology (Invitrogen) 
following the manufacturers‟ protocol. Gateway technology is based on the 
properties of bacteriophage lambda which can mediate recombination at specific 
sites known as att sites (reviewed by Nash, 1981). Recombination occurs between 
attB and attP sites to give attL and attR sites or vice versa depending on the reaction 
components. This system is used to facilitate transfer of DNA sequences (flanked by 
modified att sites) between vectors. Two recombination reactions are required to 
clone a PCR product into the desired vector. 
Initially, an attB PCR product (generated by primers containing attB sites) is 
recombined with an attP containing donor vector to create an attL containing entry 
clone. This reaction is catalysed by the BP clonase enzyme mix. Specifically, 75 ng 
of pDONR221 vector, 75 ng of attB-PCR product, 1x BP Clonase II Enzyme mix 
(containing λ integrase and E. coli Integration Host Factor) was incubated for 1-16 hr 
at room temperature. To terminate the BP reaction 1 µl of the supplied Proteinase K 
solution was added followed by 10 min incubation at 37°C.  Following reaction 
termination 1 µl of the recombination mixture was used for transformation into 
DH5α E. coli (Section 2.2.3.2) and the resulting colonies were screened by 
sequencing (Section 2.4.2.3). 
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The final destination vector is created by recombination of an attL entry clone with 
an attR destination vector to create an attB containing clone catalysed by LR Clonase 
enzyme mix. Specifically, 75 ng of entry clone, 75 ng of destination vector, 1 x LR 
Clonase II Enzyme mix (containing λ integrase, E.coli Integration Host Factor and 
Excisionase proteins) were incubated for 1-16 hr at room temperature. The LR 
reaction was terminated, transformed and screened as stated above. 
2.4.3. RNA Methods 
2.4.3.1. Purification of RNA from human cells 
RNA was prepared from cells using the RNeasy Mini Kit (Qiagen). RNA was 
isolated from approximately 2x10
5
 HeLa cells following the manufacturers‟ 
instructions. Cells were homogenised using a Qiashredder column (Qiagen) by 
centrifugation at 16,000 g for 2 min. To eliminate genomic DNA contamination an 
on-column treatment with 30 U RNase-free DNase I (Qiagen) for 15 min was also 
included. RNA was eluted into 50 l RNase-free water and stored indefinitely at -
80°C. 
2.4.3.2. Reverse transcription of RNA 
DNA complementary to first strand RNA was generated using reverse transcriptase 
and random oligomer primers. A typical reaction mixture contained 1 g of each 
RNA sample, 40 U Protector RNase Inhibitor (Roche), 100 pmol random primers 
(Promega), 5 mM DTT made up to 14 µl with RNase-free H2O. To melt RNA 
secondary structures the reaction was incubated at 70°C for 5 min immediately 
followed by 5 min on ice. The reverse transcription mix was then added  (1 μM 
dNTPs, 20 U AMV Reverse Transcriptase (Roche), 1 X AMV Reverse Transcriptase 
buffer (Roche), made up to 6 μl with RNase-free H2O). The reaction was incubated 
at 42°C for 60 min then the enzyme was deactivated at 75°C for 8 min. cDNA was 
stored at -20°C until required.  
2.4.3.3. Quantitative real-time PCR (qRT-PCR) 
Quantitative measurements of gene expression were obtained using real-time PCR on 
reverse transcribed (RT) RNA. In brief, PCR was used to amplify specific cDNA 
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sequences and the amount of PCR product at each stage of PCR cycle was measured 
using the double stranded DNA (dsDNA) binding dye SYBR Green as a reporter. 
When possible, primers were designed to be intron spanning to distinguish 
amplification of genomic DNA and to generate a PCR product of similar size (~200 
bp). 
A typical reaction consisted of 50 ng template cDNA, 1 X Brilliant II Sybr Green 
qPCR Master Mix(Stratagene), 0.3 μM passive reference dye (ROX) and 0.2 μM of 
each oligonucleotide primer (Table 1d ) in a 10 µl volume. The themo-cycling 
reactions were performed in 384 well PCR plates (ABgene) with optically clear plate 
seals (ABgene) using an ABI Prism HT7900 Sequence Detection System (Applied 
Biosciences). A typical PCR program was as follows:   
 
 Denaturation  95˚C 10 min 
  Denaturation  95˚C 15 sec 
  Annealing &   
  Extension  60˚C 1 min 
  
The 7900HT continuously detected the fluorescence of each well in the plate in real 
time, producing a cycle threshold (CT) value for each well. This indicates the cycle 
number at which the amount of fluorescence detected reaches a fixed threshold. The 
CT values for each target gene were normalised to the housekeeping gene. It was 
assumed for this calculation that the amplification efficiencies of the target and 
housekeeping gene were approximately equal. The relative expression of target genes 
to a calibrator (siLUC treated or asynchronous control) was calculated using the 
comparative CT method (2
-ΔΔCT
) method (Livak and Schmittgen, 2001) and were 







2.5. Protein methods 
2.5.1. Protein preparation from cultured mammalian cells 
2.5.1.1. Whole cell protein preparations 
Protein was extracted from cultured mammalian cells by detergent mediated cell 
lysis. Cells were harvested and lysed by resuspending in whole cell extract (WCE) 
buffer (supplemented with phosphatase inhibitors; 5 mM NaF, 0.8 mM Na3VO4, 1 
mM β-glycerophosphate and EDTA free protease inhibitor tablet (Roche)) for 30 
minutes on ice. The WCE buffer volume was adjusted according to the type and 
number of cells harvested. For example, 2 x10
5
 HeLa cells were resuspended in 50-
80 µl of WCE buffer. The extract was clarified by centrifugation at 17,000 g for 10 
min on a Heraeus Fresco 17 Centrifuge (Thermo Electron Corporation). The 
supernatant was removed and stored at -80 °C until required. 
2.5.1.2. Nuclear and Cytoplasmic protein preparations 
Nuclear and cytoplasmic proteins were extracted from cells using the NE-PER 
Nuclear and Cytoplasmic Extraction Reagents (Thermo Scientific) following the 
manufacturers‟ protocol. 2x10
6 
HeLa cells were harvested and reagent volumes 
adjusted accordingly. All reagents were supplemented with 1μg/ml of pepstatin, 
leupeptin and aprotinin to inhibit proteases. 
 
2.5.2. Recombinant protein isolation from E. coli 
For recombinant protein expression in E. coli the Overnight Express Autoinduction 
System 1 from Novagen was used according to the manufacturers‟ instructions. In 
brief, 2-3 fresh colonies were used to inoculate 50 ml of LB, with antibiotics and 
ONEX solutions 1, 2 and 3 (0.01, 0.05 and 0.001 times the culture volume 
respectively). Cultures were grown at 25°C for 32 hrs and then the cells harvested.  
Harvested cell pellets were resuspended in NETN (Table 2.1) buffer; 10 ml for 50 ml 
ONEX expression culture. Cells were lysed by sonication in a Soniprep 150 
sonicator set to 3 X 10 sec bursts of maximum amplitude and 10 sec pauses in 
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between. The lysed cell mixture was clarified by centrifugation at 16,000 g for 15 
min at 4°C in a Heraeus Megafuge 1.0R centrifuge. The supernatant was used for 
purification immediately. 
Cell lysate was incubated with Glutathione agarose beads (GS4B, Amersham) for 4 h 
at 4˚C with rotation. Approximately 150 µl of GS4B beads (bed volume) were used 
for 50 ml of ONEX expression culture. The agarose beads were sedimented by 
centrifugation at 300 g for 2 min and washed three times in 5 ml and two times in 
1ml of NETN buffer. For GST pulldown experiments the beads were resuspended in 
NETN buffer and stored at 4°C until required. For Streptactin pulldown assays the 
beads resuspended in 0.5 ml of PreScission cleavage buffer (Table 2.1) with 10 U of 
precision protease (GE healthcare) and incubated at 4°C for 16 hr with agitation. The 
recombinant protein was collected from the eluate; the beads were subsequently 
washed in 250 µl of PreScission cleavage buffer and supernatant collected. The 
eluate and wash solutions were aliquoted and stored at -80˚C. 
2.5.3. Protein quantification 
To determine the concentration of proteins in cell extracts or purified recombinant 
protein the Bradford assay was performed with the Bio-Rad Protein Assay kit. 
Initially, a standard curve was drawn using a BSA concentration range of 0.2, 0.4, 
0.6, 0.8 and 1.0 mg/ml, provided by manufacturer. 20 l of each solution was mixed 
with 1 ml of 1 X Bradfords dye reagent and the A595 was measured after 5 min. 
Absorbance readings were plotted against protein concentration and a line of best fit 
was plotted. To measure unknown protein concentrations, 1-20 µl of protein sample 
was mixed with 1 ml of 1 X Bradfords dye reagent and A595 was measured after 5 
min.  The absorbance reading was compared to the BSA standard curve to calculate 
protein concentration.  
 
2.5.4. In-vitro protein phosphorylation assay  
Protein phosphorylation assays were performed with cyclin B-CDK1 (Cell 
Signaling).  To perform the kinase assays, 4 µg of Strep-tagged protein fragments 
(Section 2.5.2) and 100 ng cyclin B-CDK1were added to kinase reaction buffer 
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(Table 2.1) (supplemented with 1 mM DTT, 200 µM ATP and 0.5 µM NaF). For 
further purification of Strep-tagged fragments, 15 µl (bed volume) of Streptactin 
agarose (IBA) was added and the kinase reaction was incubated for 30 min at room 
temperature. The beads were sedimented by centrifugation at 500 g for 2 min in a 
Heraeus Fresco 17 Centrifuge, washed twice in 500 µl PBS and resuspended in 15 µl 
4 X SLB.  Samples were analysed by SDS-PAGE (Section 2.5.5), followed by silver 
staining (Section 2.5.6) or western blotting (Section 2.5.7).  
2.5.5. SDS-PAGE 
Protein samples were separated according to their molecular weight by SDS-PAGE 
using either the Mini-PROTEAN
®
3 (Biorad) or NuPage®Novex (Invitrogen) gel 
systems.  
Tris-Glycine gels were used at resolving concentrations ranging from 6%-15%. The 
resolving gel mixture was composed of 375 mM Tris pH 8.8, 0.1% (w/v) SDS, 0.1% 
(w/v) ammonium persulphate. For different resolving concentrations the amount of 
30% acrylamide/bis-acrylamide (Sigma-Aldrich) and N‟N‟N‟N‟-
tetramethylethylenediamine (TEMED) was adjusted accordingly (0.08 µl/ml 
TEMED in 6% acrylamide, 0.06 µl/ml TEMED in 8% acrylamide or 0.04 µl/ml 
TEMED in 10-15% acrylamide) . The stacking gel contained 125 mM Tris pH 6.8, 
0.1% SDS, 0.1% ammonium persulphate, 4.2% acrylamide/bisacrylamide and 1 
μl/ml TEMED. Alternatively, 4-12% Bis-Tris gels (Invitrogen) were used when 
greater separation of a wide range of molecular weight proteins was required on the 
same gel. Protein samples were electrophoresed alongside precision plus protein 
standards (BioRad) or SeeBlue® Plus2 Pre-Stained Standard (Invitrogen). High 
molecular weight proteins (> 250kDa) proteins were resolved on a 3-8% Tris-Acetate 
gel (Invitrogen) alongside HiMark™ Pre-Stained High Molecular Weight Protein 
Standard (Invitrogen).  
Protein samples were denatured by heating at 70°C for 20 min in 1 X protein sample 
loading buffer (Table 2.1) and loaded onto the gel. The gels were electrophoresed in 
different types of running buffer depending on the gel composition: 1 X Tris-Glycine 
running buffer (Table 2.1), 1 X Tris-Acetate running buffer (Invitrogen) or 1 X 
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MOPs running buffer for Bis-Tris gels (Invitrogen). A constant voltage of 150-200 
volts was applied until the desired separation was achieved. 
2.5.6. Staining of protein gels 
2.5.6.1. Coomassie Blue staining  
To allow visualisation of abundant protein bands following SDS-PAGE, 
SimplyBlue™ SafeStain (Invitrogen) was used. After electrophoresis the gel was 
washed three times for five min in 100 ml of dH2O and then mixed in 20 ml of the 
staining solution for 1 h, followed by destaining for 1-3 hr in dH2O.When protein 
bands were isolated for mass spectrometry care was taken to minimise keratin 
contamination by using clean equipment and fresh solutions. 
 
2.5.6.2. Silver Staining of protein gels 
Recombinant protein bands after SDS-PAGE were detected by silver staining using 
the SilverSNAP
®
 stain for Mass Spectrometry (Thermo Scientific) and by following 
the manufacturers‟ instructions.  
 
2.5.7. Western blotting 
Proteins were transferred from the SDS-polyacrylamide gel to nitrocellulose 
membrane (Amersham) using a Mini-Trans-Blot Cell system (Bio-Rad 
Laboratories). Electrophoretic blotting was performed in 1 X western transfer buffer 
(Table 2.1) at 100 V for 1-2 hr.  
After electrophoretic transfer, the nitrocellulose membrane was blocked to prevent 
non-specific protein binding. To block, the membrane was incubated with either 5% 
Marvel (Premier Foods) or 5% BSA (Roche) in TBST (Table 2.1) for 1 hr at room 
temperature with constant agitation. Primary antibodies were added to the blocking 
solution at the appropriate dilution (Appendix A2 a) and incubated overnight at 4°C. 
The membrane was washed 3 times for 5 min in TBST and then the appropriate HRP 
labelled secondary antibody (Appendix A2 b), diluted in appropriate blocking 
solution, was added to the membrane for 1 hr. 
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To detect horse radish peroxidase (HRP) immobilised onto membrane, ECL 
detection kit (Amersham Biosciences) was used according to the manufacturers‟ 
instructions. For a 20 cm
2
 nitrocellulose membrane, 2 ml of ECL solution (1:1 
mixture of solutions A and B) was added to the protein side of the nitrocellulose 
membrane and incubated for 1 min at room temperature. The membrane was blotted 
to remove any excess liquid, placed between two acetate sheets and exposed to 
photographic film (Kodak Biomax XAR Film). Film was developed using a Konika 
SRX-101A Developer.  For enhanced sensitivity, ECL Plus (Amersham Biosciences) 
was used according to the manufacturers‟ instructions. 
2.5.8. Western blot image analysis 
A rough quantification of the relative band intensities of Western blots was 
performed using Adobe Photoshop 7.0. An area encompassing one protein band was 
defined and the same area was used for each measurement. The mean pixel intensity 
was calculated for each area.  Intensity values for the background of a matched area 
were also obtained and subtracted from the band signal. Intensities were expressed as 
a ratio relative to uncleaved protein band.   
2.5.9. Phosphorylation site mapping of proteins by mass 
spectrometry  
Band samples containing the protein of interest were analysed by the FingerPrints 
Proteomics Facility of Dundee University. The samples were digested by 
trypsinisation and subject to a three stage analysis using the nanoLC-MS mass 
spectrometer (Liquid Chromatography, Mass Spectrometry, Dionex/LC Packings) 
coupled to a 4000 QTRAP (Applied Biosystems/Sciex). Initially proteins are 
identified by LC- MS-MS spectrometer (Dionex/LC Packings). Then phosphorylated 
peptides were identified by parent ion scanning followed by tandem MS to determine 
the site of phosphorylation. A mascot report was then generated from a comparison 





2.6. Microscopy methods 
2.6.1. Fixation of cells 
Suspension cells were adhered to poly-L-lysine slides (VWR) and adherent cells on 
to untreated (VWR) or to poly-L-lysine coated coverslips (Becton Dickinson). 
Depending on the antibody the cells were either fixed in -20ºC methanol for 7 min or 
4% PFA (TAAB) in PHEM (Table 2.1) for 5-15 min. Usually, methanol fixation was 
used for visualisation of proteins located at the centrosomes or microtubules and 
PFA for kinetochore staining and visualisation of DNA morphology. Following PFA 
fixation, cells were permeabilised by treatment in 0.2% triton-X-100 in PHEM for 2 
min. Cells were then washed in PBS 3 times for 5 min and stored at 4°C until 
required. 
2.6.2. Immunostaining 
Fixed cells were blocked in PBS/1% bovine serum albumin (Sigma-Alrich) for at 
least 30 min. Primary antibodies were diluted in blocking solution (see Appendix 2 a 
for dilutions used) and incubations were performed for 30 min at 37ºC in a humidity 
chamber. The cells were then washed three times in PBS for 5 min before incubation 
with appropriate secondary antibodies (Appendix 2 b) and 4ꞌ6-diamidino-2-
phenylindole (DAPI) (1 g/ml) for 30 min. Samples were washed and mounted in 
Vectashield (Vector Laboratories) and analysed immediately by microscopy (Section 
2.6.3).  
2.6.3. Microscopy  
2.6.3.1. Microscopy of fixed cell preparations  
Imaging was performed using an Axioplan 2 widefield fluorescence microscope 
(Ziess) fitted with an objective mounted PIFOC for accurate sectioning of cell 
thickness. Single-images or Z-series were collected using either a 63 X or 100 X 
Plan-APOCHROMAT (1.4 NA) objective. The microscope contained a three colour 
single-emission filter wheel (FITC; 489 nm excitation, 508 nm emission, TRITC; 
550 nm excitation, 570 nm emission, DAPI; 359 nm excitation, 461 nm emission). 
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Images were captured with a CoolSnap camera (Roper Scientific) using Ivision 
image capture software.  
2.6.3.2. Microscopy of live cells 
For live-cell imaging, U2OS cells stably expressing RFP-H2B and EGFP-ATUB 
were seeded on to 60 mm glass coverslips (VWR).The coverslips were sealed in to a 
closed chamber system with Leibovitz L-15 medium (Gibco).  TRITC and FITC 3D 
image data sets were collected with a DeltaVision system microscope (Applied 
Precision, Issaquah, WA) heated to 37°C equipped with a dry 40 X 
APROCHROMAT objective. Images with Z-optical spacing of 1-2 µm were 
recorded every 10 min for a 3 hr period. 
2.6.3.3. Processing of 3D datasets 
Images were deconvolved using constrained iterative restoration as implemented in 
Volocity software 5.4.2 (PerkinElmer). Three-dimensional data sets were converted 
to maximum intensity projections in Volocity and then converted into TIFF files. The 
TIFF files were imported into Adobe Photoshop 7.0 for final presentation. In 
Photoshop, levels were adjusted across each entire image to lower nonspecific 
background and haze. When comparing fluorescent signals between images, levels 
were adjusted proportionately.  
2.6.3.4. Quantification of fluorescent signals in 3D datasets 
Fluorescence intensity analysis of 3D datasets was performed using Volocity 
software 5.4.2. A region covering each centrosome was defined in a deconvolved 3D 
dataset and the signal through all the sections was summed. Intensity values for the 
cytoplasmic background of matched volume were obtained and subtracted from the 
centrosome signal. Intensities were expressed as a ratio relative to wild type.  
2.6.4. Fluorescence activated flow cytometry 
Cells were harvested by trypinisation, and transferred to a 15ml falcon tube. Before 
each washing step the cells were pelleted by centrifugation for 2 min at 800 g. The 
cells were washed once in DMEM, once in PBS/0.1 mM EDTA and then 
resuspended in 100 μl of PBS/0.1 mM EDTA. Cells were then fixed in 900 μl 70% 
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EtoH/H2O added drop-wise and stored at -20°C. The cells were washed twice in PBS 
and finally resuspended in PBS containing 100 g/ml RNase A and 50 g/ml 
propidium iodide for 40- 60 min. Cell sorting was performed on a FACScalibur (BD 
Biosciences) by Elizabeth Freyer, MRC HGU. Data was analysed using FlowJo 



















Chapter 3. Characterisation of MCPH1 isoforms in the 
cell cycle 
 
Recent studies on the Drosophila melanogaster orthologue of MCPH1 revealed the 
existence of several alternatively spliced variants of mcph1 (Brunk et al., 2007; 
Rickmyre et al., 2007). Two of the isoforms exhibit different mitotic localisation 
patterns and appear to play distinct roles in the cell cycle (Brunk et al., 2007).  
During my MSc maxi-project („Defining the functional role of a short isoform of 
microcephalin in humans and Drosophila melanogaster’, University of Edinburgh, 
2007) I experimentally confirmed the presence of alternative splicing of MCPH1 in 
humans, similar to in Drosophila.   
In Chapter 3, MCPH1 alternative splicing in humans is characterised. MCPH1 
isoform expression in the developing human brain and the effect of primary 
microcephaly MCPH1 mutations on isoform protein expression was characterised to 
assess the potential contribution of the isoforms to the pathogenesis of primary 
microcephaly. To establish if alternative MCPH1 isoforms could perform different 
functions, tissue specific isoform expression and differential regulation during the 












3.1. MCPH1 is alternatively spliced 
MCPH1 is a fourteen exon gene located on chromosome 8 at cytogenetic band p23 
(Figure 3.1A). The full-length (FL) transcript containing all fourteen exons is 
annotated in Ensembl (ENST00000344683) and has been the subject of all MCPH1 
functional studies published to date. Two sites of alternative splicing at intron 8 and 
exon 8 were identified from bioinformatics and experimentally (Figure 3.1B). One 
transcript, called MCPH1(S), contains unspliced intron 8 resulting in a premature 
stop codon and corresponds to the annotated transcript ENST00000519480 in 
Ensembl.  A second transcript, called MCPH1(Δ8), contains spliced exon 8 and was 
identified by RT-PCR and sequencing of HeLa mRNA (Figure 3.1C). The splicing of 




Figure 3.1. Human microcephalin. 
(A) Genomic organisation of MCPH1. Schematic drawing illustrating the exons (boxed) and 
coding sequence (blue) of MCPH1. The positions of the translational start site, the two 
alternative stop sites and primers used for RT-PCR are also indicated. (B) Potential 
alternative splice variants of MCPH1. Schematic drawing showing transcripts resulting from 
alternative splicing of intron 8 (short) and exon 8 (Δ8). The predicted sizes of transcripts are 
indicated. (C) RT-PCR of the MCPH1(Δ8) transcript from HeLa RNA. The approximately 1,400 
bp PCR product (denoted by arrowhead) was sequenced confirming the MCPH1(Δ8) 
transcript sequence.  The approximately 2,800 bp PCR product (denoted by asterisk) is the 







3.2. MCPH1 is alternatively spliced in human fetal brain 
During my MRes maxi-project („Defining the functional role of a short isoform of 
microcephalin in humans and Drosophila melanogaster‟, University of Edinburgh, 
2007) alternative splicing of MCPH1 intron 8 (generating the S isoform) was 
confirmed in the developing human brain.   
As our main interest is to study the potential role of MCPH1 during neurogenesis, 
alternative splicing of exon 8 (resulting in the Δ8 isoform) was also examined by RT-
PCR of human fetal brain. The primers were designed to amplify sequence unique to 
each of the transcripts (Figure 3.2A). The S transcript contains intron 8 and although 
FL or Δ8 transcripts share the same exons there are unique exon junctions (exon8/9 
junction (FL) and exon7/9 junction (Δ8)). RT-PCR products representing FL, S and 
Δ8 transcripts were generated (Figure 3.2B) confirming that alternative splicing 
occurs during neurogenesis.   
 
Figure 3.2. Expression of human MCPH1 FL, S and Δ8 transcripts. 
(A) RT-PCR primer locations in MCPH1. The location of the primer pairs designed to amplify 
FL (red arrows), S (blue arrows) or Δ8 (black arrows) transcript sequence. (B) RT-PCR 
demonstrates the synthesis of processed mRNAs representing human MCPH1 FL, S and Δ8 
isoforms. RNA extracted from human fetal brain (HFB) was reverse transcribed to make 
cDNA for PCR analysis (lanes 1, 4, 7). HFB RNA without reverse transcriptase (-RT) and H2O 
(-temp) were included as controls. Primers were designed that would specifically amplify 
products from mRNA encoding FL (lanes 1-3), S (lanes 4-6) or Δ8 (lanes 7-9).  The forward 
and reverse primers used were intron spanning allowing products generated from genomic 
or unspliced primary transcripts to be distinguished from processed transcripts. 
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3.3. MCPH1 isoform protein expression 
The alternative splicing described (Figure 3.1 & 3.2) would encode three protein 
isoforms. The FL transcript encodes the longest protein isoform containing all three 
BRCT domains, the S transcript contains only one functional, N-terminal BRCT 
domain and the Δ8 transcript encodes all three BRCT domains but is lacking most of 
the inter-BRCT spacer region (Figure 3.3A).  
To determine if MCPH1 FL, S and Δ8 are expressed as proteins in cultured human 
cells, the proteins recognised by a MCPH1 antibody was examined.  Anti-MCPH1 
antibody raised in rabbits against GST-tagged MCPH1 (Lin et al., 2005) was used to 
probe immunoblots of lymphoblastoid cell (LBC) extracts derived from a control and 




 is a splicing 
mutation in intron 4 that results in a frameshift and substantial premature protein 
truncation (MCPH1
107fs
). It is likely the MCPH1
322-1G>C
 transcript is targeted for 
nonsense mediated decay (NMD) (reviewed by Nicholson and Muhlemann, 2010). 
The anti-MCPH1 antibody detected two protein bands migrating at approximately 90 
and 65 kDa that were absent in MCPH1
107fs
 LBC extracts (Figure 3.3B) and 
corresponded to the predicted molecular weight of the MCPH1 FL (93 kDa) and S 
isoform (68 kDa). 
To further confirm that the two protein bands correspond to FL and S isoforms their 
open reading frames (ORF) were cloned into pCDNA3.1_DEST_MYC_His using 
gateway technology. These transgenes were then expressed in HEK293 cells and the 
protein mobility compared with endogenous protein (Figure 3.3C). The transgenic 
FL and S protein, recognised by the increase in abundance and additional molecular 
mass of the epitope tag, exhibited similar mobility to the endogenous proteins.  
A strong protein band corresponding to MCPH1(Δ8) was not reproducibly detectable 
in LBC or HEK293, although the MCPH1 antibody used could detect transgenic 





Figure 3.3. Immunoblot detection of MCPH1 FL and S isoforms. 
(A) Schematic of potential MCPH1 isoforms. BRCT domains are represented in blue and 
predicted molecular weight of each isoform indicated. (B) Whole cell extracts of control and 
MCPH1107fs LBC were analysed by Western blotting with antibodies to MCPH1 and α-tubulin 
(loading control). (C) Protein extracts from HEK 293 cells transiently expressing MYC(His)6-
tagged MCPH1(FL), MCPH1 (S) and MCPH1 (Δ8) isoforms were compared to extracts from 
control and MCPH1107fs LBC. Extracts were Western blotted with MCPH1 and β-actin 
antibodies (loading control).  
 
3.4 siRNA can be used to specifically deplete MCPH1 
isoforms 
To further confirm that the alternatively spliced transcripts detected by RT-PCR 
corresponded to the protein bands detected by immunoblotting with MCPH1 
antibody, RNAi oligonucleotides were designed to target specific isoforms. The 
location of the oligonucleotide target sequence is represented in the schematic of the 
MCPH1 gene (Figure 3.4A). FL oligonucleotide targets sequence in the FL 
transcript, S targets sequence in the S transcript whereas #2 and #3 target FL, S and 
Δ8 transcripts. To measure the efficiency of the RNAi mediated knockdown, 
transcript levels and protein abundance were analysed. 
The MCPH1 FL, S and Δ8 transcript levels were examined by quantitative RT-PCR. 
The forward and reverse primers used were based on those designed in Figure 3.2A 
& B. FL and Δ8 primer sets were intron spanning and gave rise to single products of 
the expected sizes. It was not possible to design S primer set that was intron spanning 
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so MCPH1 intronic primers were also included as an extra control to detect genomic 
DNA or unspliced primary transcripts. The RNAi oligonucleotides resulted in 
depletion of specific transcripts as expected from their target sequence (Figure 3.4B). 
Expression of Δ8 increased when FL or S transcripts were knocked down, this may 
be a compensatory mechanism for the loss of other isoforms.   
The changes in transcript levels corresponded to the isoform protein abundance 
providing confirmation that these transcripts are expressed as proteins (Figure 3.4 C). 
Three additional bands were detected with the MCPH1 antibody in HeLa cells 
(Figure 3.4 C, denoted by asterisks) but their abundance was not affected by RNAi 











Figure 3.4. Targeted knockdown of MCPH1 isoforms by siRNA.  
(A) siRNA oligonucleotide target sequence locations in MCPH1. The location of the siRNA 
oligonucleotides designed to target FL (black line); S (green line) or all three isoforms (red 
lines) are depicted on the schematic. (B) qRT-PCR analysis of siRNA mediated MCPH1 
transcript depletion. HeLa cells were transfected with 100 nM of control siRNA (siLUC) or 
MCPH1 siRNA (described in A) at 0, 24 and 48 hr. After 72 hr RNA was extracted from cells 
and reverse transcribed into cDNA for qPCR analysis of FL (black), S (white) or Δ8 (grey) 
expression levels. Data is shown as fold induction from siLUC controls and represented as 
the mean ± s.d. of triplicate qPCR wells. (C) Immunoblot detection of siRNA mediated 
MCPH1 protein depletion. HeLa cells from (B) were also used to make protein extracts and 
analysed by Western blotting with antibodies to MCPH1 and α-tubulin (loading control).  











3.5. MCPH1 FL and S are absent in MCPH1 patient cells 
To determine whether the loss of MCPH1 FL and/or S isoform may be relevant to 
the pathogenesis of primary microcephaly, protein expression was examined in 
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) were analysed. The mutations of primary 













The primary microcephaly patient-derived LBC were genotyped to confirm the 
presence of the expected MCPH1 mutations. Genomic DNA was extracted from 
LBC pellets, relevant MCPH1 coding exons amplified by PCR and sequenced. The 
expected mutations were confirmed using Mutation Surveyor (Figure 3.5A) (the 
genotype of MCPH1
Δ1-8 
LBC had recently been confirmed by Louise Bicknell so is 
not shown). The locations of the causative mutations in MCPH1 are illustrated 
(Figure 3.5Bi) and the predicted protein effect of each mutation represented in the 
table (Figure 3.5Bii). All the mutations are located within coding sequence for FL, S 
and Δ8 isoforms of MCPH1 but their effect on isoform protein production has not 
been characterised.  
To address what the cellular consequences of these mutations were, extracts were 
prepared from a control and the MCPH1 patient-derived LBC lines described. In 
addition, extracts from HEK293 cells overexpressing MYC(His)6-tagged FL and S 
were included. Western blotting revealed that both isoforms, which co-migrated with 
epitope-tagged FL and S, were not present in any of the MCPH1 LBCs (Figure 
3.5C). Thus, both missense and frameshift mutations result in loss of MCPH1 FL and 









Figure 3.5. Immunoblot detection of MCPH1 isoforms in MCPH1 patient-derived LBC. 
(A) Genotyping of MCPH1 patient LBC. Genomic DNA was isolated from MCPH1 patient-
derived LBC, MCPH1 exons were amplified by PCR, sequenced and analysed by Mutation 
Surveyor. (B) (i) Schematic of MCPH1 and location of causative mutations identified in 
primary microcephaly patients. (ii) Table representing the MCPH1 genetic mutations and 
their predicted effect on MCPH1 protein.  (C) Cell extracts from control (WT) and five 
MCPH1 patient-derived LBC lines were compared to extracts from HEK293 cells transiently 
over-expressing MYC(His)6-tagged FL and S. Extracts were Western blotted with MCPH1 and 
vinculin antibodies (loading control). 
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3.6. Tissue-specific differences in MCPH1 isoform 
expression 
Previously, using RT-PCR, expression of human MCPH1 was detected in a variety 
of fetal and adult tissues (Jackson et al., 2002). The primers used for PCR detected 
exon 1-6 of MCPH1 and therefore all isoforms would be detected. To characterise 
the expression pattern for each isoform, transcript levels were measured in a range of 
human adult tissue using qRT-PCR. 
The isoforms could be detected in all tissues tested (brain, heart, kidney, skeletal 
muscle, liver, spleen, thymus, adipose, colon, esophagus, lung, ovary, small intestine, 
testes, thyroid) indicating ubiquitous expression (Figure 3.6A-C). Relatively high 
levels of all isoforms were detected in the fetal brain, substantially higher than adult 
brain, consistent with MCPH1 alternative splice isoforms playing a role in 
neurogenesis (Figure 3.6A-C). There are some tissue-specific differences in 
expression, for example higher levels of the S isoform are observed in testes (Figure 
3.6B) and higher levels of Δ8 in heart and liver (Figure 3.6C). This suggests that 





Figure 3.6. Expression patterns of MCPH1 isoforms in human tissue. 
qRT-PCR demonstrates tissue specific differences in MCPH1 isoform expression. RNA 
isolated from human tissue panel was reverse transcribed to make cDNA for qPCR analysis 
of FL (A), S (B) or Δ8(C) expression levels. Values were normalised to the housekeeping gene 
porphobilinogen deaminase (PBDG). PBDG expression was established as having good inter-
tissue reproducibility with CT values between 21-24 cycles. Data are shown as mean ± s.d. 










3.7. Cell-cycle differences in MCPH1 isoform expression 
Although all transcripts are expressed in human fetal brain suggesting a role in 
neurogenic proliferation, each isoform may be required for distinct functions during 
cell proliferation. To determine if the isoforms are regulated differently during the 
cell cycle, transcript and protein levels were analysed.   
HeLa cells were synchronised by a double thymidine block, released and collected at 
various time points. Isoform transcript levels were measured as the cells progressed 
through the cell cycle by using quantitative RT-PCR (Figure 3.7A). Whereas the 
expression levels of FL remained constant throughout the cell-cycle (black line), S 
(red) and Δ8 (green) levels varied. There was an incremental increase in Δ8 levels as 
the cells progressed from G2/M phase into G1 and S transcript levels peaked at S 
phase with lower levels in G1 and G2/M.  
Western blot analysis of extracts with the MCPH1 antibody also showed relative 
differences in isoform protein abundance through the cell cycle (Figure 3.7B). FL 
protein levels were high in G1 to S phase whereas S protein levels were low. During 
G2/M phase FL protein levels were reduced whereas S levels increased. The decrease 
in abundance of FL protein in G2/M is not due to changes in FL transcript levels 
suggesting there may be a post translational mechanism that targets the protein for 
degradation. Cell cycle progression was followed by immunodetection of cell cycle 
markers polokinase1, cyclin A, cyclin B1 and phospho-histone H3 (Figure 3.7B) and 










Figure 3.7. MCPH1 isoform levels during the cell cycle. 
(A) qRT-PCR demonstrates cell cycle specific differences in MCPH1 isoform expression. HeLa 
cells were synchronised during a double thymidine block, released to progress through the 
cell-cycle and RNA extracted from cells at indicated time points. RNA was reverse 
transcribed to make cDNA for qPCR analysis of FL (black), S (red) or Δ8 (green) expression 
levels. Values were normalised to the housekeeping gene PDGB which showed constant 
levels of expression throughout the cell cycle. Data is presented as mean ± s.e.m. of 
triplicate qPCR wells from three independent experiments. (B) Immunodetection of MCPH1 
demonstrates cell cycle specific differences in isoform protein levels. Protein extracts from 
HeLa cells, synchronised as described in (A), were analysed by Western blotting with 
antibodies to MCPH1, β-actin (loading control), polokinase1, cyclin A, cyclin B1 and 
phospho-histone H3 (pH3 blotting performed by Rachel Rigby). (C) Cells were treated with 
propidium iodide (PI) and DNA content sorted by FACs. Analysis was performed in FlowJo 
using the Dean-Jett-Fox model (FlowJo analysis performed by Rachel Rigby). G1 is shown in 
green, S phase in yellow and G2/M in blue.  
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3.8. Discussion  
Recent studies on the Drosophila orthologue of MCPH1 revealed the existence of 
alternatively spliced variants of mcph1 (Brunk et al., 2007; Rickmyre et al., 2007). 
Two of these isoforms exhibited distinct localisation patterns during mitosis and 
appeared to play distinct roles in the cell cycle in Drosophila syncytial embryos 
(Brunk et al., 2007). 
In Chapter 3, alternative splicing of human MCPH1 was characterised. The 
contribution of the isoforms to the pathogenesis of primary microcephaly was 
investigated and the potential separation of isoform function was also examined.  
3.8.1. Alternative splice isoforms of MCPH1 
In this chapter, RT-PCR of human fetal brain RNA established alternative splicing of 
MCPH1 intron 8 and exon 8 (Figure 3.2). These transcripts encode three proteins, 
one that contains all three BRCT domains (FL), one lacking the C-terminal tandem 
BRCT domains (S) and one lacking the majority of the inter-BRCT space (Δ8). An 
MCPH1 antibody detected both the FL and S isoform. These isoforms were absent in 
MCPH1 patient LBC and co-migrated with epitope-tagged versions of FL and S 
(Figure 3.3 & 3.5). In addition, RNAi oligonucleotides designed to specifically target 
individual isoforms led to a concomitant decrease in transcript and protein (Figure 
3.4).  
In contrast to MCPH1 FL and S, MCPH1(Δ8) protein could not be detected by 
Western blot. The MCPH1 antibody could detect MYC(His)6-tagged Δ8 protein 
(Figure 3.3 C) but could not detect a protein band of the correct molecular weight 
that was either absent in MCPH1 patient-derived cells (Figure 3.3 & 3.5) or cells 
with siRNA mediated depletion of Δ8 (Figure 3.4). It is likely that this isoform is 
translated and not subject to NMD as it shares a transcriptional start site and 
termination codon with FL (Figure 3.1). It is possible that endogenous Δ8 protein is 
present at much lower abundance than FL and S and may be difficult to detect by 
Western blotting (similar difficulty reported in detecting PLK4 by Western blot 
(Cunha-Ferreira et al., 2009)). Lower abundance of MCPH1(Δ8) may be due to 
lower transcript levels or reduced protein stability (for example, MCPH1(Δ8) may be 
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subject to rapid degradation or post-translational regulation). MCPH1(Δ8) may be 
detectable by Western blot from extracts of tissues, such as heart or liver, where 
transcript levels were highest (Figure 3.6).  
3.8.2. Contribution of MCPH1 isoforms to primary 
microcephaly pathogenesis 
It has been proposed that the brain specific phenotype of primary microcephaly could 
arise due to the existence of paralogues that can supply functional redundancy in all 
tissues except the brain (Bond and Woods, 2006; Megraw et al., 2011). Indeed, 
potential paralogues have been identified for all primary microcephaly genes except 
STIL and MCPH1 (Table 1.2). It is possible that the brain specific phenotype of 
MCPH1-linked primary microcephaly arises due to loss of only one MCPH1 isoform 
to which the neuronal progenitor cells are uniquely sensitive. However, the 
preliminary studies of this thesis are inconsistent with this hypothesis. First, all the 
MCPH1 isoform transcripts are expressed in fetal brain so all the protein isoforms 
may play a role in neurogenic proliferation (Figure 3.6). Second, all the reported 
MCPH1 mutations are within the coding region for FL, S and Δ8 (Figure 1.8 & 3.5) 
and all 5 MCPH1 patient mutations tested led to loss of MCPH1 FL and S protein 
(Figure 3.5). Primary microcephaly FL and S protein with the E88K substitution 
were also not detectable (Figure 3.5) suggesting that this substitution may lead to 
loss of MCPH1 protein stability. This was consistent with work from my Masters 
project („Defining the functional role of a short isoform of microcephalin in humans 
and Drosophila melanogaster‟, University of Edinburgh, 2007) that demonstrated 
that the introduction of E88K substitution into recombinant BRCT1 domain had a 
huge impact on this domains solubility. There are three other MCPH1 missense 
mutations that have been identified (Darvish et al., 2010; Trimborn et al., 2005) and 
it would be interesting to determine the effect these have on the MCPH1 protein. 
Thus, primary microcephaly cannot be assigned to loss of one particular MCPH1 
isoform that is specifically expressed in the human fetal brain. However it is still 
possible there are uncharacterised MCPH1 isoforms with a different expression 
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pattern in the brain or that the already characterised isoforms have different functions 
in the neuronal progenitor cells. 
3.8.3. Potential roles of MCPH1 isoforms 
What is the biological purpose of generating alternative isoforms? In Drosophila, it 
serves as a mechanism by which to separate localisation and function during the cell 
cycle (Brunk et al., 2007). Mcph1 mutant embryos arrest during the syncytial 
divisions due to uncoordinated centrosome and nuclear cycles. Only Mcph1(S) can 
rescue this phenotype possibly due to its unique centrosomal localisation.  
From the published MCPH1 biology it is likely that the MCPH1 isoforms identified 
will behave differently. The BRCT domains are phospho-protein binding modules 
(Manke et al., 2003; Yu et al., 2003) and their absence is likely to have functional 
consequences for the protein. For example the BRCT2/3 domain, which is absent in 
MCPH1(S), has been implicated in a number of important processes. Firstly, it is 
required for recruitment of MCPH1 to sites of DNA damage (Jeffers et al., 2008; 
Wood et al., 2007; Wu et al., 2009). Secondly, it is required for MCPH1 
oligomerisation and to function in E2F1 mediated transcriptional regulation (Yang et 
al., 2008). The inter-BRCT space, most of which is missing in MCPH1(Δ8), has also 
been implicated in a number of important processes. MCPH1(Δ8) lacks the 
condensin II interaction site which is required for MCPH1 to function in homologous 
recombination  (Wood et al., 2008) and also lacks a strong bipartite nuclear 
localisation signal (PSORT II predictions) which may affect its subcellular 
localisation. It is interesting that the MCPH1 orthologue identified in chicken 
(cMcph1) also lacks most of the inter-BRCT space and has a very similar sequence 
alignment to MCPH1(Δ8) (Jeffers et al., 2008). Further work will determine if there 
are multiple cMcph1 isoforms in chicken or if the cMcph1 orthologue identified 
performs all cMcph1 functions in chicken. 
Indeed there were considerable differences in isoform transcript and protein levels 
during the cell cycle (Figure 3.7) consistent with the idea that different isoforms may 
be required at different stages of the cell cycle. The high levels of FL protein present 
during S-phase could reflect the requirement for this isoform to function in 
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homologous recombination (Liang et al., 2010; Peng et al., 2009; Wood et al., 2008) 
which predominantly occurs during this time in the cell cycle. The higher levels of 
MCPH1(S) protein during G2 to M phase may be important in mitosis as suggested 
from work in Drosophila syncytial embryos that show Mcph1(S) is required to 
coordinate nuclear and centrosomal divisions (Brunk et al., 2007). The variation in 
MCPH1 levels during the cell cycle is also the first piece of evidence to demonstrate 
that MCPH1 is a cell cycle regulated protein. It is interesting that FL levels are 
decreased during G2/M, by a mechanism independent of transcription. FL may be 
subject to post-translational regulation possibly targeting it for degradation. This 
finding is further elaborated in chapter 6 where post-translational regulation of 
MCPH1 is the main focus.  
In addition to a role in neurogenesis MCPH1 isoforms may play other functionally 
important physiological roles in vivo. Although expression was ubiquitous in adult 
tissue tested, expression levels of isoforms varied between tissues. For example, 
higher levels of Δ8 transcript expression were observed in heart and liver (Figure 3.6 
A). The S transcript was highly expressed in adult testes (Figure 3.6 B) which may 
correlate with the high levels of cell proliferation in this organ. Consistent with this, 
it has been demonstrated that Mcph1 is required for the development of mice 
spermatocytes (Liang et al., 2010). However, this developmental defect is linked to a 
perturbation of meiotic homologous recombination which is likely to be the function 
of Mcph1(FL) rather than Mcph1(S) (see above). Nevertheless Mcph1(S) may be 









Chapter 4. Localisation studies of MCPH1 isoforms 
In Drosophila melanogaster, the Mcph1 isoforms localised to distinct subcellular 
compartments during mitosis which may underlie their different functions during the 
cell cycle. The Long isoform localised as discrete foci on the mitotic DNA whereas 
the Short isoform appears to localise to the centrosomes and mitotic spindle in 
syncytial embryos (Brunk et al., 2007).  
In Chapter 3, the human MCPH1 isoforms FL, S and Δ8 were characterised.  
MCPH1 FL and S are orthologous to Mcph1 Long and Short in Drosophila and may 
also show distinct localisations. Chapter 4 describes the localisation of each of the 
MCPH1 isoforms with particular focus on mitotic distribution. In addition, individual 
MCPH1 domains were investigated to establish their roles in directing MCPH1 
localisation.  
4.1. MCPH1 isoforms exhibit distinct localisations during 
interphase 
To determine the intracellular distribution of each of the MCPH1 isoforms, 
transcripts were cloned into the pEGFP_DEST vector and transiently expressed in 
Cos-7 cells under a cytomegalovirus (CMV) promoter. Expression of each of the N-
terminally GFP-tagged isoforms was confirmed by immunoblot analysis with an 
anti-GFP antibody (Figure 4.1 A). Immunofluorescence demonstrated that during 
interphase all the isoforms were present in the nucleus but only GFP-MCPH1(Δ8) 
was found in the cytoplasm (Figure 4.1 B). Often the GFP-tagged MCPH1 isoforms 
formed nuclear aggregates (Figure 4.1 B). Nuclear aggregates were usually found in 
the cells with the greatest levels of GFP-tagged protein and so it is likely to be an 
artefact of protein overexpression.  
Consistent with the immunofluorescence, biochemical fractionation of HeLa cells 
into nucleus and cytoplasm-enriched fractions demonstrated that endogenous 
MCPH1 FL and S were only found in the nuclear fraction (Figure 4.1 C). Psort II 
sequence based localisation predictions also predicted a nuclear distribution for 
MCPH1 FL, S and Δ8 and a cytoplasmic localisation for MCPH1(Δ8) only (Figure 
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4.1 D). Thus, the MCPH1 isoforms have a distinct intracellular localisation, they all 
localise to the nucleus, but only MCPH1(Δ8) can localise to the cytoplasm which 




Figure 4.1. Localisation of MCPH1 isoforms during interphase. 
(A) GFP-tagged MCPH1 isoform protein expression. Cell lysate from Cos-7 cells transfected 
with pEGFP_MCPH1_FL, S or Δ8 vectors was electrophoresed on a 10% polyacrylamide gel 
and Western blotted with anti-GFP antibodies. (B) Localisation of GFP-tagged MCPH1 
isoforms during interphase. Cos-7 transfectants treated as in (A) were fixed in methanol 
and stained with DAPI to visualise DNA (blue). Images were of single planes captured on a 
fluorescence widefield microscope. Scale bar represents 10 µm. (C) Endogenous MCPH1 FL 
and S protein are enriched in nuclear preparations. Fractions enriched for nuclear or 
cytoplasmic components were obtained by hypotonic lysis of HeLa cells. Proteins were 
separated on a 4-12% Bis-Tris polyacrylamide gel and Western blotted with MCPH1 
antibody. Appropriate fractionation was verified by immunoblotting for the nuclear protein 
PARP1 and cytoplasmic marker GAPDH. (D) Bioinformatic predictions of endogenous 
MCPH1 isoform localisation. Schematic of location of PSORT II predicted nuclear localisation 





4.2. MCPH1(Δ8) localises to the centrosome during 
interphase 
It has been established by indirect immunofluorescence and biochemical purification 
that MCPH1 localises to the centrosome during interphase (Tibelius et al., 2009; 
Zhong et al., 2006). To determine what isoforms localise to the centrosome, co-
immunofluorescence of GFP-tagged MCPH1 isoforms and a centrosome marker (γ-
tubulin) was undertaken. During interphase, GFP-Δ8 did co-localise with γ-tubulin 
whereas FL and S were absent from the centrosomes (Figure 4.2). Thus only 
MCPH1Δ8 can localise to the centrosome during interphase and it is likely that it is 
this isoform that is detected at the centrosome by indirect immunofluorescence. 
 
Figure 4.2. Centrosomal localisation of MCPH1 Δ8 during interphase. 
(A) Co-localisation of GFP-tagged MCPH1 isoforms with the centrosome. HeLa cells 
transiently expressing GFP-tagged MCPH1 FL, S or Δ8 isoforms were fixed in methanol and 
stained with ϒ-tubulin (red) antibodies to visualise the centrosome. Images were of single 
planes captured on a fluorescence widefield microscope. The insets show 4 x magnified 




4.3. MCPH1 isoforms exhibit distinct subcellular 
localisation during mitosis 
4.3.1. Inducible regulation of MCPH1 expression 
After establishing MCPH1 isoform localisation during interphase, the mitotic 
distribution was investigated. It had been previously established in the lab (Kathy 
Surinya & Andrew Jackson, unpublished) that over-expression of MCPH1(FL) with 
a CMV-driven promoter led to a G2 phase arrest making visualisation of GFP-
MCPH1 localisation during mitosis very difficult with the current vector system. To 
circumvent this problem a tetracycline inducible vector with a GFP N-terminal tag 
was generated (Figure 4.3A). In this system MCPH1 expression is under the control 
of an inducible promoter enabling regulation of expression to levels permissive for 
cell cycle progression. 
To characterise the regulation of MCPH1 levels by the tetracycline inducible 
promoter, dose-response and the kinetics of induction were examined. HeLa 
tetracycline-on cells were transfected with the pTRE_GFP_MCPH1(FL) vector and 
treated with varying levels of doxycycline (0, 0.1, 1, 10, 100, 1000 ng/ml). 
Expression levels, measured by immunoblotting of cell extracts with anti-GFP 
antibody, were detectable at doxycycline concentrations above 10 ng/ml and 
maximal activation was achieved at 100 ng/ml (Figure 4.3B). To measure the 
kinetics of induction, GFP-MCPH1(FL) expression levels were measured after 
treatment with 1 µg/ml of doxycycline for 0, 2, 4, 6 and 8 hr. Following 2 hr of 
induction, GFP-MCPH1(FL) was detectable by Western blot showing a rapid 
response to doxycycline treatment (Figure 4.3C). These experiments demonstrated 
that the inducible promoter exhibited a sensitive and rapid response to doxycycline 







Figure 4.3. Tetracycline-inducible gene expression system. 
(A) Schematic of pTRE_tight_EGFP_DEST. Tetracycline-inducible expression vector 
pTRE_tight was engineered with EGFP ORF and Gateway destination cassette by 
conventional cloning methods (see Table 2.3 for cloning details). (B) Dose-response of 
MCPH1(FL) induction after doxycycline treatment. HeLa Tet-On cells were transfected with 
pTRE_tight_EGFP plasmid expressing GFP-MCPH(FL) and grown in the presence of the 
indicated amounts of doxycycline for 16 hr. The cells were harvested, 40 µg of protein from 
cell extracts was separated on a 8 % polyacrylamide gel and Western blotted with GFP and 
α-tubulin antibodies (loading control). (C) Kinetics of MCPH1(FL) induction after doxycycline 
treatment. HeLa Tet-On cells were transfected with pTRE_tight_EGFP plasmid expressing 
GFP-MCPH1(FL) and grown in the presence of 1 µg/ml doxycycline for up to 8 hr. The cells 
were harvested at the indicated time points, and 55 µg of protein from extracts was 






















4.3.2. MCPH1 isoform localisation during mitosis 
The tetracycline responsive promoter allowed expression levels that permitted a 
small fraction of cells to progress into mitosis whilst over-expressing MCPH1. This 
was observed by immunofluorescence as an increase in GFP-MCPH1 mitotic cells. 
To increase this proportion further, following transfection, cells were synchronised 
by a single thymidine block, released and fixed when the mitotic cell population is 
enriched (Figure 4.4A). This protocol was followed for the majority analysis of 
mitotic cells over-expressing MCPH1.  
Following this protocol the localisation of GFP-MCPH1(FL) was analysed. 
Immunofluorescence of mitotic cells expressing GFP-tagged MCPH1(FL) and co-
stained for α-tubulin, a microtubule marker, showed that MCPH1(FL) was present as 
discrete foci at the plus and minus ends of the microtubules of the mitotic spindle 
(Figure 4.4B). This localisation was maintained from prometaphase through to late 
anaphase. However by late anaphase MCPH1(FL) only weakly associates to the plus 
end of microtubules (see also Figure 4.6 and 6.10A). At telophase the nuclear 
envelope reforms and MCPH1(FL) diffusely localises to the nucleus. This distinct 
distribution is likely to represent MCPH1(FL) localisation to the centromeres on 
DNA and centrosomes at the spindle poles but requires confirmation by co-
immunofluorescence with the appropriate markers. These findings were reproducible 
in unsynchronised cells over-expressing GFP-tagged MCPH1(FL), confirming this 
localisation is independent of synchronisation treatment. Thus, it appears that during 




Figure 4.4. Localisation of GFP-tagged MCPH1 FL during mitosis. 
(A) Diagrammatic representation of pTRE_tight_EGFP transfection, thymidine block and 
doxycycline treatment protocol. HeLa Tet-On cells were transfected with pTRE-
Tight_EGFP_MCPH1 vector. After 6 hr cells were treated with thymidine for 19 hr, followed 
by a 12 hr release with doxycycline treatment to induce GFP- tagged protein expression. (B) 
HeLa Tet-On cells treated according to the protocol in (A) were fixed in methanol and 
stained with α-tubulin (red) antibody to visualise the mitotic spindle. DNA was stained with 
DAPI (blue). Images are projections of deconvolved z-stacks captured on a widefield 
microscope. Insets represent 4 X magnification images showing the localisation of GFP-
MCPH1(FL) at the centrosome in prometaphase, centromeres in metaphase and anaphase. 
Scale bar represents 10 µm. 
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The metaphase localisation was compared between GFP-tagged MCPH1 FL, S, Δ8 
and MYC(His)6 as a control. Expression of each of the GFP-tagged isoforms at 
mitosis was confirmed by immunoblot analysis of extracts from cells arrested in 
prometaphase with nocodazole treatment (Figure 4.5A). Immunofluorescence with α-
tubulin demonstrated that similarly to GFP-MCPH1(FL), the Δ8 isoform also 
localised to discrete foci at the spindle pole and DNA (Figure 4.5B). In addition to 
punctate staining on the DNA, GFP-MCPH1(Δ8) also diffusely localises to the 
DNA, suggesting it can associate with the chromosomes. Surprisingly, MCPH1(S) 
showed a diffuse cellular localisation with no association to any subcellular 
compartments, similar to the MYC(His)6 control (Figure 4.5B). Thus, there are 
similarities between MCPH1 FL and Δ8 localisation during mitosis but MCPH1(S) is 





Figure 4.5. Localisation of GFP-tagged MCPH1 isoforms during metaphase. 
GFP-tagged MCPH1 isoform protein expression during mitosis. (A) HeLa Tet-On cells were 
transfected with pTRE_Tight_EGFP_MCPH1 FL, S or Δ8 vectors, treated with doxycycline 
and nocodazole for 16 hr.  Cell lysates were fractionated on a 10% polyacrylamide gel and 
Western blotted with anti-GFP antibodies. Both panels represent immunoblots of the same 
exposure. (B) HeLa Tet-On cells transiently expressing GFP-tagged MCPH1 isoforms were 
fixed in methanol, immunostained with α-tubulin (red) antibodies to reveal the 
microtubules and DAPI to visualise the DNA. GFP-MCPH1(FL) metaphase cell from Figure 
4.4 was included for comparison. Scale bar represents 10 µm.  
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4.4. MCPH1(FL) and Δ8 localise to the kinetochores  
During mitosis, GFP-tagged MCPH1(FL)  localised to discrete foci at the plus-end of 
microtubules (Figure 4.5). This localisation appeared to be centromeric or 
kinetochore associated and to confirm this GFP-MCPH1(FL) expressing cells were 
stained with anti-centromere antibodies (ACA). ACA antibody serum is isolated 
from patients with scleroderma CREST that produce autoantibodies against a variety 
of characterised centromeric and kinetochore proteins including CENP-A, CENP-B 
and CENP-C (Earnshaw and Rothfield, 1985). MCPH1(FL) co-localised with ACA 
from prometaphase through to anaphase (Figure 4.6A). At anaphase MCPH1(FL) 
begins to redistribute to the chromatin (Figure 4.6A). This dynamic cell-cycle 
dependent co-localisation is most consistent with MCPH1(FL) being a component of 
the kinetochore.  
Many of the components of the kinetochore are transiently associated and often their 
concentration levels at the kinetochore are influenced by the kinetochore-microtubule 
(kMT) attachment state. To determine whether MCPH1(FL)  kinetochore localisation 
is affected by microtubule attachment state, GFP-MCPH1(FL) localisation was 
examined following treatment with the microtubule destabilising agent, nocodazole, 
or microtubule stabiliser, taxol. Under these conditions, both MCPH1(FL) and ACA 
immunostaining was maintained at the kinetochores (Figure 4.6B). This indicates 
that distribution of MCPH1(FL) to the kinetochores was independent of the 
microtubules suggesting it is a core component of the kinetochores.  
Both MCPH1 FL and Δ8 can localise to the kinetochores suggesting that a shared 
domain is responsible for this localisation. FL and Δ8 isoforms share amino acid 
residues 1-223 and 608-836 which contain all three BRCT domains (Figure 4.6C). 
To further narrow-down the region of MCPH1 required for directing MCPH1 
kinetochore localisation, various fragments of MCPH1 (residues 1-89, 1-223 and 
634-836) were cloned into the pTRE_EGFP_DEST vector, expressed in HeLa cells 
and kinetochore localisation investigated by immunofluorescence (Figure 4.6D). 
None of these fragments are sufficient for kinetochore localisation, suggesting all 




Figure 4.6. Analysis of kinetochore localisation of MCPH1.  
(A) Co-localisation of GFP-tagged MCPH1 FL with the kinetochore. Cells expressing GFP-
MCPH1(FL) were fixed in 4 % PFA , stained with DAPI to visualise DNA and with anti-
centromeric antibodies (ACA) (red). (B) GFP-tagged MCPH1 FL localisation to the 
kinetochore is independent of kMT attachment status. Synchronised cells expressing GFP-
MCPH1(FL) were treated with nocodazole or taxol for 4 hr. The cells were then fixed in 
methanol and stained with ACA antibodies and DNA was visualised by DAPI. The insets are 
3 x magnified images. Scale bars are 10 µm. (C) Schematic representation of MCPH1 protein 
showing location of BRCT domains. (D) Table summarising the GFP-MCPH1 fragments 
expressed and their localisation to the kinetochores. 
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4.5. MCPH1(FL) localises to the centrosomes in a 
microtubule-dependent manner 
GFP-tagged MCPH1 FL and Δ8 appeared to localise to the centrosome during 
mitosis (Figure 4.5). MCPH1(Δ8) localisation to the centrosomes during interphase 
has already been established (Figure 4.2). To confirm that GFP-MCPH1(FL) 
localised to the centrosome at mitosis co-immunofluorescence with pericentrin, a 
marker for the centrosome, was performed (Figure 4.7A). GFP-MCPH1(FL) staining 
is often distinct from pericentrin (a marker for the pericentriolar material (PCM)) as 
often two distinct foci per centrosome could be visualised. This suggests that 
MCPH1 may localise to the centrioles rather than PCM. However this has not been 
formally validated by co-localisation with centriolar markers.  
To examine the dependence of MCPH1(FL) mitotic centrosome localisation upon 
microtubules, HeLa cells expressing GFP-MCPH1(FL) were treated with nocodazole 
for 4 hr. Under these conditions, pericentrin immunostaining was maintained at the 
centrosomes, much of GFP-MCPH1(FL) staining was lost but there is still some 
weak association with the centrosomes, possibly co-localising with the centrioles 
(Figure 4.7B). This indicates that although there is a microtubule-dependent pool of 
MCPH1(FL) there also appears to be microtubule independent pool of MCPH1(FL) 







Figure 4.7. Localisation of GFP-MCPH1 FL to the centrosome during mitosis. 
(A) Co-localisation of GFP-tagged MCPH1(FL) with centrosome marker pericentrin.  HeLa 
Tet-On cells transiently expressing GFP-tagged MCPH1(FL) were fixed in methanol, 
immunostained for the centrosome with pericentrin antibodies (PCNT) (red). (B) GFP-
tagged MCPH1(FL) localises to centrosome in a microtubule dependent and independent 
manner. Synchronised cells expressing GFP-MCPH1(FL) were treated with nocodazole for 4 
hr. The cells were then fixed in methanol and stained with pericentrin antibodies. The 
insets show 3 x magnified images. The arrowheads in B show GFP-MCPH1(FL) associated 




4.6. MCPH1 N-terminus is sufficient for centrosomal 
localisation 
This thesis has established that MCPH1 FL and Δ8 can localise to the centrosomes 
suggesting that a shared domain is responsible for MCPH1 centrosomal localisation. 
FL and Δ8 share amino acid residues 1-223 and 608-836 which contain all three 
BRCT domains (Figure 4.8A). To further narrow-down the region of MCPH1 
required for directing MCPH1 centrosomal localisation, various fragments of 
MCPH1 (residues 1-89, 1-223 and 634-836) were cloned into the 
pTRE_EGFP_DEST vector and expressed in HeLa cells. The centrosomal 
localisation is investigated by co-immunofluorescence with γ-tubulin (Figure 4.8B). 
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As shown in Figure 4.8C, the N-terminus (aa residues 1-223) is sufficient for 
centrosomal localisation at interphase and mitosis. This region contains the BRCT1 
domain (aa residues 1-89), a protein-protein interaction module, which alone is not 
sufficient for a strong centrosomal localisation (Figure 4.8B) but may be necessary 
for its recruitment. 
 
Figure 4.8. Analysis of centrosomal localisation of MCPH1 fragments. 
(A) Schematic representation of MCPH1 protein showing location of BRCT domains. (B) 
Table summarising the GFP-MCPH1 fragments analysed and their centrosomal localisation. 
(C) MCPH1 Nterm localises to the centrosome. Images showing the localisation of GFP-
MCPH1 Nterm (green), ϒ-tubulin (red) and DNA (blue) in HeLa cells. The insets are 3 x 





4.7. The BRCT1 domain of MCPH1 interacts with 
centrosomal component PCNT  
The BRCT1 domain is required for an interaction with centrosomal protein γ-tubulin 
by GST pull-down assays (Elen Griffiths HGU, personal communication). This 
suggests that although this domain alone is not sufficient for centrosome localisation 
it may still be important for mediating some centrosomal interactions and for 
centrosomal recruitment; indeed in DT40 cells, the BRCT1 domain is required for 
cMcph1 centrosomal localisation in irradiated cells (Jeffers et al., 2008). 
Therefore, the interaction of BRCT1 with other centrosomal proteins was 
investigated using recombinant GST or GST-BRCT1 in pull-down assays from HeLa 
cell lysates. In this experiment, the interaction between BRCT1 and γ-tubulin was 
confirmed (Figure 4.9A). Additionally, a novel interaction with pericentrin was 
identified (Figure 4.9B). Interestingly, BRCT1 only interacts with the 350 kDa 
isoform of pericentrin (PCNT B) and not the C-terminally truncated isoform (PCNT 
A) (Figure 4.9B) (Flory and Davis, 2003; Li et al., 2001; Miyoshi et al., 2006). Only 
PCNT B contains the PACT domain, which is important for centrosomal targeting 
(Gillingham and Munro, 2000), suggesting that this interaction may be relevant to 
the centrosomal function/localisation of MCPH1. Indeed an interaction between 
MCPH1 and PCNT has been subsequently confirmed by endogenous 
immunoprecipitation (Tibelius et al., 2009).  Thus, BRCT1 is sufficient for an 
interaction with two key centrosome components pericentrin and γ-tubulin which 






Figure 4.9. MCPH1-BRCT1 interacts with pericentrin and ϒ-tubulin. 
Two experiments were performed in which HeLa lysates were incubated with glutathione-
S-sepharose beads coated with GST (control) or GST tagged MCPH1 BRCT1. After washing, 
the binding of ϒ-tubulin (A) and pericentrin (B) was assessed by immunoblotting. The lane 
marked input was 5% of the volume used for pull-down. (C) Prior to pull-down analysis 



























In this chapter, MCPH1 isoform localisation during mitosis was investigated and it 
was established that specific MCPH1 isoforms (characterised in Chapter 3) localise 
to the kinetochore and centrosome. This is the first conclusive evidence that MCPH1 
can localise to the kinetochores during mitosis. This possibility was first raised by 
the localisation of Drosophila GFP-Mcph1(L) to discrete foci on the DNA during 
mitosis (Brunk et al., 2007). Similar to in Drosophila, MCPH1(FL) (orthologue of 
Mcph1(L)) can localise to kinetochores. 
4.8.1. Validation of epitope-tagged localisation studies 
Attempts have been made to validate the epitope-tagged localisation studies by 
indirect immunofluorescence using commercially available MCPH1 antibodies 
(Bethyl laboratories #A300-368A, Abcam #ac2612 and Abnova #6265,), published 
antibodies (Lin et al., 2005; Tibelius et al., 2009) and some developed in the A. 
Jackson lab. Unfortunately none of these antibodies could unequivocally detect 
MCPH1 localisation at the kinetochores or centrosomes by immunofluorescence, 
despite three of these antibodies being reported to detect MCPH1 at the centrosome 
(Rai et al., 2008; Tibelius et al., 2009; Zhong et al., 2006). Many of the antibodies 
simply do not detect MCPH1 cytologically, as there was no co-localisation when 
GFP-MCPH1(FL) was expressed. Other antibodies, particularly mouse monoclonals 
developed with Carl Smythe (University of Sheffield), did detect over-expressed 
GFP-MCPH1(FL) but did not reproducibly detect MCPH1 at the centrosome and 
kinetochore. It is likely that in this case the MCPH1 epitopes may be masked at the 
centrosome/kinetochore or that the antibody cannot gain access to the epitope in this 
location (Martinez-Campos et al., 2004). Indeed detection of GFP-MCPH1(FL) at 
the centrosomes and kinetochores with an anti-GFP antibody has also been difficult 
to show. Alternatively endogenous levels of MCPH1 may be so low that it is difficult 
to detect with traditional immunofluorescence (Cunha-Ferreira et al., 2009). Some of 
these limitations may be overcome by using enzyme-amplification techniques, such 
as the tyramide amplification kit (Perkin-Elmer Life Sciences), which can 
significantly increase immunofluorescence sensitivity (Bobrow et al., 1992; van 
Gijlswijk et al., 1997).  
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4.8.2. MCPH1 kinetochore localisation 
MCPH1(FL) localisation to the kinetochores was demonstrated by the co-localisation 
with anti-centromeric antibodies (ACA) during mitosis (Figure 4.6A). The inner 
kinetochore consists of a large network of proteins called the constitutive centromere 
associated network (CCAN) that assembles on centromeric chromatin throughout the 
cell-cycle (reviewed by Amor et al., 2004). ACA is reactive against CENP-A, 
CENP-B and CENP-C, all components of the CCAN (Earnshaw and Rothfield, 
1985). MCPH1 appears to localise to the kinetochores during mitosis; this temporal 
localisation is more consistent with MCPH1 being a component of the outer 
kinetochore. The outer kinetochore assembles on the CCAN prior to mitosis and their 
role is to ensure correct segregation of the chromosomes through functionally 
mediating microtubule attachments during mitosis (reviewed by Cheeseman and 
Desai, 2008; Przewloka and Glover, 2009). The MCPH1 kinetochore localisation 
therefore suggests that it too may function in this process.  
In immunofluorescence experiments, the MCPH1(FL) signal often appeared 
immediately adjacent to the ACA signal rather than completely overlapping it. 
Technically, the experiments performed in this thesis have not been designed to 
address MCPH1(FL) localisation on such a fine scale. Future experiments using 
temperature control and capturing every channel of a single z-section will ensure 
greater accuracy during acquisition. This combined with specific markers to define 
the centromere and outer kinetochore will enable the exact location of MCPH1 to be 
determined.  
Some proteins are more transiently associated with the kinetochores, for example 
some microtubule motors or plus-end binding proteins (reviewed by Maiato et al., 
2004). The localisations of these transient components of the kinetochore are often 
influenced by the microtubule attachment state. Some plus-end binding proteins 
require microtubules to localise to the kinetochores, for example EB1 (Tirnauer et 
al., 2002) whereas some microtubule motor proteins, such as CENP-E and dynein, or 
spindle checkpoint proteins, such as MAD1, MAD2 and BUBR1, localise to the 
kinetochore at higher levels when the microtubules are not attached (Hoffman et al., 
2001). MCPH1(FL) kinetochore localisation is fairly constant from prometaphase 
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through to anaphase (Figure 4. 4), nor is its localisation significantly affected by 
kMT attachment status (Figure 4.6B) suggesting that it may comprise part of the 
structural core of the kinetochore.  
Kinetochore proteins are recruited in a temporal, step-wise fashion from G2 phase 
through to mitosis (Figure 4.10). A result of this is that the timing of kinetochore 
localisation and delocalisation can help identify candidate proteins required for 
MCPH1 recruitment as well as provide information about potential kinetochore 
function. For example, the Mis12 complex, one of the first kinetochore proteins to be 
recruited, appears to play a particularly important role in licencing kinetochore 
assembly (Kline et al., 2006; Obuse et al., 2004). The exact stage of MCPH1 
recruitment has not been established, MCPH1(FL) can be observed at kinetochores at 
early prometaphase but prophase or late G2 c ells have not been specifically 
investigated (Figure 4.6). MCPH1 begins to delocalise from the kinetochores during 
anaphase (Figure 4.6). This suggests that MCPH1 may play a core kinetochore 
function as it is present during most stages of mitosis. Further refining when MCPH1 
is recruited to the kinetochore may also identify candidate proteins required for its 
kinetochore recruitment. This could then be investigated further by looking at 





Figure 4.10. Cell-cycle regulated localisation of kinetochore components. 
Immunofluorescence pictures of human cells progressing through the cell cycle, DNA (blue), 
centromeres (red) and microtubules (green). Kinetochore proteins are boxed and the 
direction of kinetochore localisation and delocalisation are represented by arrows. (Figure 
reproduced from Cheeseman and Desai, 2008). 
 
 
Despite MCPH1(FL) being present in the nucleus throughout interphase, it exhibits 
dynamic, cell cycle regulated localisation to the centromeres during mitosis. It is 
likely that its localisation is affected by cell cycle regulatory mechanisms involving 
post-translational modifications, such as phosphorylation. Such modifications could 
mark sites of kinetochore proteins allowing MCPH1 to be recruited or modify 
MCPH1 to permit binding to kinetochores. The second possibility, that post-
translational modifications of MCPH1 regulate its temporal kinetochore localisation 
is explored in Chapter 6.  
4.8.3. MCPH1 centrosomal localisation 
Centrosomal localisation during mitosis has been demonstrated for epitope-tagged 
MCPH1 orthologues in Drosophila embryos (Brunk et al., 2007) and chicken DT40 
cells (Jeffers et al., 2008). In Drosophila it is Mcph1(S) but not Mcph1(L) that can 
localise to the centrosome and only during mitosis (Brunk et al., 2007). Whereas in 
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chicken DT40 cells, the MCPH1 orthologue cloned is more similar to MCPH1(Δ8) 
and it can localise to the centrosome throughout the cell cycle (Jeffers et al., 2008). 
This led to the prediction that there may be variation in centrosomal localisation 
between the human MCPH1 isoforms characterised in Chapter 3. 
In this chapter, it was demonstrated that GFP-MCPH1(FL) and Δ8 could localise to 
the centrosome  during mitosis (Figure 4.4 & 4.5) and the N-terminus (aa 1-223) was 
identified as the domain sufficient to direct centrosome localisation (Figure 4.8). It is 
surprising that GFP-MCPH1(S) does not localise to centrosome, it shares the 
centrosome targeting region (aa 1-223) and indeed it was the Drosophila orthologue 
of MCPH1(S) that localised to the mitotic centrosome (Brunk et al., 2007). However, 
GFP-MCPH1(S) also failed to localise to the centrosomes when stably expressed in 
DT40 cells (Paola Vagnarelli, University of Edinburgh, personal communication) 
suggesting maybe different developmental contexts could account for the differences 
between Drosophila, chicken and human cell lines. To confirm these observations it 
would be worthwhile to establish endogenous MCPH1(S) localisation by 
biochemical purification of the centrosomes.  
MCPH1(FL) specifically localises to the centrosome from nuclear envelope 
breakdown at prometaphase until nuclear envelope reformation during telophase 
(Figure 4.4B). This is in contrast to MCPH1(Δ8) which localises to the centrosome 
throughout the cell cycle (Figure 4.2). It is likely that the differences in localisation 
between the two isoforms are due to their different subcellular localisation; FL is 
distributed in the nucleus whereas Δ8 is also cytoplasmic allowing it access to the 
centrosome at interphase (Figure 4.1). It is likely that it is the MCPH1(Δ8) isoform 
that is detected at the centrosome during interphase by indirect immunofluorescence 
(Tibelius et al., 2009), particularly as the detecting antibody was raised against 
epitopes contained within Δ8.  
What is the function of MCPH1at the centrosome during interphase? This thesis, 
established that MCPH1(Δ8) co-localises with γ-tubulin, a marker for the centrioles 
(Fuller et al., 1995) and pericentriolar material (PCM) (Shu and Joshi, 1995; Stearns 
et al., 1991) (Figure 4.2). This localisation is consistent with the published role for 
MCPH1 in PCM recruitment during interphase (Tibelius et al., 2009). The evidence 
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presented here suggests that MCPH1 function at the centrosome during interphase is 
attributable to MCPH1(Δ8), although it cannot be ruled out that uncharacterised 
MCPH1 isoforms could also play a role. In support of this, MCPH1(Δ8) contains the 
BRCT1 domain that is required for interaction with pericentrin and γ-tubulin (Figure 
4.7), two centrosome components that MCPH1 is required to recruit during 
interphase (Tibelius et al., 2009). 
The functional role of MCPH1 at the centrosome during mitosis is not known. It is 
centrosomal localisation during mitosis that is shared between all of the MCPH1 
proteins (Barrera et al., 2010; Hatch et al., 2010; Higgins et al., 2010; Hung et al., 
2000; Nicholas et al., 2010) and so defining MCPH1 function at the centrosome 
during mitosis could help to pinpoint a single shared pathway important during 
neurogenesis. One possibility, and a natural progression from MCPH1 function 
during interphase, is that MCPH1 could play a role in centrosome maturation during 
mitosis. Centrosome maturation describes the increased microtubule nucleation 
capacity of the mitotic centrosomes (reviewed by Blagden and Glover, 2003). Most 
of the primary microcephaly proteins can be linked in some way to this process 
either through roles in centriole duplication (Blachon et al., 2008; Hatch et al., 2010; 
Kohlmaier et al., 2009; Schmidt et al., 2009; Stevens et al., 2010a; Tang et al., 
2009), PCM expansion (Fong et al., 2008) or focusing of microtubules (Higgins et 
al., 2010; Pfaff et al., 2007). MCPH1 centrosomal localisation is consistent with the 
possibility that it too could play a role in centrosome maturation. MCPH1 may 
possibly function in this process through its tandem BRCT domains which can 
recognise phosphorylated proteins (Manke et al., 2003; Yu et al., 2003).  Centrosome 
maturation also depends upon the activity of mitotic kinases such as polokinase 1 
(Lane and Nigg, 1996) and aurora A (Hannak et al., 2001). MCPH1 may act as an 
assembly platform for these phosphorylated proteins at the mitotic centrosome. The 




Chapter 5. The characterisation of MCPH1-deficient 
cells 
 
Chapter 3 and 4 established that MCPH1 is regulated during the cell cycle. MCPH1 
protein levels fluctuate with the cell cycle phase and MCPH1 cyclically localises to 
the centrosome and kinetochores during mitosis. This raises the question what are the 
functional consequences of this spatio-temporal mitotic regulation.  
In this chapter, the function of MCPH1 during mitosis is investigated.  Three 
different tools were utilised to examine the role of MCPH1 in mitosis: RNAi-
mediated depletion of MCPH1 in human cell lines, MEFs with Mcph1 gene-trap and 
MCPH1 patient-derived lymphoblastoid cells.  
5.1. RNAi mediated depletion of MCPH1 
5.1.1. Knockdown of MCPH1 isoforms by RNAi  
Small interfering RNA (siRNA) oligonucleotides were utilised to efficiently deplete 
MCPH1 for functional studies. Three siRNA oligonucleotides were designed to 
target MCPH1 3ꞌ UTR, the unique sequence of the short isoform and MCPH1 exon 3 
(Figure 5.1A). The first two oligonucleotides were pooled (siMCPH1#1) to ensure all 
three MCPH1 isoforms were targeted, whereas the oligonucleotide targeting MCPH1 
exon 3 (siMCPH1#2) should deplete all the isoforms.   
As shown in Figure 5.1B, the endogenous levels of MCPH1 FL and S were 
significantly reduced following transfection of HeLa cells with siMCPH1#1 or 
siMCPH1#2 but not following control transfection with siRNA oligonucleotides 
against luciferase. This confirms that the oligonucleotides specifically deplete 
MCPH1 FL and S.  
MCPH1(Δ8) is not detectable with current antibody reagents and so evidence of 
protein depletion by immunoblotting is not possible. However it has been 
demonstrated that transfection with siMCPH1#2 leads to a similar reduction of Δ8 
transcript levels to FL and S isoforms (Figure 3.4B), which are undetectable by 
138 
 
immunoblotting analysis (Figures 3.4B & 5.1B). The reduction of Δ8 transcript 
levels with siMCPH1#1 is yet to be confirmed but it is likely to be targeted similarly 
to MCPH1(FL) as they both share the 3ꞌ UTR. Thus, siMCPH1#1 and siMCPH1#2 
are presumed to efficiently deplete MCPH1 isoforms.  
 
 
Figure 5.1. MCPH1 isoform depletion by RNAi. 
(A) Schematic of MCPH1 and location of sequences targeted by siRNA. MCPH1#1 is a pool 
of oligonucleotides designed to target the unique exon junction of S isoform (blue bar) and 
the 3ꞌUTR (black bar) of MCPH1 FL and Δ8. MCPH1#2 targets all three MCPH1 isoforms (red 
bar). (B) Depletion of MCPH1 FL and S protein isoforms by siRNA. HeLa cells were 
transfected with luciferase siRNA (control) or MCPH1 siRNA (described in (A)).  After 24 hr, 
the transfection was repeated and at 72 hr cells were harvested and lysates prepared. The 
lysates were separated on a 8% Tris-Glycine polyacrylamide gel and Western blotted with 
MCPH1 and vinculin (loading control) antibodies. 
 
 
5.1.2. MCPH1 depletion leads to multipolar spindle formation 
To examine the effect of MCPH1 depletion on mitosis, HeLa cells were transfected 
with control or MCPH1 #1 siRNAs. The cells were fixed and mitotic cells assessed 
by α-tubulin & γ-tubulin immunofluorescence to visualise microtubules & 
centrosomes, DAPI staining was used to visualise DNA. siRNA mediated depletion 
of MCPH1 in HeLa cells led to an increase in the number of cells with multipolar 
spindles (Figure 5.2A). 59 % of mitotic MCPH1 depleted cells had greater than two 
γ-tubulin foci surrounded by clusters of microtubules whereas only 1.5% of mitotic 
control cells had this phenotype (Figure 5.2B).  
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The siMCPH1#1 oligonucleotide pool does not target MCPH1(FL) ORF enabling 
RNAi rescue experiments to be performed. As shown in Figure 5.2B spindle 
multipolarity is partially rescued by the transfection of cells with GFP-tagged 
MCPH1(FL) (42 % in comparison to 59 %). However this difference has not quite 
reached statistical significance (p=0.0549, Fisher‟s exact test) and so requires further 
validation (Figure 5.3B). This partial rescue does suggest that spindle multipolarity is 
a specific defect caused by the depletion of MCPH1 rather than non-specific effects 
exerted by RNAi oligonucleotides.  
Spindle multipolarity was also observed following MCPH1 depletion in U2OS cells 
(Figure 5.2C) and following transfection with siMCPH1#2 oligonucleotides (Figure 
5.2D) confirming that this phenotype is independent of cell type and siRNA 












Figure 5.2 MCPH1 depletion by RNAi leads to mitotic spindle multipolarity. 
(A) MCPH1 depletion by RNAi leads to mitotic spindle multipolarity. HeLa cells were 
transfected with luciferase siRNA (siLUC) or MCPH1 siRNA (siMCPH1#1). After 48 hr cells 
were fixed in methanol and subjected to immunofluorescence staining with ϒ-tubulin (red) 
and α-tubulin (green) antibodies. DNA was visualized with DAPI (blue). (B) MCPH1(FL) 
expression partially rescues spindle multipolarity. HeLa cells were transfected with 
luciferase siRNA (control) or MCPH1 siRNA (siMCPH1#1).  After 24 hr, the cells were 
transfected with luciferase siRNA, MCPH1 siRNA or MCPH1 siRNA and a plasmid expressing 
GFP-tagged MCPH1(FL). The cells were fixed in methanol 48 hrs after first transfection. Data 
presented are the percentages of mitotic cells with multipolar spindles (mean +/- s.e.m. of 
two independent experiments with >50 cells counted per experiment). (C) Spindle 
multipolarity is independent of cell type. (i) A similar protocol to (A) was followed in U2OS 
cells stably expressing GFP-α-tubulin and RFP-Histone 2B. (ii) Quantitative analysis of 
multipolar spindles in cells depleted of MCPH1. The graph represents one experiment of 50 
cells. (D) Spindle multipolarity is also present following MCPH1 depletion by MCPH1#2 
siRNA. (i) A similar protocol to (A) was followed with siMCPH1#2 oligonucleotides. (ii) 
Quantitative analysis of multipolar spindles in cells depleted of MCPH1. The graph 
represents one experiment of 50 cells. Scale bars are 10 µm. 
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5.1.3. MCPH1 depletion leads to chromosome alignment 
defects 
siRNA-mediated depletion of MCPH1 in HeLa cells also led to an increase in the 
number of metaphase cells with chromosomes misaligned from the metaphase plate, 
a partial metaphase plate was formed but many chromosomes were located at the 
spindle poles (Figure 5.3A). 72 % of MCPH1 depleted cells with a normal bipolar 
spindle had this phenotype (Figure 5.3A & B) compared to only 1.5% of control 
metaphase cells (Figure 5.3B).  
These defects appear to be partially rescued by the transfection of cells with GFP-
tagged MCPH1(FL) (49% in comparison to 72%, p<0.0005 (Fisher‟s exact test)). A 
similar phenotype was observed following MCPH1 depletion in U2OS cells (Figure 
5.3C) and following transfection with siMCPH1#2 oligonucleotides (Figure 5.3D) 
providing further support that the phenotype observed is specifically due to depletion 
of MCPH1. Thus, MCPH1 is required for normal chromosome alignment during the 







Figure 5.3. MCPH1 depletion by RNAi leads to chromosome alignment defects. 
(A) MCPH1 depletion by RNAi leads to chromosome misalignment in metaphase cells with 
bipolar spindles. HeLa cells were transfected with luciferase siRNA (control) or MCPH1 
siRNA (siMCPH1#1).  After 48 hr cells were fixed in methanol and stained with α-tubulin 
antibodies and DAPI. (B) GFP-MCPH1(FL) expression rescues chromosome misalignment 
defects. HeLa cells were transfected with luciferase siRNA (control) or MCPH1 siRNA 
(siMCPH1#1).  After 24 hr, the transfection was repeated with luciferase siRNA; MCPH1 
siRNA; or MCPH1 siRNA and a plasmid expressing GFP-MCPH1(FL). The cells were fixed in 
methanol 48 hr after first transfection. Data presented are the percentages of metaphase 
cells with a bipolar spindle which have misaligned chromosomes (mean +/- s.e.m. of two 
independent experiments with >50 cells counted per experiment). Asterisk denotes a 
statistically significant difference analysed by a two-tailed Fisher’s exact test (P<0.0005). (C) 
Chromosome alignment defects are independent of cell type. (i) A similar protocol to (A) 
was followed in U2OS cells stably expressing GFP-α-tubulin and RFP-Histone 2B. (ii) 
Quantitative analysis of misaligned chromosomes in cells depleted of MCPH1. The graph 
represents one experiment with 50 metaphase cells counted. (D) Similar chromosome 
alignment defects with MCPH1#2 siRNA. (i) A similar protocol to (A) was followed with 
siMCPH1#2 oligonucleotides in HeLa cells. (ii) Quantitative analysis of misaligned 
chromosomes in cells depleted of MCPH1. The graph represents one experiment with 50 
metaphase cells counted. Scale bars represent 10 µm. 
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5.1.4. Live-imaging of MCPH1-deficient cells  
siRNA-mediated depletion of MCPH1 resulted in two phenotypes at mitosis i) 
chromosome misalignment and ii) multipolar spindles. It is unclear if both of these 
phenotypes are a primary phenomenon or if one precedes the other. Thus, to study 
the sequence of events, live-cell imaging of U2OS cells stably expressing GFP-
tagged α-tubulin and RFP-tagged histone 2B was performed (live-cell imaging was 
performed in conjunction with Paola Vagnarelli, University of Edinburgh). As shown 
in Figure 5.4, the control siRNA treated cells underwent normal mitosis (progressing 
from metaphase to telophase in 20 min) whereas the cells depleted of MCPH1 failed 
to enter anaphase. These cells spent a prolonged time in metaphase, a normal 
metaphase plate was formed but subsequently chromosomes were lost from this 
alignment increasing in number with time. Initially a bipolar spindle is formed but 
after a prolonged time in metaphase the spindle collapses. Thus, the live-imaging 
revealed that chromosome misalignment precedes spindle multipolarity but follows 





Figure 5.4. Live-imaging of MCPH1 depleted cells.  
Stills from time-lapse movies of U2OS cells stably expressing RFP-histone 2B and GFP-α-
tubulin in either luciferase (siLUC) or MCPH1 (siMCPH1#1) depleted cells. Numbers in each 
image represent the relative time in minutes. Time-lapse movies were collected by Paola 











5.1.5. Spindle checkpoint appears to be active in MCPH1-
deficient cells 
The prolonged time in metaphase observed after MCPH1 depletion could be due to 
activation of the spindle checkpoint. Checkpoint activation is achieved by sustained 
recruitment of checkpoint proteins, such as BUBR1 and MAD2, to the kinetochores 
which prevents activation of the anaphase promoting complex/cyclosome (APC/C) 
and targeting of cellular cyclin-B for degradation. Direct confirmation has not yet 
been possible as detection of BUBR1 localisation to the kinetochores has been 
difficult to demonstrate due to technical issues with BUBR1 immunofluorescence. 
However, immunofluorescence of MCPH1 depleted cells with misaligned 
chromosomes (of various severities) demonstrated a bright stain for cyclin-B1with 
levels comparable to metaphase siLUC control cells (Figure 5.5). This suggests that 
cyclin-B1 is not targeted for degradation in metaphase MCPH1-deficient cells, in 





Figure 5.5. High cyclin-B1 levels are present in MCPH1 depleted cells. 
HeLa cells were transfected with luciferase or MCPH1 siRNAs and, after 48 hr, fixed in 4 % 
PFA and subjected to immunofluorescence staining with cyclin-B1 antibodies. DNA was 
visualized with DAPI (blue). All images were acquired with the same camera exposure. For 
comparison, a control siRNA transfected cell in metaphase with high cyclin-B1 levels is 






5.1.6. Multipolar spindle phenotype is due to fragmentation 
of PCM 
The live-cell imaging established that the formation of multipolar spindles is 
secondary to chromosome misalignment. Consistent with this, excess γ-tubulin foci 
in fixed cell preparations was only observed in MCPH1-deficient mitotic cells and 
not interphase cells, suggesting that multiple centrosomes arise during mitosis 
(Figure 5.6A). Such multipolar spindles could arise during mitosis through a number 
of different mechanisms. Firstly, aberrant centriole disengagement could lead to the 
formation of multipolar spindles (Thein et al., 2007). If this was the case, then each 
of the spindle poles would contain a single centriole. Centriole staining (using CPAP 
antibody) of MCPH1 depleted cells revealed that the majority of γ-tubulin foci (68%) 
did not contain centrioles (Figure 5.6B). In most cells, CPAP localisation overlapped 
with only two of the γ-tubulin foci. Thus premature centriole separation does not 
appear to account for the observed spindle multipolarity. 
The second possibility is that multipolar spindles are due to fragmentation of the 
PCM surrounding the centrioles. As shown in Figure 5.6C, PCM proteins, such as 
aurora A, pericentrin and CDK5RAP2, all localise to each of the spindle poles 
suggesting that they resemble normal centrosomes regardless of the absence of 
centrioles. This is consistent with the hypothesis that multipolar spindle phenotype 






















Figure 5.6. Multipolar spindles arise due to fragmentation of PCM. 
(A) Proportion of siLUC or siMCPH1 transfected HeLa cells with more than two ϒ-tubulin 
foci in interphase and mitosis. Quantification of triplicate experiments of at least 50 cells 
each. (B) (i) Control or MCPH1-depleted cells were stained with antibodies against CPAP 
(green) and ϒ-tubulin (red). DNA was visualized with DAPI. The insets show 2 x magnified 
images. (ii) Quantitative analysis of the centriole number at each ϒ-tubulin foci in cells 
depleted of MCPH1. The number of poles containing zero, one, or two centrioles was 
plotted as a percentage of the total number of ϒ-tubulin foci. The graph represents one 
experiment of 50 cells. (C) Control or MCPH1 depleted cells were stained with antibodies 
against ϒ-tubulin (red), aurora A (green), pericentrin (green) or CDK5RAP2 (green). DNA was 
visualized with DAPI. Scale bar represents 10 µm. 
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5.1.7. MCPH1 deficiency compromises chromatid cohesion 
Chromosome alignment defects occurring after MCPH1 depletion might result from 
loss of chromatid cohesion. To investigate this possibility, MCPH1-RNAi cells were 
stained with the centromeric marker ACA. As shown in Figure 5.7, siMCPH1 
transfected cells, with only a few chromosomes misaligned, have centromere 
doublets escaping from the metaphase plate (Figure 5.7, panel 2). It is only when 
more DNA is lost from the metaphase plate that single centromeres on separated 
chromatids are present (Figure 5.7, panel 3 & 4). This suggests that loss of sister 
chromatid cohesion is unlikely to be the initial cause of chromosome misalignment 
but a secondary consequence, possibly due to prolonged time in metaphase.   
 
Figure 5.7 Chromatids prematurely separate in MCPH1 deficient cells. 
Hela cells were transfected with control or MCPH1 siRNAs, fixed in methanol:acetone and 
subjected to immunofluorescence staining with centromere autoantibodies (ACA, red). 
DNA was visualized with DAPI (blue). Immunofluorescence staining and imaging was 
performed by Paola Vagnarelli. The fourth panel shows 2 x magnified images of panel 3. 









5.2. Mcph1-/- MEFs 
5.2.1. Generation and characterisation of Mcph1-/- MEFs 
To validate the MCPH1 RNAi findings, the phenotype of MEFs from Mcph1 
„knockout first‟ genetrap mice was investigated. Mcph1
-/- 
mice were obtained from 
the European Conditional Mouse Mutagenesis Program (EUCOMM). In the Mcph1 
gene targeting allele (Figure 5.8A), the cassette was inserted into intron 3 of the 
Mcph1 gene and results in the splicing of exon 3 to the splice acceptor in the 
targeting cassette (En2 SA). This results in the formation of a fusion transcript of 
Mcph1 exon 1-3 with β-galactosidase (βgal) and neomycin phosphotransferase (neo), 
which inactivates the original version of the gene leading to a knockout at the RNA 
processing level. The functional consequences are likely to be null and therefore the 
mice are denoted as Mcph1
-/-
. In addition, there is a conditional element to the Mcph1 
gene-targeting allele (FRT and LoxP sites) that would enable a conditional genetic 
knockout of exon 5 but this is not utilised in this study.  
To examine the phenotype of primary cells deficient for MCPH1, mice heterozygous 
for Mcph1 gene trap were mated and embryos collected. The embryos were 
genotyped by PCR (Figure 5.8B) with the primers annealing to Mcph1 sequence 
indicated in Figure 5.8A. The size of the PCR products enabled the Mcph1 allele 
with or without the gene trap to be differentiated. Those with the desired genotype, 
either Mcph1
+/+
 (244 bp PCR product only) or Mcph1
-/-
 (366 bp PCR product only), 
were dissected to generate primary fibroblast cultures. 
Phenotypic analysis was used to confirm that the Mcph1
-/-
 MEFs were deficient in 
MCPH1. Cells lacking MCPH1 show abnormal chromosome condensation. This 
phenotype is distinct, easily characterised and present in all MCPH1-deficient cells 
analysed, including patient-derived cells (Trimborn et al., 2004), MEFs (Trimborn et 
al., 2010; Wood et al., 2008) and as a result of RNAi mediated knockdown 
(Trimborn et al., 2004). Staining of the DNA of Mcph1
-/-
 MEFs demonstrated that 
they too show a significant number of cells with abnormally condensed 
chromosomes (Figure 5.8Ci). This phenotype is highly penetrant with 35 % of non-
mitotic Mcph1
-/-





 MEFs (Figure 5.8Cii). This is in comparison to 30-35 % of Mcph1
-/-
 
MEFs displaying PCC previously published (Wood et al., 2008). Thus, the Mcph1 
gene-trap does appear to be successfully depleting most, if not all, of the MCPH1 
protein and, by inference, is correctly targeted to the endogenous locus.  
 
 
Figure 5.8. Characterisation of the Mcph1 gene-trap allele.  
(A) Schematic of EUCOMM Mcph1 gene-trap allele. Mcph1 exons are displayed in black, the 
FRT sites in grey, the reporter gene and LoxP sites are in white. (B) PCR-based genotype 
analysis of Mcph1+/+, Mcph1+/- and Mcph1-/- mouse embryos. Positions of PCR primers (F, R1 
& R2) are indicated in (A).  A 244 bp PCR product was detected in the absence of Mcph1 
gene trap and a 366 bp PCR product detected in the presence of Mcph1 gene trap. (C) 
Analysis of chromosome condensation in Mcph1-/- cells. (i) Mcph1+/+ or Mcph1-/- MEF cell 
cultures were fixed and stained with DAPI. The right panel shows a prophase-like cell. (ii) 
Proportion of prophase-like cells in Mcph1+/+ and Mcph1-/- cell cultures. The graph 





To determine the role of MCPH1 during mitosis in MEFs, Mcph1
-/-
 cells were 
analysed by immunofluorescence. Initially, chromosome alignment during 
metaphase was investigated, chromosomes were visualised by DAPI staining and α-
tubulin antibody was used to visualise the microtubules. Mcph1
-/-
 MEFs showed an 
increase in cells with misaligned chromosomes compared to Mcph1
+/+
 (12.5% in 
comparison to 3.5%, p<0.05 (Fisher‟s exact test)) (Figure 5.9A). To investigate this 
further the immunofluorescence was repeated in cells treated with the proteasome 
inhibitor MG132 for 2 hr. MG132 arrests cells in metaphase by preventing cyclin B 
and securin degradation (reviewed by Lee and Goldberg, 1998). This treatment 
increases the number of metaphase cells available to quantify, facilitating analysis of 
primary cells with a low mitotic index. In addition, MG132 has been reported to 
enhance the Cdc20 hypomorphic phenotype in MEFs by increasing the incidence of 
misaligned chromosomes (Malureanu et al., 2010). Again, the Mcph1
-/-
 MEFs 
showed a statistically significant increase in chromosome alignment defects 
compared to Mcph1
+/+
 MEFs (9.1 % compared to 1.9 %, p<0.01 (Fisher‟s exact test)) 
following treatment with MG132 (Figure 5.9B). Importantly, the incidence of 
chromosome misalignment was similar between untreated and MG132-treated 
Mcph1
+/+
 MEFs, so prolonging the time to establish ktMT connections neither 
improved nor exacerbated this phenotype.  
The majority of Mcph1
-/-
 MEFs quantified had 2-10 misaligned chromosomes 
(Figure 5.9B panel 2 & 3). Gross chromosome alignment defects and spindle 
multipolarity, as with MCPH1 RNAi, were not apparent. An increase in premature 
chromatid separation was also not evident from chromosome spreads of Mcph1
-/- 
MEFs compared to Mcph1
+/+ 
(Figure 5.9C). Thus, Mcph1
-/-
 MEFs show chromosome 
alignment defects at metaphase but these did not progress in severity to the scale of 









Figure 5.9. MCPH1-deficient MEFs show chromosome alignment defects. 
(A) Analysis of chromosome alignment in Mcph1-/- MEFs. Asynchronous Mcph1+/+ and 
Mcph1-/- MEF cell line cultures were fixed in methanol and stained with α-tubulin 
antibodies and DAPI. Metaphase cells with a bipolar spindle and misaligned chromosomes 
were quantified. (B) Increased levels of misaligned chromosomes are also seen in Mcph1-/- 
MEFs following MG132 treatment. Cells were treated with MG132 for 2 hr, fixed in 4 % PFA 
and stained with α-tubulin antibodies and DAPI. Scale bar represents 10 µm. Data 
presented are the percentages of metaphase cells with misaligned chromosomes (mean +/- 
s.e.m. of five independent experiments with 50 cells counted per experiment). An asterisk 
denotes a statistically significant difference analysed by two-tailed Fisher’s exact test 
(P<0.01). (C) Chromosome spreads of Mcph1-/- MEFs. Following the addition of colcemid to 
Mcph1-/- and Mcph1+/+ MEFs for 45 min, cells were collected, treated with KCl and fixed in 
Methanol:acetic acid (3:1, fixation performed by Margaret Harley). Slides were prepared 







5.3. MCPH1 patient lymphoblastoid cells 
Primary microcephaly proteins could all play a role in the maturation of the 
centrosome during mitosis. Centrosome maturation is a term used to describe the 
recruitment of pericentriolar material (PCM), microtubule nucleating and anchoring 
proteins to confer increased microtubule nucleation capacity to mitotic centrosomes 
(reviewed by Blagden and Glover, 2003; Palazzo et al., 2000). Various centrosomal 
proteins such as γ-tubulin (Khodjakov and Rieder, 1999), pericentrin (PCNT) 
(Zimmerman et al., 2004), CDK5RAP2 (Fong et al., 2008) and polo-like kinase 1 
(Lane and Nigg, 1996) are required for this process.  
All of the primary microcephaly proteins localise to the centrosome during mitosis 
and I hypothesise that they may all have a common role in centrosome maturation 
(Figure 5.10). CPAP, CEP152 and Ana2 (the STIL Drosophila orthologue) all play a 
role in centriole duplication (Cizmecioglu et al., 2010; Hatch et al., 2010; Kohlmaier 
et al., 2009; Schmidt et al., 2009; Stevens et al., 2010a; Tang et al., 2009) and the 
centrioles act as a scaffold for the recruitment of PCM (Basto et al., 2006; Bobinnec 
et al., 1998; Conduit et al., 2010; Kirkham et al., 2003; Salisbury, 2003). Another 
primary microcephaly protein, CDK5RAP2 is a PCM component, with enhanced 
levels at mitosis (Haren et al., 2009) and is required for recruitment of γ-tubulin 
(Fong et al., 2008; Zimmerman et al., 2004), a component of the γTURC complex 
responsible for microtubule nucleation (reviewed by Wiese and Zheng, 2006). The 
ASPM orthologue in Drosophila, Asp, also plays a role in nucleation and focussing 
of microtubules (do Carmo Avides and Glover, 1999; do Carmo Avides et al., 2001; 
Wakefield et al., 2001), and it is possible that ASPM plays a similar role in a 
vertebrate system (Higgins et al., 2010). Thus, many of the primary microcephaly 
proteins can already be functionally linked to the process of centrosome maturation. 
Analysis of centrosomal maturation had been difficult using the other systems 
described so far; the MCPH1 RNAi chromosome misalignment phenotype had 
secondary consequences on centrosome morphology and the relevant antibody 
reagents were not available for a thorough analysis of Mcph1
-/-
 MEFs. Thus, to 
investigate the role of MCPH1 in centrosome maturation, lymphoblastoid cell lines 





Figure 5.10. Hypothesis: primary microcephaly genes act in a centrosome maturation 
pathway. 
Centriole function, PCM maturation, microtubule nucleation and focussing are all 
interlinked processes that can affect the mitotic spindle pole. Thus, although the primary 
microcephaly proteins are implicated in distinct centrosomal functions they may all 
contribute to mitotic spindle pole formation. (Figure adapted from Haren et al., 2009). 
 
 
5.3.1. CDK5RAP2, ASPM and γ-tubulin protein abundance is 
unaffected in MCPH1 LBCs 
Given that MCPH1 is reported to regulate BRCA1 and CHK1 levels (Lin et al., 
2005; Xu et al., 2004; Yang et al., 2008) the abundance of  PCNT, CDK5RAP2, 
CPAP, ASPM and γ-tubulin was assessed in MCPH1 LBC whole cell extracts. A 
PCNT LBC was also included in this analysis as it serves as a positive control in 
subsequent experiments. Immunoblotting of the extracts from two WT LBC lines 




) and one 
PCNT patient LBC line (PCNT
E220X





 LBC  and PCNT A & B protein isoforms 
were absent in PCNT
E220X
 LBC (Figure 5.11). The abundance of ASPM, 
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CDK5RAP2 and γ-tubulin was similar between all the LBC lines (CPAP was not 
detectable by immunoblotting with the antibody available). Thus, neither MCPH1 
nor PCNT regulate total levels of CDK5RAP2, ASPM or GTUB protein in the cell. 
 
 
Figure 5.11. Protein levels of PCNT, CDK5RAP2, ASPM and γ-tubulin are unaffected in 
MCPH1 and PCNT patient LBC. 
Cell extracts from LBC of two controls (WT1 & WT2), two MCPH1 patients ( MCPH1143fs, 
MCPH107fs)  and one PCNT patient ( PCNTE220X) were Western blotted with MCPH1, PCNT, 
CDK5RAP2, ASPM, γ-tubulin and vinculin antibodies. 
 
5.3.2. CPAP localisation and centriole duplication is 
unaffected in MCPH1 LBCs 
MCPH1 could act in centriole biogenesis, perhaps even by localising the primary 
microcephaly protein CPAP to the centrioles (Figure 5.12A). To investigate this 
possibility the role of MCPH1 in centriole duplication was analysed by 
immunofluorescence with CPAP (Figure 5.12Bi). CPAP levels were similar between 
MCPH1
107fs
 and control LBC suggesting that MCPH1 is not required for CPAP 
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recruitment to centrioles. In addition, there were no significant differences in 
centriole number between MCPH1
107fs
 and control LBC (Figure 5.12Bii). Due to 
centriole pair orientation relative to the plane of microscope, often only one centriole 
could be distinguished at the spindle pole by microscopy, however the occurrence of 
this finding was equal between both LBC lines tested. Thus, MCPH1 does not appear 
to be required for centriole duplication in LBC.  
 
 
Figure 5.12. CPAP localisation and centriole number is not affected in MCPH1 patient 
derived LBC.   
(A) Hypothesis: MCPH1 could be required for centriole formation and/or structure. (Bi) 
Control and MCPH1107fs LBC were fixed in methanol and stained with PCNT (red) and CPAP 
(green) antibodies. DNA was visualised by DAPI staining. The left panel represents a cell 
with 4 stained centrioles and the right panel represents a cell with 3 centriole signals. Insets 
show 2 x magnified images. Scale bar is 10 µm. (ii) Quantitation of centriole number in 
control and MCPH1107fs LBC. The number of cells containing two, three, four or five CPAP 
stained centrioles plotted as a percentage of the total cell number. The graph represents 






5.3.3. Centrosome maturation is unaffected in MCPH1 LBCs 
Given that many of the primary microcephaly proteins or their orthologues play a 
role in PCM expansion (Conduit et al., 2010; Dobbelaere et al., 2008; Haren et al., 
2009; Kirkham et al., 2003) and MCPH1 is required for recruitment of some PCM 
proteins during interphase (Tibelius et al., 2009), the role of MCPH1 in the mitotic 
recruitment of three PCM markers PCNT, CDK5RAP2 and γ-tubulin was 





). The PCNT patient LBC line (PCNT
E220X
) was also 
included in this analysis as a positive control as depletion of PCNT is known to have 
an effect on γ-tubulin and CDK5RAP2 levels at mitosis (Griffith et al., 2008; Haren 
et al., 2009; Zimmerman et al., 2004).  
Immunofluorescence microscopy established that levels of PCNT, CDK5RAP2 and 
γ-tubulin in MCPH1 LBC are similar to the control LBC (Figure 5.13B i-iii). Pixel 
intensity of the volume encompassing the centrosome was quantified for each signal 
in order to confirm the subjective interpretation that there was no substantial 
difference in levels. As expected, PCNT LBC showed a pronounced reduction of 
CDK5RAP2 (80%) (Figure 5.13Bi) and γ-tubulin (60%) (Figure 6.3 B iii) compared 
to WT LBC. Thus, PCNT but not MCPH1 is required for recruitment of PCM 








Figure 5.13. Recruitment of CDK5RAP2, PCNT and γ-tubulin are unaffected in MCPH1 
patient derived LBCs.  
(A) Hypothesis: MCPH1 acts in PCM recruitment during mitosis. (B) LBC were fixed in 
methanol and stained with (i) CDK5RAP2, (ii) PCNT or (iii) γ-tubulin antibodies. Bar graphs 
represent quantification of (i) CDK5RAP2, (ii) PCNT or (iii) γ-tubulin signal in prometaphase 
or metaphase MCPH1143fs, MCPH1107fs and PCNTE220X LBCs, relative to control. Error bars 
represent s.d. of 20 prometaphase or metaphase cells (for CDK5RAP2 staining two 









5.3.4. Microtubule focussing and ASPM localisation is 
unperturbed in MCPH1 LBCs 
Many of the primary microcephaly proteins or their orthologues play a role in 
nucleating and organising the microtubules (Choi et al., 2010; do Carmo Avides and 
Glover, 1999; Fong et al., 2008; Gonzalez et al., 1990). MCPH1 is required for γ-
tubulin recruitment to PCM during interphase (Tibelius et al., 2009), which is 
required to confer microtubule nucleating and organisation capacity to centrosomes 
(Oakley et al., 1990; Oakley and Oakley, 1989). To assess if MCPH1 is required for 
spindle morphology during mitosis, MCPH1 LBC were assessed using α-tubulin 
antibody to visualise microtubules and ASPM to stain the minus-ends of 
microtubules. Immunofluorescence analysis of ASPM stained cells revealed that 
levels were similar between MCPH
107fs 
and control LBC and that the minus-end 
microtubules were appropriately focused around the centrosome (visualised with 
aurora A antibodies) (Figure 5.14B). Staining of α-tubulin was consistent with 
ASPM staining showing that microtubule nucleation and focusing at the spindle pole 
was similar between MCPH
107fs 
and control LBC (Figure 5.14C). Thus, the 







Figure 5.14. Microtubule nucleation and focusing is not affected in MCPH1 patient 
derived LBC.  
(A) Hypothesis: MCPH1 is required for microtubule organisation during mitosis. (B) Control 
and MCPH1107fs LBC were fixed in 4 % PFA and stained with ASPM (red) and aurora A 
(green) antibodies. Insets represent ASPM signal alone. (C) Control and MCPH1107fs were 
fixed in methanol and stained with α-tubulin antibody. DNA was visualised by DAPI staining. 








5.4.1. MCPH1 is required for chromosome alignment 
This chapter establishes that MCPH1 is required for chromosome alignment during 
metaphase. RNAi-mediated depletion of MCPH1, delayed cells at metaphase and 
during this time chromosomes and chromatids are lost from the metaphase plate 
(Figure 5.1 & 5.4). Overexpression of GFP-MCPH1(FL) partially rescued this 
phenotype, consistent with this phenotype arising specifically due to loss of MCPH1 
(Figure 5.1B). In addition, genetic ablation of Mcph1 gene function in MEFs also 
leads to chromosome alignment defects (Figure 5.9).  
The severity and frequency of the phenotype in primary MEF cells is substantially 
lower than due to RNAi-mediated depletion of transformed HeLa cells (12.5 % 
compared to 72 %) (Figure 5.2 & 5.9). This is not entirely surprising, Mcph1
-/-
 mice 
are healthy with only subtle phenotypic abnormalities detected to date 
(www.sanger.ac.uk/mouseportal/search/MGI:2443308) and so the severe mitotic 
defects observed with MCPH1-RNAi was unlikely. There are a number of possible 
explanations to account for the differences in phenotype between MEFs and HeLa 
RNAi cells. First, MEFs are primary cells so they may possess checkpoints and 
apoptotic responses that have been dampened or lost in transformed cells. As a result 
the MEFs may be more sensitive to chromosome misalignments which could trigger 
apoptosis before progression of this phenotype. Second, HeLa cells have a greater 
chromosome complement than MEFs (approximately 76-80 versus 42) (Bennett, 
1965; Macville et al., 1999) and with more chromosomes to align, HeLa cells may 
have an increased frequency of alignment errors. Third, splice-trap mutations, which 
was used to knockdown Mcph1 in MEFs, can often be leaky and hypomorphic 
(Barrera et al., 2010; Trimborn et al., 2010) and it is possible that there are residual 
levels of MCPH1 protein that may exert some function. Finally, the severe 
phenotype observed due to MCPH1 RNAi may reflect the immediate response to 
MCPH1 depletion, whereas during chronic absence of MCPH1, like in Mcph1
-/-
 
MEFs, the cells may have been able to adapt to loss of MCPH1 through upregulation 
of redundant pathways. Consistent with this possibility, phenotype severity differs 
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between acute and chronic depletion of Aspm in mice (Fish et al., 2006; Pulvers et 
al., 2010).  
 
5.4.2. Chromatid cohesion is lost in MCPH1-RNAi cells 
Chromatid cohesion between sister chromatids during a metaphase arrest is lost in 
MCPH1 depleted cells (but not Mcph1
-/-
 MEFs) (Figure 5.7). Such cohesion is 
maintained by the cohesin protein complex which tethers sister chromatids at the 
centromere until anaphase onset (reviewed by Peters et al., 2008). Proteins such as 
shugoshin 1 (Kitajima et al., 2005; McGuinness et al., 2005; Salic et al., 2004; Tang 
et al., 2004) and protein phosphatase 2A (PP2A) (Kitajima et al., 2006; Tang et al., 
2006) are required to protect centromeric cohesin from cleavage until anaphase. At 
anaphase, separase mediated cleavage of cohesin releases it from the centromere and 
allows chromosome segregation to occur (Hauf et al., 2001). 
It is unclear if MCPH1 plays a direct role in cohesion protection. Recently it has 
been demonstrated that spindle pulling forces on kinetochores during a prolonged 
metaphase can lead to chromatid separation (Daum et al., 2011). Daum et al. 
demonstrated that cohesin is maintained on centromeres of separated chromatids but 
hypothesised that during metaphase kinetochore-microtubule attachments rupture the 
molecular linkages of the cohesin complex. There is some evidence to suggest that 
prolonged time in metaphase could be the cause of chromatid separation due to 
MCPH1-RNAi. First, fixed-cell preparations of MCPH1-RNAi cells established that 
separated chromatids were only evident when there was significant loss of DNA 
from the metaphase plate (Figure 5.7). Live-cell imaging demonstrated the severity 
of chromosome/chromatid misalignment progressed with prolonged time in 
metaphase (Figure 5.4) which would suggest that the role of MCPH1 in maintaining 
chromatid cohesion may be time-dependent. In addition, MCPH1-RNAi cells do 
form a normal metaphase plate and if MCPH1 was directly required for cohesin 
protection at the centromeres then chromatid cohesion would likely be lost in 
prometaphase, after loss of cohesin along the length of sister chromatid arms in 
prophase (Waizenegger et al., 2000). However, reports do differ on whether 
chromatid separation due to SGO1 RNAi mediated depletion arises during 
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prometaphase or metaphase, differences are possibly dependent on efficiency of 
protein depletion (Daum et al., 2011; Daum et al., 2009; Salic et al., 2004). Thus, 
although it is more likely that MCPH1 phenotype is related to time spent in 
metaphase further work to confirm this would be worthwhile. One possibility would 
be to perform live-cell imaging of a cell line stably expressing GFP-CENP-A 
following depletion of MCPH1 or SGO1. If the role of MCPH1in chromatid 
cohesion is dependent on a prolonged metaphase then loss of chromatid cohesion is 
likely to arise much later during mitosis than due to SGO1 depletion. 
5.4.3. MCPH1 is required for spindle bipolarity  
RNAi-mediated depletion of MCPH1 leads to spindle multipolarity during mitosis 
(Figure 5.3A). Overexpression of GFP-tagged MCPH1(FL) can rescue this 
phenotype, suggesting it arises due to the specific depletion of MCPH1 (Figure 
5.3B). However the rescue of spindle multipolarity or chromosome alignment is only 
partial and further work may be required to get a more significant phenotype rescue. 
Rescue may be incomplete due to the GFP epitope-tag impairing full biological 
function and so rescue experiments with untagged MCPH1 may be more penetrant. 
Alternatively, more than one MCPH1 isoform may need to be expressed for 
complete rescue of chromosome misalignment or spindle multipolarity. Targeting 
specific MCPH1 isoforms by RNAi (Figure 3.4) may enable the contribution of each 
isoform to chromosome segregation and spindle bipolarity to be assigned. Lastly, 
precise MCPH1 levels may limit rescue efficiency; indeed cells are very sensitive to 
MCPH1 expression levels (Section 4.3.1). Rescue with MCPH1 under its 
endogenous promoter element may overcome this limitation. Often rescue 
experiments are performed with the orthologous gene in murine bacterial artificial 
chromosomes (Kittler et al., 2005) which is usually resistant to RNAi. However, it is 
worth noting that a partial phenotype rescue was only achieved in mcph1 Drosophila 
syncytial embryos stably expressing Mcph1 and so it may be that a more penetrant 
rescue with MCPH1 is not achievable (Brunk et al., 2007).  
What is the underlying cause of spindle multipolarity? Multipolar spindles can arise 
through several distinct pathways: i) failed cell division which can lead to the 
formation of a tetraploid cell with four centrosomes (Borel et al., 2002; Meraldi et 
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al., 2002); ii) centriole overduplication which can be triggered by prolonged time in 
S-phase and loss of centriole engagement (Loncarek et al., 2008); iii) compromised 
centrosome stability (Oshimori et al., 2006). Tetraploidization or centriole 
amplification would lead to the presence of extra centrioles and centrosomes during 
interphase which is not the case in MCPH1-RNAi cells. Live and fixed preparations 
of MCPH1-RNAi cells established that extra PCM foci only appear during mitosis 
and that most of these foci do not contain centrioles (which also rules out premature 
centriole disengagement during mitosis as a causative mechanism (Thein et al., 
2007)) (Figure 5.6). Thus, it is likely that extra spindles arise due to fragmentation of 
the PCM from the centrosomes during mitosis (Figure 5.6C).     
PCM fragmentation during mitosis could be a primary or secondary phenomenon. 
Firstly, as MCPH1 does localise to the centrosome it could play a structural role in 
maintaining centrosome stability during mitosis. It has been demonstrated that 
microtubule forces on a structurally weakened centrosome can cause the PCM to 
fragment (Abal et al., 2005; Oshimori et al., 2006). Further characterisation of 
centrosome morphology before chromosomes misalign may also be helpful in 
examining the possibility of a primary centrosome phenotype.  
Secondly, as spindle multipolarity follows the disintegration of the metaphase plate it 
could be a secondary consequence of this. Indeed, it has been demonstrated that loss 
of chromatid cohesion can lead to loss of spindle pole bipolarity during metaphase 
(Dai et al., 2009). If this was the case for MCPH1-deficient cells, then preventing 
resolution of DNA catenations by topoisomerase II inhibitor may rescue the 
phenotype by maintaining association of sister-chromatids (Toyoda and Yanagida, 
2006).  
5.4.4. What is the primary function of MCPH1 at mitosis? 
A range of phenotypes were observed due to RNAi-mediated loss of MCPH1 
including metaphase arrest, chromosome misalignment, loss of chromatid cohesion 
and spindle multipolarity. Fixed and live-cell imaging suggests that loss of chromatid 
cohesion and spindle multipolarity are secondary defects following metaphase arrest 
and chromosome misalignment (Figures 5.4, 5.6 & 5.7).  
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It will be important to determine if the metaphase arrest in the MCPH1-RNAi cells is 
due to the spindle activation checkpoint (SAC). Activation of the SAC can be 
inferred by visualisation of kinetochore accumulation of MAD1, MAD2 or BUBR1 
during metaphase (Hoffman et al., 2001) or by demonstrating rescue of arrest 
through inhibition of checkpoint signalling (for example by treatment with the aurora 
B inhibitor ZM447439 (Ditchfield et al., 2003) or BUBR1/MAD2 RNAi (Meraldi et 
al., 2004). If the SAC is indeed activated during metaphase then it will be relevant to 
determine the primary cause of its activation. Two possibilities are kMT attachment 
defects which sustain SAC activation (reviewed by Musacchio and Salmon, 2007) 
and/or failure to silence the SAC (reviewed by Vanoosthuyse and Hardwick, 2009b).  
As chromosomes become misaligned from the metaphase plate this suggests that 
MCPH1 may well be required for kMT attachments. However, if kMT attachments 
are defective, it is surprising that a normal metaphase plate can be formed in 
MCPH1-deficient cells. One possibility is that defects in kMT attachments increase 
the time taken for chromosome congression but eventually normal chromosome 
alignment is achieved, as has been reported for  SKAP, ska1 and ska2 (Dunsch et al., 
2011; Hanisch et al., 2006; Schmidt et al., 2010). This can be investigated by live-
cell imaging of RFP-H2B U2OS cells depleted of MCPH1 to follow chromosome 
behaviour during progression from prophase through to metaphase. In addition, the 
stability of kMT attachments could also be directly assessed. When microtubules 
attach to kinetochores they become much more resistant to depolymerisation induced 
by cold treatment (Brinkley and Cartwright, 1975). Thus, the role of MCPH1 in kMT 
attachments could be analysed by measuring kMT fibres in MCPH1-RNAi cells 
following exposure to cold temperatures (Lampson and Kapoor, 2005).  
Another possibility (that is not mutually exclusive to a role in kMT attachment) is 
that MCPH1 is required to switch off the spindle checkpoint. In this case, the loss of 
chromosomes may be a consequence of extended time in metaphase arrest. How 
MCPH1 could potentially function in silencing the checkpoint is undefined. Two 
mechanisms proposed to account for checkpoint silencing is dynein dependent 
stripping of spindle checkpoint proteins, such as MAD1 and MAD2, from the 
kinetochores (Howell et al., 2001) or protein phosphatase 1 (PP1) mediated reversal 
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of aurora B and other kinase phosphorylation events that occur during SAC 
activation (Pinsky et al., 2009; Vanoosthuyse and Hardwick, 2009a). 
In regards to a how MCPH1 may participate in these processes at the kinetochore, 
exploring the relationship between MCPH1 and PP1 may be particularly interesting. 
PP1α has a similar spatio-temporal distribution to MCPH1, localising to the 
kinetochores at metaphase and then chromatin at late anaphase (Trinkle-Mulcahy et 
al., 2006). Indeed, a component of the PP1α catalytic domain (PPP1CA) was 
recently identified as a preliminary MCPH1 interactant in a mass spectrometry 
screen of proteins associated with GFP-tagged MCPH1 (Margaret Harley, personal 
communication). Thus, it is possible that MCPH1 may be required for targeting 
protein phosphatases such as PP1α to the kinetochores to oppose aurora B 
phosphorylations, stabilising kMT interactions and/or silencing the spindle 
checkpoint. 
There is also a striking similarity between the range of phenotypes identified in 
MCPH1-deficient cells and that reported for a number of kinetochore proteins such 
as astrin, the ska1 complex (ska1-3) and SKAP (Fang et al., 2009; Gaitanos et al., 
2009; Hanisch et al., 2006; Mack and Compton, 2001). Metaphase arrest and 
chromosome misalignment have been reported for all these proteins with astrin and 
ska3 additionally presenting with loss of chromatid cohesion and spindle 
multipolarity (Daum et al., 2009; Gaitanos et al., 2009; Thein et al., 2007; Theis et 
al., 2009) (Dunsch et al., 2011; Fang et al., 2009; Hanisch et al., 2006; Schmidt et 
al., 2010; Welburn et al., 2009). However the interpretation of the primary defect has 
varied between publications and roles in regulation of separase activity (Fang et al., 
2009; Thein et al., 2007), chromosome movement (Welburn et al., 2009), spindle 
checkpoint silencing (Daum et al., 2009) and kMT attachment have been proposed 
(Gaitanos et al., 2009; Manning et al., 2010; Raaijmakers et al., 2009; Thein et al., 
2007; Theis et al., 2009; Welburn et al., 2009). It would be particularly worthwhile 
to investigate if MCPH1 functions in the same pathway as any of these proteins since 
they share the same phenotypes. Further studies could include screening for these 
proteins as MCPH1 interactants and to determine if MCPH1 is required for the 
recruitment of these proteins to the kinetochores or vice versa.  
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5.4.5. MCPH1 does not appear to be required for centrosome 
maturation 
Notably centrosome maturation did not appear to be affected in MCPH1 patient-
derived LBC suggesting that this is not a shared pathway contributing to primary 
microcephaly pathogenesis. MCPH1 LBC, null for MCPH1 FL and S protein (Figure 
5.11), had normal centriole numbers (Figure 5.12), efficiently recruited three PCM 
proteins CDK5RAP2, pericentrin and γ-tubulin during mitosis (Figure 5.13) and 
formed well-focussed spindle poles (Figure 5.14). Initial observations in Mcph1
-/-
 
MEFs and MCPH1 RNAi cells are also consistent with these findings in MCPH1 
patient-derived LBC. During mitosis, centriole numbers were normal, PCM proteins 
were recruited (only γ-tubulin antibody reagent was available for MEFs) and spindle 
pole morphology looked normal (data not shown). However, these preliminary 
findings require further validation and subtle defects are yet to be excluded. 
LBC, HeLa and MEFs are very different to neuronal progenitor cells and so it 
remains possible that defects in centrosome maturation only manifest in this specific 
cell type. However, most of the primary microcephaly proteins localise and function 
at the centrosome in a range of species, cell-types and developmental contexts, for 
example centrosome phenotypes during mitosis due to CDK5RAP2 depletion are 
apparent in MEFs, mouse neuronal cells, chicken lymphoblastoid, HeLa, and U2OS 
(Barr et al., 2010; Barrera et al., 2010; Fong et al., 2008; Lizarraga et al., 2010). 
Thus, although primary microcephaly mutations result in a brain specific phenotype 
this may reflect the sensitivity of this tissue to centrosomal dysfunction rather than 
reflecting a cell-type specific centrosome function. 
MCPH1 shares an interphase centrosomal localisation with many of the primary 
microcephaly proteins and it is possible that an interphase function could contribute 
to primary microcephaly pathogenesis. It has been demonstrated that MCPH1 is 
required for the recruitment of pericentrin and γ-tubulin during interphase (Tibelius 
et al., 2009). This is not inconsistent with the findings in mitotic PCM recruitment as 
some PCM proteins, such as γ-tubulin, appear to be recruited by different 
mechanisms during interphase and mitosis (Rapley et al., 2005). In addition to 
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interphase PCM recruitment, MCPH1 could also share a cilia function with the 
primary microcephaly proteins. Recently cilia length has been implicated in control 
of cell-cycle length and linked to neural progenitor cell fate choice (Kim et al., 2011; 
Li et al., 2011). Indeed, many of primary microcephaly proteins are required for 
ciliogenesis (CPAP, STIL and CEP152) and so this could be shared function between 
all the primary microcephaly proteins (Basto et al., 2006; Blachon et al., 2008; 
Izraeli et al., 1999). Therefore it will be of interest to investigate the cilia in primary 
microcephaly protein deficient cells and in particular their effect on cell cycle length. 
5.4.6. Phenotypic differences between MCPH1 RNAi, Mcph1-/- 
MEFs and MCPH1 LBC 
There are some differences in severity of mitotic phenotype between transformed 
cells depleted of MCPH1 by RNAi, transcriptional ablation of MCPH1 in MEFs and 
genetic ablation in patient LBCs.  There are a number of possibilities which could 
account for these differences. First it is worth noting that one of the earliest defects, 
chromosome misalignment, was present due to RNAi depletion of MCPH1 in 
transformed cells and in Mcph1
-/-
 MEFs. This phenotype was not analysed in 
MCPH1 patient derived LBCs because metaphase plates are much more spread 
making this phenotype difficult to analyse in this suspension cell line. There are 
differences in the progression of mitotic phenotype as loss of chromatid cohesion or 
spindle multipolarity was not apparent in MEFs or LBC due to MCPH1 depletion. 
This may be accounted for by cell type specific differences. Indeed chromatid 
scattering due to a prolonged time in metaphase was reported to be of lower 
penetrance and longer arrest time in karotypically normal cells compared to 
transformed cells (Stevens et al., 2011). Finally the MCPH1 MEFs or LCLs cells 
may be able to adapt to loss of MCPH1 following transcriptional or genetic ablation 





Chapter 6. Post-translational modifications of MCPH1 
 
The temporal localisation and stability of MCPH1 (Chapter 3 and 4) presented the 
intriguing possibility that MCPH1 may be regulated by post-translational 
modifications during the cell cycle. The regulation of mitosis relies predominantly on 
two post-translational mechanisms: protein phosphorylation and proteolysis. As a 
result, this chapter focuses predominantly on the phosphorylation and proteolysis of 
MCPH1 during mitosis but does characterise other non-mitotic modifications of this 
protein. 
6.1. GFP-MCPH1 is cleaved by caspases 
6.1.1. MCPH1 FL and Δ8 proteins demonstrate cleavage 
GFP antibody immunoblotting of GFP-tagged MCPH1 (Chapter 2) often revealed 
the appearance of a band migrating approximately 25 kDa below GFP-FL and GFP-
Δ8 (called FL* and Δ8*) (Figure 6.1A). A band migrating below GFP-S was never 
observed, making it unlikely that FL* and Δ8* was simply a degradation product or 
due to non-specific protein detection. Notably FL* was often more apparent when 
the extracts were from cells treated with nocodazole. The explanation for this is 
unclear. It is unlikely that generation of FL* is mitosis specific since Δ8* was 
apparent in asynchronous cells and it is assumed cleavage is by the same mechanism. 
FL* also appeared in a time-dependent manner upon treatment with cycloheximide, a 
drug used to inhibit protein translation (Figure 6.1B). This suggested that generation 
of this band did not require de novo protein synthesis and was most likely to result 
from post-translational modification of FL. Thus, taken together this evidence 
suggested that both MCPH1 FL and Δ8 are post-translationally cleaved. 
The approximate site of cleavage was apparent from the cleavage products produced 
(Figure 6.1A). The GFP-tag was located at the NH2-terminus thus the cleaved 
proteins (detected by GFP antibodies) must contain the NH2-terminal. MCPH1(S) 
was not visibly cleaved suggesting that cleavage must occur in a region shared 
between FL and Δ8 but absent in S. In addition, FL* is approximately the same size 
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as MCPH1(S) suggesting that the cleavage site must be in the region immediately 
following the MCPH1(S). Within this region, two putative caspase-3 and caspase-7 




↓) (Talanian et al., 1997; 
Thornberry et al., 1997) (Figure 6.1C) that may account for this finding.  
 
Figure 6.1. GFP-MCPH1 FL and Δ8 are cleaved.  
(A) GFP-tagged MCPH1 FL and Δ8 are cleaved. HeLa cells transiently expressing GFP-tagged 
MCPH1 FL, S or Δ8 were either mock-treated or treated with nocodazole (noc) for 16 hr.  
Cell lysates were prepared and subjected to immunoblotting with GFP antibodies. (B) 
Cleavage of MCPH1 FL is not inhibited by cycloheximide (CHX). HeLa cells transiently 
expressing GFP-tagged MCPH1 FL were treated with 40 µg/ml cycloheximide for up to 2 hr. 
Cell lysates were prepared at the indicated time points after CHX addition and subjected to 
immunoblotting with GFP antibodies. (C) Schematic diagram of MCPH1 isoforms and 




6.1.2. MCPH1 FL and Δ8 are cleaved by a caspase-dependent 
mechanism 
Caspases are the executioners of programmed cell death (apoptosis) and actively 
cleave substrates when an apoptotic program has been activated. If GFP-MCPH1 is 
cleaved by a caspase-dependent mechanism then it is likely there is activation of 
apoptosis. By using cleavage of the caspase substrate PARP1 as an indicator, 
apoptosis was indeed induced during overexpression of MCPH1(Δ8) or due to 
nocodazole treatment  (Figure 6.2A & B, lane 1). Apoptosis was further confirmed 
visually by observation of cells with apoptotic morphology. This confirmed caspases 
were active and I next examined whether they could be involved in MCPH1 FL and 
Δ8 cleavage. To verify this, cells overexpressing GFP-MCPH1 FL or Δ8 were 
treated with a pan-caspase inhibitor Z-VAD-FMK. As shown in Figure 6.2A & B, 
FL* and Δ8* did not appear in the presence of the inhibitor, indicating that caspases 
contributed to the generation of GFP-MCPH1 FL* and Δ8 * cleavage products. 
PARP1 cleavage was also suppressed by Z-VAD-FMK confirming inhibition of 










Figure 6.2. GFP-MCPH1 FL and Δ8 are cleaved by a caspase dependent-mechanism. 
HeLa cells transiently expressing GFP-tagged MCPH1 FL (A) or Δ8 (B) were either untreated 
(GFP-Δ8) or treated with nocodazole (noc) for 16 hr (GFP-FL). In combination the cells were 
either mock treated or treated with Z-VAD-FMK for 16 hr. Cell lysates were prepared and 
subjected to immunoblotting with GFP antibodies. Appropriate inhibition of caspases was 
confirmed by immunoblotting for cleaved PARP1. The bar graphs represent quantification 
analysis of the fold change in cleaved protein signal intensity normalised to uncleaved 
protein levels (mean ± standard deviation of two independent experiments).  
 
 
6.1.3. MCPH1 FL and Δ8 are cleaved at aspartate 625 
Given that cleavage of GFP-FL and GFP-Δ8 required caspases (Figure 6.2); it was 
tested whether caspases were directly involved in MCPH1 cleavage. In Figure 6.1C, 




↓) located within 
the expected region of cleavage were identified. The classic caspase 3 and 7 
recognition consensus is DxxD↓ (Talanian et al., 1997; Thornberry et al., 1997). 
However, the residue preceding the fourth aspartate (D) (P1ꞌ) is also very important 
and charged or bulky residues are poorly tolerated here (Stennicke et al., 2000).  
Thus, it is likely that the second caspase consensus site DSCD
625
↓G presents as a 
strong candidate for cleavage catalysis whereas DVLD
621
↓D with a charged aspartate 
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residue in P1ꞌ position would be poor. To confirm this, each of the caspase cleavage 
sites was tested for functionality. For each of the candidate caspase consensus sites, 
the fourth (i.e., distal) aspartate residue was mutated to glutamate and expressed as 
GFP_MCPH1(Δ8) (Fig. 6.3A) to establish whether the mutagenesis would disrupt 
cleavage. When these constructs were expressed in HeLa cells, the control GFP-
MCPH1(Δ8) protein was still cleaved, but this was abolished in the presence of the 
D625E substitution (Figure 6.3 B). The D621E substitution may lead to a reduction 
in cleavage efficiency (Figure 6.3 B) since there was a reduction in Δ8* band 
intensity relative to uncleaved Δ8 band. Quantification in replicate experiments 
would be helpful to unequivocally establish this finding.  The D625E substitution 
also abolished cleavage of GFP-FL (Figure 6.3 C) confirming cleavage is by the 
same mechanism. Thus, MCPH1 is likely cleaved by caspase 3 and/or 7 proteolysis 







Figure 6.3. GFP-MCPH1 is cleaved after residue aspartate 625.  
(A) Schematic diagram of MCPH1 isoforms and location of putative caspase 3 & 7 cleavage 
sites. Mutation of Asp625 abolishes MCPH1 FL and Δ8 cleavage. HeLa cells were transfected 
with plasmids expressing GFP-tagged MCPH1 Δ8, Δ8 (D621E), Δ8 (D625E) (B), FL or FL 
(D625E) (C). HeLa cells transfected with FL constructs were additionally treated to 
nocodazole (noc) for 16 hr. Lysates were prepared and subjected to immunoblotting with 












6.2. MCPH1 is degraded in late mitosis and early G1 phase 
Levels of MCPH1 FL and S are cell cycle regulated with a decrease in abundance 
during mitosis (FL) and G1 (FL and S) (Chapter 3). In light of the identification of 
caspase cleavage as a mechanism to regulate MCPH1, cell cycle fluctuation in 
MCPH1 protein levels was confirmed to be independent of caspase inhibition by Z-
VAD-FMK treatment (Appendix 3). Thus, the decrease in protein abundance is not 
due to an increase in apoptosis at this stage of the cell cycle.  
To further investigate the regulation of endogenous MCPH1 protein during the cell 
cycle, protein levels were followed after release from a prometaphase arrest. MCPH1 
FL and S levels rapidly decreased as HeLa cells were released into the cell cycle 
from a nocodazole-induced arrest (Figure 6.4A). Decrease in MCPH1 FL and S is 
evident before the completion of mitosis (cells were followed live) and paralleled 
that of cyclin B1. This is consistent with the findings from the double thymidine 
block release (Figure 3.7) although the decrease in MCPH1(S) appeared to occur at 
mitotic exit following release from a prometaphase arrest, rather than G1 phase as 
previously concluded. This difference may be accounted for by changes to 
MCPH1(S) transcript levels following the two synchronisations. Nevertheless, both 
synchronisations are consistent in showing that MCPH1 FL and S abundance is cell 
cycle regulated. 
The fact that MCPH1 FL and S levels paralleled that of cyclin B1 suggests that 
MCPH1, like cyclin B1, may be degraded by the anaphase promoting complex or 
cyclosome (APC/C) (King et al., 1995; Sudakin et al., 1995). The APC/C targets 
proteins for degradation by the 26S proteasome from prometaphase through to G1 
phase (Pines, 2006). To determine whether MCPH1 FL and S are targeted for 
degradation by the APC/C, RNAi mediated knockdown of a subunit of the APC/C, 
APC3, was undertaken, to test consequences on MCPH1 FL and S accumulation. 
Indeed, this did lead to a considerable increase in the protein abundance of MCPH1 S 
and FL (Figure 6.4B). This finding is unlikely to be due to an indirect effect on cell 
cycle progression as although APC3 knockdown does lead to an accumulation of 
prometaphase cells, the difference in MCPH1 protein levels between asynchronous 
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and prometaphase cells is not substantial (Figure 6.4B). Thus, MCPH1 is likely to be 
targeted for degradation by the APC/C. 
The APC/C is an E3 ubiquitin ligase that assembles polyubiquitin chains on substrate 
proteins to target them for destruction by the 26S proteasome (King et al., 1995; 
Sudakin et al., 1995). To confirm that MCPH1 is a substrate of APC/C it was 
established that GFP-FL and GFP-S are modified in vivo in the presence of (His)6-
tagged ubiquitin and MG132, which inhibits the 26S proteasome (Figure 6.4C). As 
only whole cell extracts were used, further studies are required to establish that the 
modified form of MCPH1 is due to polyubiquitination (for example, GFP-MCPH1 
purification followed by immunoblotting with anti-ubiquitin antibodies). Certainly 
MCPH1 modification is consistent with polyubiquitination given the substantial 
mobility shift and dependency on inhibition of the 26S proteasome. 
APC/C primarily recognises substrates containing one of two consensus motifs 
called the D box (Glotzer et al., 1991) and KEN box (Pfleger and Kirschner, 2000). 





 (Figure 6.4D) which was conserved in mouse and can 
act as a functional degradation motif in securin (Zur and Brandeis, 2001). This motif 
was mutated (KEN→AAA) in GFP-MCPH1(FL) and the stability of GFP-
MCPH1(FL)
KEN→AAA
 compared to GFP-MCPH1(FL) was assayed during mitotic 
exit and in early G1 phase. However, overexpressed GFP-MCPH1(FL) was not 
targeted for degradation at mitotic exit (data not shown). This may be due to GFP-
MCPH1(FL) protein abundance, which could prevent cell cycle progression or it 
may be that the APC/C and 26S proteasome cannot maintain degradation of such 






Figure 6.4. MCPH1 is degraded in late mitosis and early G1 phase. 
(A) MCPH1 protein levels decrease following release from a nocodazole block. Extracts 
prepared from HeLa cells released from a prometaphase arrest by nocodazole treatment 
and harvested at the indicated timepoints. Extracts were analysed by immunodetection of 
MCPH1, cyclin B1, phospho histone H3 and vinculin (loading control). Reproducible in two 
independent experiments. (B) MCPH1 protein levels correlate with APC/C activity. HeLa 
cells were treated with siRNA oligonucleotides against luciferase (control) or APC3. After 72 
hr, the cell lysates were prepared and subjected to immunodetection by MCPH1, APC3 and 
vinculin antibodies. APC3 inhibition leads to a prometaphase arrest so for a comparison of 
protein levels a MCPH1 Western blot of extracts from asynchronous and cells arrested at 
prometaphase by nocodazole was included. (C) MCPH1 is modified by (His)6-ubiquitin 
during MG132 mediated proteasome inhibition. Extracts prepared from HeLa cells 
transfected with plasmids expressing GFP-tagged MCPH1 FL or S and (His)6 tagged ubiquitin 
(UB). Where indicated cells were treated with MG132 for 8 hr before harvesting. GFP-
tagged proteins were detected using GFP antibodies. (D) Schematic diagram of MCPH1 
isoforms, location and conservation of putative KEN box.  
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6.3. MCPH1 is phosphorylated during mitosis 
Endogenous MCPH1 from prometaphase arrested cells showed a reduced mobility 
during SDS-PAGE gel electrophoresis compared with MCPH1 from asynchronous 
cells (Figure 6.4B) suggesting that it may be post-translationally modified during 
mitosis. To determine whether the shifted form of MCPH1 is phosphorylated, 
extracts from mitotic cells were treated with λ-phosphatase (Figure 6.5). This 
treatment removes protein phosphorylation and indeed reversed the mobility shift of 
extracts from mitotic cells, confirming that endogenous MCPH1 is phosphorylated at 
mitosis. 
 
Figure 6.5. MCPH1 is hyperphosphorylated during a prometaphase arrest. 
Extracts prepared from asynchronous or nocodazole-arrested HeLa cells were treated with 
protein phosphatase inhibitors in buffer alone or with λ-phosphatase. All samples were 
incubated at room temperature for 30 min and subsequently analysed by MCPH1 
immunodetection. This result was reproducible in three independent experiments. 
 
 
6.4. Identification of MCPH1 phosphorylation sites  
 
The substantial band shift between asynchronous and mitotic MCPH1 could suggest 
that MCPH1 is phosphorylated at multiple sites. This makes it difficult to identify 
individual phosphorylated residues by a candidate approach. Thus, to identify 
phosphorylated residues, MCPH1 was analysed by mass-spectrometry and ion-
precursor scanning. For maximum tryptic peptide coverage for mass-spectrometry 
large amounts of purified protein was required. To satisfy this requirement, DT40 
cells stably expressing GFP-tagged human MCPH1(S) was used as a source of 
MCPH1 (DT40 stable cells were created by Paola Vagnarelli, University of 
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Edinburgh). MCPH1(S) shared the substantial band shift with MCPH1(FL) (Figure 
6.5) but is easier to express and purify (Figure 6.6A).  
Figure 6.6B summarises the phosphorylated residues identified from mass 
spectrometry and ion-precursor scanning. A substantial number of phosphorylated 
residues were identified, although in some cases, the phosphorylation group cannot 
be confidently localised to an exact residue. Interesting phosphorylation sites include 
S333, S335 and S548 which have also been identified in large-scale phosphorylation 
proteomics screens (Chen et al., 2009; Dephoure et al., 2008; Olsen et al., 2010) and 
phosphorylation sites conserved between humans and mice. S191-S195 and S410-
S417 are well conserved regions (Appendix 4).    
 
Figure 6.6. Identification of MCPH1 phosphorylation sites by phosphopeptide mapping.   
(A) Mapping of phosphorylation sites in MCPH1. DT40 cells stably expressing GFP-MCPH1(S) 
were either mock-treated or treated with Colcemid (colc) for 16 hr. Cell lysates were 
prepared and GFP-MCPH1(S) was affinity purified with GFP-TRAP agarose beads, separated 
on a SDS-PAGE gel and stained with coomassie blue. Bands representing GFP-MCPH1(S) 
were excised, trypsinised and analysed by nano-LC-MS-MS (Dundee Fingerprints Facility). 
(B) Summary of phosphorylated residues identified by phosphopeptide mapping. The 
underlined sites represent ambiguous assignment, the sites in bold represent residues 
conserved in mouse and the sites denoted by asterisks represent sites also identified in 











6.5. CDK1 and PLK1 contribute to MCPH1 mitotic 
phosphorylation  
6.5.1. CDK1 mediated phosphorylation of MCPH1 
The phosphopeptide mapping led to the identification of a number of phosphorylated 
residues in CDK1 consensus sites (Figure 6.7A). To determine if CDK1 contributes 
to MCPH1 phosphorylation during mitosis, CDK kinase activity was inhibited by 
treatment of nocodazole arrested cells with Roscovitine or Purvalanol A. Roscovitine 
(Meijer et al., 1997) and Purvalanol A (Gray et al., 1998) inhibit a range of cyclin 
dependent kinases including CDK1, CDK2 and CDK5. Inhibition of CDK1 can 
override prometaphase arrest due to microtubule destabilising drugs such as 
nocodazole (Potapova et al., 2006; Skoufias et al., 2007) and as a result incubation 
with these drugs was restricted to short time intervals and only rounded mitotic cells 
were collected by shake off for immunoblotting. Both CDK inhibitors completely 
reverse the MCPH1 mobility shift, suggesting MCPH1 phosphorylation in vivo is 
mainly driven by CDKs (Figure 6.7B).  
To determine whether MCPH1 was directly phosphorylated by CDK1, Strep-tagged 
MCPH1 fragments were purified (Figure 6.7C) and subjected to an in vitro CDK1-
cyclin-B1 protein phosphorylation assay. To detect in vitro phosphorylation of 
MCPH1, purified MCPH1 fragments were immunoblotted with MPM-2 antibody 
which can recognize phospho-epitopes generated by CDK1 (Westendorf et al., 1994; 
Yaffe et al., 1997). MPM-2 recognized CDK1-phosphorylated MCPH1 NB domain, 
but not the BRCT1 or BRCT2/3 domains (Figure 6.7D). This was consistent with the 
findings from phosphopeptide mapping where all the CDK1 consensus 
phosphorylation sites were located in the NB domain (Figure 6.6) (although it is 
worth noting that the BRCT2/3 domain was not represented in the phosphopeptide 






Figure 6.7. MCPH1 is phosphorylated by CDK1 during mitosis.   
(A) Summary of MCPH1 CDK1 consensus phosphorylation sites identified by 
phosphopeptide mapping. CDK1 consensus phosphorylation sites are highlighted in red. (B) 
MCPH1 hyperphosphorylation is lost following CDK inhibition. Asynchronous or nocodazole-
arrested HeLa cells were treated with Roscovitine (rosc) or with Purvalanol A (purv A) for 1 
hr. Mitotic cells were collected by shake-off and extracts subjected to immunodetection 
with MCPH1 antibodies. Blot representative of three independent experiments. (C) 
Schematic of MCPH1 protein fragments used for in vitro pulldowns. The locations of T120 
and S548 residues on MCPH1 protein are represented. (D) MCPH1 is phosphorylated in 
vitro by CDK1-cyclin-B1. Recombinant CDK1-cyclin-B1 was incubated with the indicated 
recombinant strep-tagged MCPH1 fragments in kinase buffer. Phosphorylated protein 
fragments were detected by immunodetection with MPM2 antibody that recognises CDK1 
phospho-epitopes. (E) Equivalent amounts of the GST-tagged proteins were determined by 
silver staining.  
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6.5.2. PLK1 mediated phosphorylation of MCPH1 
The phosphopeptide mapping also led to the identification of two phosphorylated 
residues in PLK1 consensus sites (identified by ELM predictions) (Figure 6.8A). To 
determine if PLK1 contributes to MCPH1 phosphorylation in vivo, PLK1 kinase 
activity was inhibited by the highly specific drug B12536 (Lenart et al., 2007). 
Mitotic cells arrested in prometaphase were obtained by shake-off after treatment 
with nocodazole in the presence or absence of B12536. Western blotting of cell 
extracts revealed that inhibition of PLK1 subtly increased the mobility of MCPH1 
during mitosis (Figure 6.8B). This finding was confirmed by RNAi-mediated 
knockdown of PLK1 that led to a similar shift in MCPH1 migration compared to 
extracts from siLUC nocodazole arrested cells (Figure 6.8C). Thus, PLK1 










Figure 6.8. MCPH1 is phosphorylated by PLK1 during mitosis.   
(A) Summary of MCPH1 PLK1 consensus phosphorylation sites identified by 
phosphopeptide mapping. PLK1 consensus phosphorylation sites are highlighted in red. (B) 
PLK1 inhibition leads to increased mobility of mitotic MCPH1 on SDS-PAGE. Asynchronous 
or nocodazole-arrested HeLa cells were mock-treated or treated with B12536 for 90 min. 
Mitotic cells were collected by shake-off and extracts subjected to immunodetection with 
MCPH1 and PLK1 antibodies. This experiment is reproducible in three independent 
experiments. (C) PLK1 depletion by RNAi leads to increased mobility of mitotic MCPH1 on 
SDS-PAGE. HeLa cells were treated with siRNA oligonucleotides against luciferase (control) 
or PLK1. After 32 hr, the cells were either mock-treated or treated with nocodazole for 16 




6.6. PLK1 or CDK1 phosphorylation does not appear to be 
required for MCPH1 kinetochore localisation 
6.6.1. Mutation of PLK1 or CDK1 phosphosites did not affect 
MCPH1 localisation  
Chapter 4 had demonstrated that GFP-MCPH1(FL) localisation to kinetochores was 
cell cycle regulated. One hypothesis is that phosphorylation modifies MCPH1 to 
allow it to temporally bind kinetochores.  
To determine if phosphorylation plays a role in targeting MCPH1 to the 
kinetochores, candidate PLK1 and CDK1 phosphorylation sites were mutated in 
GFP-MCPH1(FL) and the localisation investigated. GFP-tagged MCPH1(FL) was 
constructed with a series of phosphorylation-dead alanine mutations in either PLK1 
consensus phosphorylation motifs (A89, A254, A548, triple mutant) or CDK1 
consensus phosphorylation  motifs (A120, A191, A333, A365) (Figure 6.9A). All but 
residue S89 had been identified as potential phosphorylated residues by 
phosphopeptide mapping (Figure 6.9B, red). The individual mutant proteins were 
expressed in cells depleted of endogenous MCPH1 by siMCPH1#1 (described in 
Chapter 5). All the PLK1 and CDK1 alanine mutants localised to the kinetochores 
during mitosis, suggesting that no individual phosphorylation is sufficient to target 
MCPH1 to the kinetochores (Figure 6.9Bi & C). The PLK1 triple mutant also 
localised to the kinetochores (Figure 6.9D) but time constraints did not allow for 
analysis in MCPH1-depleted background or generation of a CDK1 quadruple mutant. 
In addition GFP-tagged MCPH1(FL) with a series of phosphorylation-mimetic 
aspartate mutations in the PLK1 and CDK1 consensus phosphorylation motifs (D89, 
D120, D191, D254, D333, D365, D548) were constructed. The PLK1 and CDK1 
aspartate mutants localised to the kinetochores normally during mitosis with no 




Figure 6.9. MCPH1 PLK1 and CDK1 phospho-dead and constitutively active mutants 
localise to the kinetochores.   
(A) Schematic of MCPH1 FL protein and locations of consensus PLK1 and CDK1 
phosphorylation sites. Potential phosphorylated residues identified by phosphopeptide 
mapping were highlighted in red. (B) MCPH1 PLK1 and CDK1 phosphorylation-dead and 
phosphorylation-mimetic mutants localise to the kinetochores. Table summarising 
phosphorylation-dead (i) and phosphorylation-mimetic  (ii) mutants used. HeLa cells were 
co-transfected with MCPH1 RNAi oligonucleotides (MCPH1#1) and plasmid expressing GFP-
tagged FL with the indicated substitutions. (C) Representative images of findings in table B. 
HeLa cells expressing GFP-FL or GFP-FLS365A. GFP-FL cell was also included in Figure 4.5. (D) 
HeLa cells were transfected with plasmids expressing GFP-MCPH1 FL or GFP- FLS89A, S254A, S548A 
were fixed in methanol and stained with ACA antibodies. For C and D DNA was visualised 









6.6.2. MCPH1 localisation appears to be independent of CDK1 
phosphorylation of PLK1 binding sites 
An alternative hypothesis is that PLK1 recruits MCPH1 to the kinetochores. Both 




Figure 6.10. MPH1 and PLK1 co-localise at the centrosomes and kinetochores during 
mitosis. 
(A) MPH1 and PLK1 co-localise at the centrosomes and kinetochores during mitosis. HeLa 
cells transfected with GFP-MCPH1 FL were arrested at G1/S phase with thymidine, released 
to progress through the cell cycle and fixed in methanol after 10 hr. Cells were stained with 









 PLK1 contains a polo-box domain (PBD) that can interact with a phosphorylated 
consensus site SpS/T (Elia et al., 2003a; Elia et al., 2003b). This consensus site often 
overlaps with a CDK1 consensus site, for example, SpS/TP (Elia et al., 2003b), and 
indeed proteins that bind PLK1 in early and mid-mitosis, such as kinetochore 
proteins, are often primed by CDK1 (Goto et al., 2006; Qi et al., 2006).  MCPH1 
contains four PLK1 PBD interaction phosphorylation consensus sequences at CDK1 
consensus sites of which two were identified as possible phosphorylated residues by 
phosphopeptide mapping (Figure 6.11A).  
To test whether CDK1 phosphorylation of PLK1 PBD interaction motifs could 
recruit MCPH1 to kinetochores, GFP-tagged MCPH1(FL) with a series of 
phosphorylation-dead alanine or phosphorylation-mimetic aspartate mutations in the 
CDK1 phosphorylation sites (S277A, S287A, S417A, S483A,S769A, quadruple 
mutant [S277D_S287D_ S417D_ S483D_ S769D]) (Figure 6.11B & C) were 
constructed. All the CDK1 alanine and aspartate mutants localised to the 
kinetochores during mitosis with normal dynamics, suggesting that no CDK1 
phosphorylation site that could serve as a PLK1 PBD interaction motif was sufficient 





Figure 6.11. MCPH1 kinetochore localisation may be independent of CDK1 
phosphorylation. 
(A) Schematic of MCPH1 FL protein and locations of consensus CDK1 phosphorylation sites 
that could act as potential PLK1 docking sites. Sites identified by phosphopeptide mapping 
were highlighted in red. (B) MCPH1 CDK1 phosphorylation-dead and phosphorylation-
mimetic mutants localise to the kinetochores.  Table summarising phosphorylation-dead (ii) 
and phosphorylation mimetic (iii) mutants used. HeLa cells were co-transfected with 
MCPH1 RNAi oligonucleotides (MCPH1#1) and plasmid expressing GFP-tagged FL with the 
indicated substitutions. (C) HeLa cells were transfected with plasmids expressing GFP-
MCPH1 FL or GFP- FLS277A, S287A, S417A, S483A, S769A were fixed in methanol and stained with ACA 
antibodies. Image of GFP-FL was also included in Figure 6.9D. DNA was visualised with DAPI 






6.7.1. MCPH1 is proteolytically cleaved by caspases 
Protein detection assays shows that a shorter form of MCPH1 FL and Δ8 (FL* and 
Δ8*) was produced by a post-translational mechanism (Figure 6.1).  Several lines of 
evidence suggested that caspases were responsible for generation of FL* and Δ8*. 
First, it appeared to be related to activation of apoptosis through either 
overexpression of MCPH1(Δ8) or by treatment with microtubule destabilising agents 
(Figure 6.1). Second, cleavage of MCPH1 FL and Δ8 was abolished with a caspase 
inhibitor (Figure 6.2) and third, mutation of a caspase consensus site (D625) 
abrogated cleavage (Figure 6.3).  
All presented experiments were performed using overexpressed GFP-tagged MCPH1 
and it would therefore be worthwhile to establish whether there is physiological 
caspase-mediated cleavage of endogenous MCPH1. Unfortunately, endogenous NH2-
MCPH1 FL* is indistinguishable from MCPH1(S) with available antibody reagents 
while endogenous MCPH1(Δ8) is not detectable (Chapter 3). Thus further 
investigation using the detection of the endogenous COOH-MCPH1 terminal 
fragment may be the most productive experiment to pursue.  
What is the physiological role of caspase-mediated MCPH1 cleavage? In addition to 
regulation of cell death, caspases have also been implicated in control of the cell 
cycle (reviewed by Lamkanfi et al., 2007; Los et al., 2001). Many positive and 
negative regulators of the cell cycle are targeted by non-apoptotic caspase cleavage 




 (Alam et al., 1999; Eymin et al., 1999; 
Frost a et al., 2001; Frost b et al., 2001; Woo et al., 2003) leading to the hypothesis 
that caspase cleavage could remove proteins that block mitosis and thereby allow cell 
cycle progression (Levkau et al., 1998; Zhou et al., 1998). MCPH1 is also reported 
to play a role in cell cycle progression; MCPH1(FL) overexpression leads to G2/M 
phase arrest (Andrew Jackson, personal communication) and MCPH1-deficient cells 
fail to arrest at the G2/M checkpoint following DNA damage (Alderton et al., 2006; 
Lin et al., 2005). Thus, MCPH1 could be cleaved by caspases in a physiological non-
apoptotic, cell cycle-dependent manner. This could account for the concomitant 
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decreasing levels of endogenous MCPH1(FL) and increasing levels of MCPH1(S) as 
cells progressed into G2/M following a double thymidine block (Figure 3.7). 
Although this hypothesis is still possible, the cell cycle fluctuation of endogenous 
MCPH1 FL and S protein is independent of caspases suggesting that caspase-
mediated cleavage of MCPH1 during the cell cycle is unlikely (Appendix 3).  
The alternative possibility is that caspase-mediated cleavage of MCPH1 may 
function in programmed cell death. Indeed MCPH1 has been implicated in 
transcriptional regulation of apoptotic factors (Yang et al., 2008). Caspase activation 
needs to be closely controlled to avoid the inadvertent triggering of programmed cell 
death. As a result, caspase production, processing, and activity are all tightly 
regulated (reviewed by Earnshaw et al., 1999). Aberrant transcription of caspases 
and pro-apoptotic factors can trigger an apoptotic response (Kumar et al., 1997; 
Tamura et al., 1995; Tamura et al., 1996). The family of transcription factors called 
E2F, and in particular E2F1, play an important role regulating transcription of pro-
apoptotic factors (reviewed by Dimova and Dyson, 2005). Recently, it has been 
demonstrated that MCPH1 can interact with E2F1 and regulate E2F1 mediated 
transcription of genes involved in apoptosis such as p73, APAF1, caspase 3 and 7 
(Yang et al., 2008).  
This suggests that MCPH1 could play an important role in apoptosis but does 
MCPH1 cleavage have any effect on its function in transcriptional regulation of 
apoptotic factors? Two protein products would be produced following cleavage, one 
containing BRCT1 and one containing BRCT2/3. It was demonstrated that the 
BRCT2/3 domain is required for E2F1 binding and overexpression of this domain 
showed a dominant negative effect, inhibiting E2F1 mediated apoptosis (Yang et al., 
2008). Thus, it is likely that cleavage of MCPH1 would negatively regulate E2F1 
mediated transcription of apoptotic factors suggesting that MCPH1 cleavage could 
be part of a feedback loop to dampen the apoptotic response. Caspase mediated 
feedback control of the retinoblastoma protein to regulate E2F1 mediated caspase 
transcription has also been hypothesised (Chau et al., 2002; Guo et al., 2001; 
Simpson et al., 2001; Tsai et al., 1998).  
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However it is worth noting that the role of MCPH1 in transcriptional regulation is 
controversial and in some systems in which MCPH1 is genetically ablated it does not 
exhibit the same role in transcriptional regulation as reported due to MCPH1 RNAi 
(Alderton et al., 2006; Gavvovidis et al., 2010; Lin et al., 2005; Trimborn et al., 
2010; Xu et al., 2004; Yang et al., 2008). Thus, although this is an interesting 
hypothesis, establishing the role of MCPH1 in transcriptional regulation of apoptotic 
factors following genetic ablation would be worthwhile.  
6.7.2. Degradation of MCPH1 during mitotic exit 
MCPH1 is degraded during mitotic exit and G1 phase of the cell cycle (Figure 6.4A). 
The APC/C often targets proteins for degradation at this time of the cell cycle and 
preliminary evidence is consistent with APC/C playing a role in MCPH1 
degradation. The depletion of a subunit of APC/C (APC3) leads to a substantial 
increase in abundance of MCPH1 FL and S that is not simply explained by changes 
to cell cycle progression consequent on APC/C inactivation (Figure 6.4B). MCPH1 
FL and S proteins may be a substrate of APC/C as both are modified when the 
proteasome is inhibited in vivo and ubiquitin is over-expressed (Figure 6.4C). 
However, that this modification is ubiquitination needs confirmation to strengthen 
this conclusion.  
APC/C functions with co-activators CDC20 or CDH1, which act at different times of 
the cell cycle and broaden the range of substrates recognised by the APC/C (Kramer 
et al., 2000; Visintin et al., 1997). APC/C
CDC20
 recognises substrates containing a 
destruction (D) box motif (Glotzer et al., 1991; King et al., 1996) whereas 
APC/C
CDH1
 recognises substrates containing a D box or a KEN box motif (Petersen 
et al., 2000; Pfleger and Kirschner, 2000). A single KEN box motif is present in 
MCPH1 protein sequence that may be required for its recognition by APC/C (Figure 
6.4D). If the KEN box is functional then CDH1 is likely to function as the APC co-
activator. In addition, APC/C
CDH1
 functions later in mitosis than APC/C
CDC20
 usually 
from anaphase through to G1 phase mitosis (Pines, 2006) which is consistent with the 
timings of MCPH1 degradation (Figure 6.4A).  
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To build on this hypothesis it would be helpful to show that the KEN box is 
functional and that it is APC/C
CDH1
 that targets MCPH1 for proteolysis. 
Demonstrating the KEN box is functional has been difficult, probably due to the 
consequences of MCPH1 overexpression, which inhibits cell cycle progression 
(Andrew Jackson, personal communication). One way to circumvent this problem 
may be to look at MCPH1 levels when CDC20 or CDH1 is overexpressed. 
Overexpression of CDC20 or CDH1 has been reported not to affect cell cycle 
progression (Donzelli et al., 2002) and MCPH1 levels could then be analysed during 
interphase. 
Ubiquitin ligases such as members of the SKP/cullin/F-box (SCF) family can also 
have important roles in controlling protein abundance during the cell cycle (reviewed 
by Ang and Wade Harper, 2005; Cardozo and Pagano, 2004). In contrast to APC/C 
which functions primarily during mitosis and G1 phase, SCF complexes function 
throughout the cell cycle. Thus SCF could additionally contribute to MCPH1 isoform 
degradation during G1/S and G2/M when MCPH1 FL and S protein levels also 
fluctuated (Figure 3.8). SCF recognizes a phosphorylated domain (phosphodegron) 
on the substrate and it is the timing of substrate phosphorylation that alters 





(Elm motif prediction) and although Tyr 162 was not 
identified as a phosphorylated residue in the phosphopeptide mapping screen it could 
be cell cycle stage dependent and so may only be apparent by enriching for different 
cell cycle stages.  
What is the purpose of degrading MCPH1 during late mitosis and G1 phase? 
Unfortunately the answer to this question remains elusive. There are a very large 
number of proteins targeted for degradation during different stages of mitosis (Pines, 
2006). These include the cyclins, such as cyclin-B1, which must be degraded to 
inactivate CDK1 and allow the cell to progress from anaphase (Sigrist et al., 1995; 
Wheatley et al., 1997). Mitotic kinases, such as polo kinase 1 and aurora A, are 
targeted for degradation (Castro et al., 2002; Lindon and Pines, 2004; Littlepage and 
Ruderman, 2002; Shirayama et al., 1998).The group also includes structural 
components of mitosis such as components of mitotic spindle, kinetochores or 
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chromosome condensation factors, which must be disassembled to allow the cell to 
return to interphase. MCPH1 degradation at the end of mitosis may ensure efficiency 
of cell cycle progression for a number of reasons. First, it is a component of the 
kinetochore, which is disassembled after mitosis. Indeed, MCPH1 kinetochore 
staining is significantly reduced during late anaphase (Figure 4.6A) which may be 
important step in disassembling the kinetochore. Second, it is a component of the 
centrosome which undergoes a number of morphological changes during mitosis and 
mitotic exit, such as centriole disengagement (Kuriyama and Borisy, 1981; Tsou and 
Stearns, 2006) and reduction in PCM levels (Khodjakov and Rieder, 1999). Third, 
MCPH1 plays a role in the regulation of the cell cycle timing (Alderton et al., 2006; 
Tibelius et al., 2009; Trimborn et al., 2004) and so it is also possible that its 
degradation may be required to alter cell signalling pathways to facilitate mitotic 
exit. 
6.7.3. Phosphorylation of MCPH1 during mitosis 
MCPH1is also phosphorylated during mitosis. MCPH1 from nocodazole arrested 
cells showed a reduced mobility in SDS-PAGE gels compared to asynchronous cells. 
This shifted form was lost by treating the extracts from mitotic cells with λ-
phosphatase (Figure 6.5). I confirmed two integral mitotic kinases, CDK1 and PLK1, 
contribute to MCPH1 mitotic phosphorylation in vivo (Figure 6.7 & 6.8). This is 
consistent with phosphopeptide mapping studies of GFP-MCPH1(S) that identified 
phosphorylated residues in a number of consensus CDK1 and PLK1 consensus sites 
(Figure 6.6). Although the phosphopeptide mapping studies were of overexpressed 
human MCPH1(S) in chicken DT40 cells, this system can identify phosphorylations 
relevant to a mammalian system. Indeed three of the hits (Ser333, Ser335, Ser548) 
had already been identified as MCPH1 phosphorylation sites in large scale 
proteomics screens (Chen et al., 2009; Dephoure et al., 2008; Olsen et al., 2010). 
Thus, although each site could not be confirmed in vivo, due to the large number of 
phosphorylation sites, it is likely that at least some of these phospho sites are relevant 
to a mammalian system.    
What is the functional role of MCPH1 phosphorylation? Protein phosphorylation 
usually affects the stability, localisation or interactions of a protein. It is very 
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possible that phosphorylation could affect all of these aspects of MCPH1 function. 
This thesis has established that MCPH1 is targeted for degradation during the cell 
cycle (Figures 3.5 & 6.4). MCPH1 stability could be regulated by phosphorylation 
but because of the biological consequences associated with overexpression of 
MCPH1 this has not been pursued further (Figure 5.2 D). Currently, no interactions 
between MCPH1 and mitotic proteins have been established therefore the effect of 
phosphorylation on MCPH1 interactions has also not been examined. Here, the role 
of phosphorylation in MCPH1 localisation was characterised; in particular candidate 
PLK1 and CDK1 phosphorylation sites were under investigation.  
GFP-MCPH1(FL) localisation is not affected when candidate CDK1 and PLK1 
phosphorylation residues are mutated to either phosphorylation dead or 
phosphorylation mimetic form (Figures 6.9 & 6.10). All mutated forms of GFP-
MCPH1(FL) localised to the kinetochores even when endogenous MCPH1 isoforms 
were depleted. However this research requires further investigation; MCPH1 is 
hyperphosphorylated, possibly containing as many as 12 phosphorylation sites, so it 
is difficult to validate these sites and to establish whether one or a particular 
combination is required. Thus it is entirely conceivable that phosphorylation does 
affect localisation since all the phosphorylation sites have not yet been systematically 
mutated and imaged.  
The majority of the CDK1 and PLK1 sites appear to be located in the poorly 
conserved inter-BRCT space (NB domain) of MCPH1 (Appendix 4). All residues 
identified by phosphopeptide mapping were located within the NB domain (Figure 
6.6) and the NB domain was indeed phosphorylated in vitro CDK1 phosphorylation 
assays (Figure 6.7). The BRCT2/3 domains were not represented in the 
phosphopeptide mapping but it is unlikely these domains contain many 
phosphorylation sites as the phosphorylation of BRCT domains have not been widely 
reported in the literature. Indeed most reported phosphorylation sites in BRCA1, 
PARP1, XRCC1 and MDC1 (identified using the phosphosite plus database) are not 
located within BRCT domains .Thus, phosphorylation may be poorly tolerated in the 
BRCT domains, possibly due to potential disruption to protein interaction surfaces 
(Glover et al., 2004).  
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MCPH1(Δ8) lacks most of the NB domain and phosphorylation sites of MCPH1 FL 
and S which could present a key difference in regulation between the MCPH1 
isoforms. Interestingly, there are some differences in the dynamics of MCPH1(FL) 
and MCPH1(Δ8) localisation that may be accounted for by phosphorylation(s) 
because although both proteins have the capacity to localise to the kinetochores 
during mitosis,  MCPH1(Δ8) also associates with chromatin during metaphase 
whereas MCPH1(FL) chromatin localisation is delayed until anaphase (Figure 4.5 & 
4.6). It is possible that phosphorylation (s) in the NB domain during metaphase could 
be required to target MCPH1 to and from the chromatin. However, before the 
differences between MCPH1(FL) and MCPH1(Δ8) localisation can be fully 
interpreted, it needs to be confirmed that MCPH1(Δ8) can localise to the 
kinetochores independently of MCPH1(FL) as it has been established that BRCT2/3 
domains can dimerise (Yang et al., 2008). This could be tested by expressing GFP-
MCPH1(Δ8) in MCPH1
-/-
 cells or by depleting endogenous protein by RNAi. If 
GFP-MCPH1(Δ8) can indeed localise to the kinetochores independently of 
endogenous MCPH1 isoforms then this would be very informative in identifying 
sites relevant to kinetochore localisation as only residues T120, S191,T193,S194 and 
S195 are present in this isoform.  
Instead of phosphorylation of MCPH1 being important for its localisation, an 
alternative explanation for cell cycle regulated MCPH1(FL) localisation is that 
MCPH1 recognises phosphorylation marks on kinetochore proteins that allow it to be 
recruited. This would not be surprising as many tandem BRCT domains are 
established to be phospho protein binding modules (Manke et al., 2003; Yu et al., 
2003). This could be tested by investigating MCPH1 localisation in nocodazole 
arrested cells following treatment with kinase inhibitors to CDK1, PLK1 and aurora 
B.  
It is likely that at least some of the identified MCPH1 phosphorylation sites have a 
functional consequence. The mitotic function of MCPH1 was investigated in Chapter 
5 and an obvious extension of this work would be to investigate whether 
phosphorylation could play a role in MCPH1 kinetochore function. It is interesting to 
note that many of the primary microcephaly proteins are phosphorylated during 
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mitosis including ASPM, CDK5RAP2 and CPAP, and often on CDK1 and PLK1 
consensus sites (Malik et al., 2009; Nousiainen et al., 2006; Santamaria et al., 2011). 
Indeed in Drosophila it has been demonstrated that polo (PLK1 Drosophila 
orthologue) phosphorylation of  Cnn (CDK5RAP2 orthologue) or Asp (ASPM 
orthologue) is required for their roles in centrosome maturation (Dobbelaere et al., 
2008) and microtubule nucleation respectively (do Carmo Avides et al., 2001). Thus, 


















Chapter 7. Discussion 
7.1. Summary of the main findings from this thesis  
In Chapter 3, I characterise three isoforms of MCPH1generated from the alternative 
splicing of intron 8 and exon 8 called MCPH1(FL), MCPH1(S) and MCPH1(Δ8). 
All three isoforms are expressed in human fetal brain and may therefore contribute to 
MCPH1 function during neurogenesis.  
The MCPH1 protein isoforms differ significantly in domain structure. MCPH1(S) 
lacks tandem BRCT domains which likely act as a phosphopeptide binding module 
and MCPH1(Δ8) lacks most of the inter-BRCT domain space. Indeed there are 
significant differences in localisation between the isoforms. MCPH1(Δ8), lacking a 
strong NLS, localised to the cytoplasm and centrosome during interphase, whereas 
MCPH1(FL) and MCPH1(S) localised to the nucleus. During mitosis both 
MCPH1(FL) and MCPH1(Δ8) localise temporally to the centrosome and 
kinetochores, whereas MCPH1(S) is diffusely localised throughout the cell.  
Consistent with MCPH1 kinetochore localisation, MCPH1 is required for normal 
chromosome alignment. Depletion of MCPH1 by RNAi or MCPH1 deletion in 
MEFs leads to the formation of a metaphase plate with grossly misaligned 
chromosomes. Centrosome maturation appeared to occur normally in primary 
microcephaly patient-derived LBC lacking MCPH1, and although multipolar 
spindles were observed following RNAi-mediated depletion this appeared to be 
secondary to chromosome misalignment.  
Reinforcing the importance of the mitotic role of MCPH1, the protein is also subject 
to a number of post-translational modifications during this time. MCPH1 is hyper-
phosphorylated during mitosis with two key mitotic kinases, PLK1 and CDK1, 
contributing to this phosphorylation. It is also degraded as cells exit mitosis, likely 
targeted by the APC/C. These modifications may play a role in the temporal 





7.1.1. Model of the functional role of MCPH1 at mitosis 
At mitosis MCPH1 appears to play a role in chromosome condensation, kinetochore 
and possibly centrosome function. MCPH1 contains BRCT domains which act as 
protein and phosphoprotein binding modules and so we hypothesise that MCPH1 





Figure 7.1. Model of MCPH1 function in mitosis 
MCPH1 can act as a protein assembly platform to coordinate signal transduction pathways 
at various locations during mitosis.  
 
7.2. Are the primary microcephaly proteins in a shared 
pathway? 
It has been hypothesised that a single pathway shared by the primary microcephaly 
proteins can lead to microcephaly (Cox et al., 2006). Given that all of the primary 
microcephaly proteins localise to the centrosome (Bond et al., 2005; Cizmecioglu et 
al., 2010; Hatch et al., 2010; Hung et al., 2000; Nicholas et al., 2010; Pfaff et al., 
2007; Zhong et al., 2005), such a common pathway may well act at the centrosome. 
In the introduction of this thesis, potential mechanisms that could affect brain size 
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during development, all of which could be linked to centrosome function, were 
discussed. These included cilia formation, spindle orientation and DNA segregation 
which can influence neuronal progenitor cell fate choice or cell survival.  
7.2.1. Cilia function 
The primary cilium is a key signal transducer that plays an important role in 
regulating cell cycle length and neural progenitor cell fate (Kim et al., 2011; Li et al., 
2011). The mother centriole acts as a template for the primary cilia (Sorokin, 1962) 
and therefore centriolar defects can often impact on cilia formation or functioning 
(Basto et al., 2006; Graser et al., 2007a). Many of the primary microcephaly proteins 
are required for normal cilia function. For instance, the extra centrioles observed in 
Cdk5rap2
-/-
 MEFs form additional primary cilia per cell (Barrera et al., 2010). The 
presence of such extra primary cilia has been reported to reduce sonic hedgehog 
signalling (Megraw et al., 2011) which is a key developmental determinant in 
neurogenesis (reviewed by Louvi and Grove, 2011). In contrast, Drosophila dsas4 
(CPAP) and asl (CEP152) mutants that cannot duplicate their centrioles 
consequently lack cilia. As adult flies they present with phenotypes characteristic of 
cilia defects such as uncoordinated movement (due to loss of mechanosensory 
function in neurons) and immotile sperm (Basto et al., 2006; Blachon et al., 2008). 
The phenotype of Stil
 
mouse knockout is also consistent with cilia dysfunction; 
embryos present with defects in sonic hedgehog signalling, which cause a failure in 
left-right specification and neural tube defects (Izraeli et al., 2001; Izraeli et al., 
1999). However primary microcephaly patients do not present with phenotypes 
characteristic of cilia defects (termed ciliopathies) (Cardenas-Rodriguez and Badano, 
2009; Fliegauf et al., 2007; Woods et al., 2005) suggesting that there is some 
distinction in humans.  
MCPH1(Δ8) does localise to the centrosome during interphase and so it is possible 
that through interphase centrosome function, MCPH1 could contribute to cilia 
formation and function. This possibility could be tested in Mcph1
-/-
 MEFs or MCPH1 
patient derived primary fibroblast cells (MCPH1
Δ1-8 
cells are available in the lab) in 
which primary cilliation can be induced by serum starvation (Tucker et al., 1979). 
Drosophila mcph1 mutants do not present with ciliopathies (Brunk et al., 2007; 
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Rickmyre et al., 2007). However, Mcph1
-/-
 mice do present with a moderate hearing 
impairment (http://www.sanger.ac.uk/mouseportal/search?query=MGI:2443308) 
which can be associated with cilia dysfunction (Fliegauf et al., 2007). However, not 
all primary microcephaly proteins localise to the interphase centrosome, with ASPM 
and WDR62 only localising at mitosis, therefore inconsistent with a function in 
ciliogenesis (Higgins et al., 2010; Nicholas et al., 2010). 
7.2.2. Spindle orientation  
Centrosomal defects may perturb mitotic spindle orientation in neuronal progenitor 
cells correlating with changes in cell fate choice (Fish et al., 2006; Lizarraga et al., 
2010). Indeed some of the primary microcephaly proteins are required for normal 
spindle pole orientation in such cells. For instance, Drosophila asl (CEP152), dSas4 
(CPAP) and cnn (CDK5RAP2) mutants exhibit abnormal spindle pole positioning in 
asymmetric divisions of larval neuroblast cells (Basto et al., 2006; Blachon et al., 
2008; Giansanti et al., 2001; Lucas and Raff, 2007). Furthermore in mice, mutation 
of Cdk5rap2 or RNAi-depletion of Aspm leads to abnormal spindle pole orientation 
in the neuronal progenitor population in embryos, correlating with a decrease in the 
progenitor population and increase in neuronal population (Fish et al., 2008; Fish et 
al., 2006; Lizarraga et al., 2010).  
MCPH1 isoforms can localise to the centrosome at all stages of the cell cycle 
(Chapter 4) and centrosome defects were observed during RNAi-mediated MCPH1 
depletion, resulting in formation of multipolar spindles (Section 5.1). However, 
centrosomal phenotypes which could be associated with abnormal spindle orientation 
(such as defects in PCM recruitment and spindle pole focussing) were absent in 
MCPH1 patient LBC (Section 5.2). In addition, normal spindle positioning was 
reported in mcph1 Drosophila mutant larval neuroblasts (Brunk et al., 2007). Thus, it 
is unclear if loss of MCPH1 could impact on spindle pole orientation in patient 
neuronal progenitor cells and analysis in this system is essential to address this 
possibility (discussed in Section 7.4). 
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7.2.3. Chromosome segregation and apoptosis 
From the work described in this thesis, the primary function of MCPH1 during 
mitosis appears to be to ensure chromosome alignment and timely metaphase 
progression (Sections 5.1 & 5.2) and it is likely that this function is related to 
MCPH1 kinetochore localisation (Chapter 4). The other primary microcephaly 
proteins have not been reported to localise to the kinetochore nor are they implicated 
in kinetochore function. However, a role at the kinetochore remains a possibility. For 
example, CDK5RAP2 localises to the plus-end of microtubules in interphase cells, 
mediated through an interaction with EB1 and this localisation could be maintained 
during mitosis (Fong et al., 2009).  
Although the primary mitotic function of MCPH1 appears to be distinct from other 
primary microcephaly proteins, they could still have the same cellular consequences. 
The fate of cells following depletion of MCPH1 has not yet been established. 
MCPH1-RNAi cells in prolonged metaphase may well undergo apoptosis as 
depletion of astrin leads to a very similar phenotype that terminates with apoptosis 
(Thein et al., 2007). Genetic ablation of MCPH1 leads to a significantly less severe 
phenotype than RNAi (Chapter 5) and may result in delayed progression through 
metaphase and chromosome missegregation rather than apoptosis. Indeed, Mcph1
-/- 
mice exhibit increased micronuclei 
(www.sanger.ac.uk/mouseportal/search/MGI:2443308) which can arise due to 
chromosome segregation errors during mitosis (Rao et al., 2008). Although this 
could equally be related to the role of MCPH1 in HR and NHEJ (Liang et al., 2010; 
Peng et al., 2009; Wood et al., 2008). 
Perturbed centrosome function is also linked to chromosome missegregation (Ganem 
et al., 2009). Thus it is possible that through centrosome dysfunction many of the 
primary microcephaly proteins could also be associated with errors in chromosome 
segregation (Figure 7.2). Indeed there are reports of chromosome missegregation due 
to loss of primary microcephaly proteins. For example, RNAi-mediated depletion of 
aspm-1 in C. elegans or asp mutant Drosophila exhibit defects in chromosome 
segregation during meiosis (Casal et al., 1990; van der Voet et al., 2009). In 
Drosophila, asl (CEP152) mutants have evidence of chromosome segregation 
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defects in spermatocytes during male meiosis (Bonaccorsi et al., 1998) and in 
neuroblasts (Giansanti et al., 2001). A high level of chromosomal aneuploidy was 
also reported in primary cultures from cells derived from mice with a truncating 
Cdk5rap2 mutation (Eppig and Barker, 1984; Lizarraga et al., 2010). Misaligned 
chromosomes were also apparent in Cdk5rap2
-/-
 MEFs and due to RNAi-mediated 
CDK5RAP2 and CPAP depletion in cells (Barrera et al., 2010; Cho et al., 2006; 




Figure 7.2. Primary microcephaly proteins are required for accurate chromosome 
segregation. 
Schematic showing that the primary microcephaly proteins could potentially share a role in 
ensuring accurate chromosome segregation during neuronal progenitor cell divisions. CPAP, 
CDK5RAP2, STIL and CEP152 all play key roles at the centrosome. ASPM is required for 
spindle microtubule nucleation and focussing during mitosis. MCPH1 is required for 
chromosome alignment. Disruption of any of these functions could lead to chromosome 
segregation errors and aneuploidy. (Figure adapted from Pellman, 2007). 
 
In rodents and humans, a surprising number of cerebral cortical neurons are 
aneuploid arising due to defects in chromosome segregation (Kaushal et al., 2003; 
McConnell et al., 2004; Rehen et al., 2001; Rehen et al., 2005; Yang et al., 2003). 
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Absence of any of the primary microcephaly proteins may reduce the fidelity of 
chromosome segregation causing a higher incidence of chromosome aneuploidy that 
could decrease cell survival (Torres et al., 2008; Weaver et al., 2007), resulting in a 
decrease in neuronal cell number and therefore reduction in brain size.  
7.3. Summary 
In summary, during this thesis I have shown MCPH1 plays an important role in 
metaphase progression and chromosome alignment. It is likely MCPH1 performs this 
function at the kinetochore where it localises throughout mitosis. MCPH1 is highly 
regulated during mitosis, hyper-phosphorylated and targeted for degradation at 
mitotic exit, reinforcing the importance of this protein during the cell cycle. 
7.4. Future work 
7.4.1. MCPH1 isoform function 
A key unresolved question is what the different functions of MCPH1 isoforms are. 
Differences in localisation, regulation and post-translational modification of the 
isoforms clearly suggest there is some separation of function. MCPH1 isoforms may 
potentially act separately in homologous recombination (Liang et al., 2010; Peng et 
al., 2009; Wood et al., 2008), interphase centrosome function (Tibelius et al., 2009), 
chromosome condensation (Trimborn et al., 2010), kinetochore function and timely 
progression through metaphase (Chapters 4 & 5). The tools are available to 
knockdown specific MCPH1 isoforms by RNAi (Section 3.4) or knockdown all the 
isoforms and rescue by expressing individual RNAi-resistant isoforms (Section 5.1). 
One area of particular interest would be to determine if MCPH1 FL and Δ8 play 
differing roles in mitosis, particularly at the kinetochore. Currently it is unclear if 
MCPH1(Δ8) localises to the kinetochores independently of MCPH1(FL). If it does 
then one of the key differences between these isoforms is the inter-BRCT space 
which is phosphorylated during mitosis (Sections 6.4 and 6.5). Functional differences 
between the two isoforms at the kinetochore could therefore be due to differences in 
the proteins phosphorylation status.  
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7.4.2. The role of MCPH1 at the kinetochores 
Of particular interest is MCPH1 role at the kinetochores, which could well be a 
major role of MCPH1 during mitosis. The work in this thesis is consistent with a role 
for MCPH1 in kMT attachment and/or silencing of the SAC. First it is important to 
establish if the prolonged time spent in metaphase in the MCPH1-RNAi cells is due 
to activation of SAC. This possibility could be confirmed by immunofluorescence 
with BUBR1, MAD2 and BUB1 antibodies (Hoffman et al., 2001). If SAC is active 
in MCPH1-deficient cells then the stability of kMT attachments could be tested by 
cold temperature assays (Brinkley and Cartwright, 1975). 
Once this is established the key issue is how MCPH1 participates in these processes. 
We hypothesise that MCPH1 can act as an assembly platform in signal transduction 
pathways (Section 7.1.1). Thus, identification of MCPH1 interactants during mitosis 
may provide significant insight into the pathways that MCPH1 is acting in. To 
identify MCPH1 interactants two different strategies could be undertaken. Firstly, a 
hypothesis independent approach to identify all proteins associated with MCPH1 
during mitosis. For example, purification of epitope-tagged MCPH1 during mitosis 
followed by mass spectrometry to identify MCPH1 associated proteins. This strategy 
has been very productive in the identification of MCPH1 interactants in chromosome 
condensation and chromatin remodelling (Leung et al., 2011; Peng et al., 2009; 
Wood et al., 2008) and could be utilised to specifically investigate mitosis. 
Alternatively, a hypothesis driven approach could be undertaken. Depletion of astrin, 
SKA1-3 complex or SKAP proteins have very similar phenotypes to MCPH1-RNAi 
(Daum et al., 2009; Dunsch et al., 2011; Fang et al., 2009; Gaitanos et al., 2009; 
Hanisch et al., 2006; Thein et al., 2007; Theis et al., 2009; Welburn et al., 2009) and 
so using a targeted approach to determine if these proteins interact with MCPH1 may 





7.4.3. MCPH1 function in neuronal progenitor cells  
Lastly it remains to be determined if the function of MCPH1 during mitosis is 
relevant to primary microcephaly pathogenesis or is it another, possibly non-mitotic 
role that leads to disease? The former is strongly suggested by other primary 
microcephaly protein functions. Thus it is important to study the impact of MCPH1 
loss in neuronal progenitor cells and the effect it has on metaphase progression, 
spindle orientation and chromosome segregation, as well as cell fate choice and cell 
survival. A number of systems are available to study MCPH1 in neural progenitors 
including Drosophila, rodents and humans.  
7.4.3.1. Human neuronal progenitor cells as models of primary 
microcephaly 
There are significant differences in the development of the brain in humans, rodents 
and Drosophila (reviewed by Fish et al., 2008) and notably many primary 
microcephaly models in Drosophila and mouse do not demonstrate microcephaly 
(Barrera et al., 2010; Basto et al., 2006; Dzhindzhev et al., 2010; Lucas and Raff, 
2007). Humans have a much larger brain comprising of many more neurons than 







(Braitenberg, 2001; Scott et al., 2001). Thus more subtle defects in progenitor 
divisions are likely to only become apparent in humans. In addition, many of the 
primary microcephaly genes have undergone adaptive evolution (Evans a et al., 
2004; Evans b et al., 2004; Evans et al., 2006; Wang and Su, 2004) and so they may 
have evolved new functions only apparent in primates. For example, EB1 binding is 
a function that appears to have evolved in CDK5RAP2 with the EB1 binding domain 
absent in rodents but present in primates (Fong et al., 2009). 
Thus, functional studies of the primary microcephaly proteins in human neuronal 
stem and progenitor cells could provide important insightS. There are a number of in 
vitro systems that could be utilised for this purpose. One possibility would be to 
create immortalised human neural stem cell lines that stably express MCPH1 shRNA 
(Carlessi et al., 2009; De Filippis et al., 2007). These cells could then be 
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differentiated into neural progenitor cells and multiple neuronal lineages enabling the 
role of MCPH1 in mitosis and cell fate choice to be analysed (Figure 7.3). 
 
 
Figure 7.3. Differentiation of immortalised human neural stem cells.  
The schematic illustrates the process required to maintain and then differentiate 
immortalised human neuronal stem cells into neural progenitors and neuronal cell types 
such as neurons, oligodendrocytes and astrocytes. (Figure reproduced from Carlessi et al., 
2009). 
 
Alternatively induced pluripotent stem cells (iPS) could be utilised (reviewed by 
Yamanaka, 2009). iPS cells are created by transcriptionally reprogramming somatic 
differentiated cells (Takahashi and Yamanaka, 2006). Recently disease-specific 
somatic cells isolated from patients have been reprogrammed into iPS cells. These 
cells can be maintained as neural stem cells and differentiated into multiple neuronal 
lineages (Dimos et al., 2008; Joannides et al., 2007) enabling disease pathogenesis to 
be directly studied (Figure 7.4). This technique has been used to develop disease 
models such as muscular atrophy (Ebert et al., 2009), amyotrophic lateral sclerosis 
(Dimos et al., 2008) and a variety of genetic diseases such as Huntington, Parkinson 
disease and schizophrenia (Brennand et al., 2011; Park et al., 2008). Primary 
microcephaly patient cells with MCPH1 mutations are available and so this 




Figure 7.4.  Generation and differentiation of iPS cells. 
The schematic depicts the process of generating iPS cells from patient fibroblast cells and 
then differentiating the iPS cells into neuronal precursor cells and neurons which are 
genetically identical to the patient. (Figure reproduced from Chamberlain et al., 2008). 
7.4.3.2. MCPH1 function in neuronal progenitor cells in 
Drosophila and rodents 
One limitation of studies in human neuronal progenitor cells is that it is a cellular 
system and so neuronal progenitor cells would not be studied in a developmental 
context. In this regard, Drosophila and rodents may be useful. Many of the 
regulatory mechanisms controlling neuronal progenitor divisions and specification of 
cell fate choice are conserved between humans, Drosophila and rodents (reviewed by 
Brand and Livesey, 2011), suggesting that such systems could provide substantial 
insight. Indeed the asymmetric divisions of neuroblasts in Drosophila larval brain are 
very well characterised by high resolution live-cell imaging with many of the 
components influencing these processes being conserved in metazoans (reviewed by 
Gonczy, 2008; Knoblich, 2010; Lesage et al., 2010). Rodents can also provide a 
good system to investigate the role of MCPH1 in a developmental context. The 
neuroepithelium of mouse embryo brain can be analysed by immunofluorescence 
following genetic ablation or RNAi-mediated knockdown delivered into embryonic 
brain (Calegari et al., 2002). Both strategies can be successful in investigating 
spindle orientation, cell fate choice and cell death (Buchman et al., 2010; Fish et al., 
2008; Fish et al., 2006; Lizarraga et al., 2010). Thus to fully investigate MCPH1 
regulation of  brain size, a number of different systems should be utilised to study it 




Appendix 1. Oligonucleotides 
(a) Site-directed mutagenesis 
  
Oligo Name                                Sequence              Description  
   
T267G_A269G_F GGACAGCTGGAGCACACATTGATG
AAGCGTTGTTCCCTGCAGCT 
Forward primer can be used to 
introduce T267G and A269G  mutation 
in MCPH1 open reading frame (ORF) 
T267G_A269G_R AGCTGCAGGGAACAACGCTTCATCA
ATGTGTGCTCCAGCTGTCC 
Reverse primer can be used to 
introduce T267G and A269G mutation 




Forward primer can be used to 






Reverse primer can be used to 
introduce A360G mutation in MCPH1 
ORF A360G _F TGAAGGAGAAAAGGGAAAATCTTG
CCCCCACCTCTT 
 
Forward primer can be used to 




Reverse primer can be used to 
introduce T573G mutation in MCPH1 
ORF T762G_F GAAATCAGGAAAGGAAGTTGGAAG
GAGCCATTAATGACATTAAAAG 
Forward primer can be used to 
introduce T762G mutation in MCPH1 
ORF T762G_R CTTTTAATGTCATTAATGGCTCCTTC
CAACTTCCTTTCCTGATTTC 
Reverse primer can be used to 
introduce T762G mutation in MCPH1 
ORF T831G_F ATTGAAAGCAAATAATATTCATTCA
GCACCATCTTTCACTCACCTCG 
Forward primer can be used to 




Reverse primer can be used to 
introduce T831G mutation in MCPH1 
ORF A861G_G862C_F ACCATCTTTCACTCACCTCGATAAAT
CAGCTCCTCAGAAATTTCTG 
Forward primer can be used to 
introduce A861G and G862C mutation 
in MCPH1 ORF A861G_G862C_R CAGAAATTTCTGAGGAGCTGATTTA
TCGAGGTGAGTGAAAGATGGT 
 
Reverse primer can be used to 
introduce A861G and G862C mutation 
in MCPH1 ORF T999G_F GAGTATCACATGGCTCCCATGCACC
TCCGAAG 
Forward primer can be used to 
introduce T999G mutation in MCPH1 
ORF T999G_R CTTCGGAGGTGCATGGGAGCCATG
TGATACTC 
Reverse primer can be used to 
introduce T999G mutation in MCPH1 
ORF T1095G_F GAGTATCACATGGCTCCCATGCACC
TCCGAAG 
Forward primer can be used to 




Reverse primer can be used to 




Forward primer can be used to 




Reverse primer can be used to 











Forward primer used to induce 






Reverse primer can be used to 
introduce A1752G and G1753C 
mutations in MCPH1 ORF 
A2307G_G2308C_
F 
TCGCCTGCCAGCGCCCCCCCAGTGGC Forward primer can be used to 
introduce A2307G and A2308C 
mutations in MCPH1 ORF 
A2307G_G2308C_
R 
GCCACTGGGGGGGCGCTGGCAGGCGA Reverse primer can be used to 
introduce A2307G and G2308C  





Forward primer can be used to 
introduce T267G, C268Aand A269T 





Reverse primer can be used to 
introduce T267G, C268A and A269T 





Forward primer can be used to 
introduce A360G, C361Aand A362T 





Reverse primer can be used to 
introduce A360G, C361A and 
A362T mutations in MCPH1 ORF 
T573G_C574A_F ATTGAAAGCAAATAATATTCATTCAGCA
CCATCTTTCACTCACCTCG 
Forward primer can be used to 
introduce T573G and C574A 




Reverse primer can be used to 
introduce T573G and C574A 
mutations in MCPH1 ORF 
T762G_C763A_F ACCATCTTTCACTCACCTCGATAAATCA
GCTCCTCAGAAATTTCTG 
Forward primer can be used to 
introduce T762G and C763A 




Reverse primer can be used to 
introduce T762G and C763A 






Forward primer can be used to 
introduce T831G,  C832A and 






Reverse primer can be used to 
introduce T831G,  C832A and 
A834T mutations in MCPH1 ORF 
A861G_G862A_F ACGTTTGAAGAGAAGTATCGTTTGGAT
CCTACCTTATCTTCAACAAAAGG 
Forward primer can be used to 
introduce A861G and G862A 
mutations in MCPH1 ORF 
A861G_G862A_R CCTTTTGTTGAAGATAAGGTAGGATCCA
AACGATACTTCTCTTCAAACGT 
Reverse primer can be used to 
introduce A861G and G862A 




Oligo Name                                    Sequence                Description  




Forward primer can be used to introduce 





Reverse primer can be used to introduce 







Forward primer can be used to introduce 







Reverse primer can be used to introduce 







Forward primer can be used to introduce 







Reverse primer can be used to introduce 






Forward primer can be used to introduce 






Reverse primer can be used to introduce 







Forward primer can be used to introduce 







Reverse primer can be used to introduce 






Forward primer can be used to introduce 






Reverse primer can be used to introduce 




Forward primer can be used to introduce 
T1865G  mutation in MCPH1 ORF 
T1865G_R AAAGCCGTCACATGAGTCCTCTA
AAACATCATGCCTTG 
Reverse primer can be used to introduce 
T1865G  mutation in MCPH1 ORF 
C1877G_F TGATGTTTTAGATGACTCATGTG
AGGGCTTTAAGGACCTC 
Forward primer can be used to introduce 
C1877G  mutation in MCPH1 ORF 
C1877G_R GAGGTCCTTAAAGCCCTCACAT
GAGTCATCTAAAACATCA 
Reverse primer can be used to introduce 






Forward primer can be used to introduce 








Reverse primer can be used to introduce 




 (b) Gateway recombination 
To generate PCR products suitable for use as substrates in a gateway BP reaction 
with a donor vector, attB sites were incorporated into the PCR products. To 
introduce attB sites the forward primer contains the following structure: 
GGG-ACA-AGT-TTG-TAC-AAA-AAA-GCA-GGC-TCC- template specific 
sequence 
The reverse primer contains the structure: 
GGG-AC-CAC-TTT-GTA-CAA-GAA-AGC-TGG-GTC- template specific sequence 
Table A1.2 represents the template specific sequence used for attB PCR products. 
 
Oligo Name                          Sequence Description  
   
MCPH1_FL_F ATGGCGGCCCCCATCCTGA Forward primer at 5' end of MCPH1 
full-length (FL) isoform ORF 
MCPH1_FL_R TCCTTGTGACAATAGGTAGTTTT
CAG 
Reverse primer removing the stop 
codon at 3' end of MCPH1 FL ORF 
MCPH1_FL_RX TCATTGTGACAATAGGTAGTTTT
CAG 




Reverse primer removing the stop 










Reverse primer introducing a stop 
codon anneals to nt. 239-267 of 






Reverse primer introducing a stop 
codon anneals to nt. 644-669 of 
MCPH1 FL ORF 
MCPH1_NB_F GGAGCACACATTGATGAATC Forward primer anneals to nt. 246-
266 of MCPH1 FL ORF 
MCPH1_NB_R TCCCCCACTTTTCTTCAATTCCTC Reverse primer introducing a stop 
codon anneals to nt. 1902-1923 of 
MCPH1 FL ORF 
MCPH1_B2/3_F GAGGAATTGAAGAAAAGTGGG Forward primer anneals to nt. 1902-





Oligo Name                        Sequence    Description  
   
MCPH1_F1 GCCCCCATCCTGAAAGAT MCPH1 nt.7-25  
MCPH1_F2 CACATTGATGAATCATTG MCPH1 nt.252-270  
MCPH1_F3 ATTAATAGTAGTCACCAC MCPH1 nt.501-519  
MCPH1_F4 TGGAAGGATCCATTAATG MCPH1 nt.751-769  
MCPH1_F5 CCTTATCTTCAACAAAAG MCPH1 nt.1003-1021  
MCPH1_F6 GATAATCTTAAGGAAAGG MCPH1 nt.1254-1272  
MCPH1_F7 CCCCTGAAGAAGCCCTAA MCPH1 nt.1503-1521  
MCPH1_F8 ATAGTTGACTGTAACATG MCPH1 nt.1758-1776  
MCPH1_F9 TGAAAGGCTTTTCAATTG MCPH1 nt.2008-2026  
MCPH1_F10 AACCCTCTTTGCCGACCA MCPH1 nt.2316-2334  
MCPH1_R10 AATGCAGGACAGCTGGAG Reverse complement of 
nt.232-250  
M13_F GTAAAACGACGGCCA pDONR221 nt. 537-552 
M13R_pentry GTCATAGCTGTTTCCT pDONR221 nt. 2027-3043 
pGEX_F GGGCTGGCAAGCCACGTTTGGTG pGEX_4T3 nt. 869-894 











(d) PCR and qPCR 
Oligo Name                        Sequence                 Description  
   
PBGD_F AGCTATGAAGGATGGGCAAC Forward primer anneals to nt. 964-




Reverse complement of PDGB 
nt.1011-1033 
qFL/S_F AAGGCGAAGCCCAGAGTG Forward primer anneals to nt. 1723-
1741 in MCPH1 FL ORF 
qFL_R CTATTTTTAACACTTCCACTGTA
TCC 




Reverse  primer anneals to nt. 12-32 
in MCPH1 intron 8 
qΔ8_F CAGCGCAATGGAGAAGAGAT Forward primer anneals to  nt.518-
538 MCPH1 FL ORF 
qΔ8_R CTATTTTTAACACCTGAACACA
AAG 
Reverse  primer anneals to nt. 658-
670 & 1825-1838 in MCPH1 FL ORF 
qS_int8_F AGAGCTTTGGGACCTTCAGTC 
 












Reverse primer anneals to Flippase 
Recognition Target (FRT) site  
mMcph1_R2 CAACGGGTTCTTCTGTTAGTC 
 












All RNA oligonucleotides were synthesised with dTdT at the 3‟end of the sense 
strand to facilitate RNA-induced silencing complex (RISC) loading (Dharmacon). 
Oligo Name  Sequence (sense strand)                    Description 
    
LUC  CUUACGCUGAGUACUUCGAdTdT Control that targets luciferase  
MCPH1_1  GCACAGUACUGCCAAAUAAUUdTdT Targets MCPH1 FL 3' UTR 
MCPH1_2  GCGCAAUGGAGAAGAGAUUdTdT Targets nt. 520-539 of MCPH1 FL 
ORF 
MCPH1_3  GGAGCACACAUUGAUGAAUdTdT Targets nt. 246-265 of MCPH1 FL 
ORF 
MCPH1_FL  GGAUACAGUGGAAGUGUUAAA Targets nt. 1812-1834 of 
MCPH1FL  ORF 
MCPH1_S  GGAUACAGUGGAAGUAUGUdTdT Targets nt. 1812-1831 of MCPH1 S 
ORF 
PLK1  AATTCTCCGAACGTGTCACGTdTdT (Oshimori et al., 2006) 
APC3_1  GGAAAUAGCCGAGAGGUAAUUdTdT (Nilsson et al., 2008) 
APC3_2  CAAAAGAGCCUUAGUUUAAUUdTdT (Nilsson et al., 2008) 











Appendix 2. Antisera  
(a) Primary antibodies 
Antibody Species 
Dilution for  
WB or IF 
Reference 
    
Actin (C-11) Goat 1:1000 (WB) Santa Cruz Biotechnology (sc-1615) 
ASPM (IHC) Rabbit 1:1000(WB) 
1:500(IF) 





BD Transduction Laboratories 
(610939) 
CDK5RAP2 Rabbit 1:1000(WB) 
1;2000(IF) 
Bethyl Laboratories (A300-554A) 
CPAP Mouse 1:500(IF) Santa Cruz Biotechnology (sc-
81432) 
cyclin A (H-432) Rabbit 1:500(WB) Santa Cruz Biotechnology (sc-751) 
cyclin B (V152) Mouse 1:500(WB) Cell Signaling Technology (4135) 
GFP (JL8) Mouse 1:1000(WB) BD Transduction Laboratories 
(8371-1) 
MCPH1 Rabbit 1:1000(WB) 
 
Generous gift from P.Lin  (Lin et al., 
2005) 
Pericentrin Rabbit 1:1000(WB) Abcam (ab4448) 
Plk1 Rabbit 1:2000(WB) Cell Signalling 
Plk1 Mouse 1:200(IF) 
1:1000(WB) 
Santa Cruz Biotechnology (sc-
17783) 
 






γ-Tubulin Rabbit 1:500(IF) Sigma-Aldrich (T5192) 








Mouse 1:500(IF) Generous gift from C.Janke (Wolff 
et al., 1992) 










 (b) Secondary antibodies 
 
Antibody Species 
Dilution for  
WB or IF 
Reference 
    
Anti-rabbit IgG, HRP linked Goat 1:5000(WB) Cell signalling (7074) 
Anti-mouse IgG, HRP linked Rabbit 1:5000(WB) Dako (P0260) 
Anti-rabbit IgG  
Alexa Fluor 488 linked 
Goat 1:500(IF) Invitrogen (A11034) 
Anti-rabbit IgG 
Alexa Fluor 568 linked 
Goat 1:500(IF) Invitrogen (A11036) 
Anti-human IgG 
Alexa Fluor 568 linked 
Goat 1:500(IF) Invitrogen (A21090) 
Anti-mouse IgG 
Alexa Fluor 568 linked 
Goat 1:500(IF) Invitrogen (A11031) 
Anti-mouse IgG 
Alexa Fuor 488 linked 
Goat 1:500(IF) Invitrogen (A11029) 
 
Appendix 3. Cell cycle regulation of MCPH1 is 
independent of caspases 
HeLa cells were synchronised by a double thymidine block, treated with Z-VAD-
FMK and released to progress through the cell cycle. Extracts were prepared at 
various time points, separated on a polyacrylamide gel and immunoblotted with 





Appendix 4. Conservation of microcephalin 
phosphorylation sites between human and mouse  
Amino acid sequence alignment of human (H.s.) and mouse (M.m.) MCPH1. Black 
shading in H.s. sequence represents phosphorylated residues identified by phospho-






















H. s.  1    MAAPILKDVVAYVEVWSSNGTENYSKTFTTQLVDMGAKVSKTFNKQVTHVIFKDGYQSTW  60 
            +    LKDVVAYVEVWSS GTENYS+TF  QL DMGA VSKT NKQVTHVIFKDGYQSTW 
M. m.  7    VGGAFLKDVVAYVEVWSSKGTENYSRTFAKQLEDMGATVSKTLNKQVTHVIFKDGYQSTW  66 
 
H. s.  61   DKAQKRGVKLVSVLWVEKCRTAGAHIDESLFPAANMNEHLSSLIKKKRKCMQPKDFNFKT 120 
            DKAQK G KLVSVLWVEKCR AGA +DESLFPA N +EHL +L +KK KCMQPKDF  KT 
M. m.  67   DKAQKTGAKLVSVLWVEKCRMAGALVDESLFPAVNTDEHLPNLSRKKHKCMQPKDFILKT 126 
 
H. s.  121  PENDKRFQKKFEKMAKELQRQKTNLDDDVPILLFESNGSLIYTPTIEINSRHHSAMEKRL 180 
            PENDKR QKKFEKMA+ELQRQK  LDDDVP+LLFES  SL+Y+  + +       M++RL 
M. m.  127  PENDKRLQKKFEKMAEELQRQKAALDDDVPVLLFESPRSLVYSSPVNV-------MKRRL 179 
 
H. s.  181  QEMKEKRENLSPTSSQMIQQSHDNPSNSLCEAPLNISRDTLCSDEYFAGGLHSSFDDLCG 240 
            Q+MKEKRENLSPTSSQM++QS  NP  SL E  LNIS   L SDE FA G HSSF D    
M. m.  180  QDMKEKRENLSPTSSQMLEQSQQNPCVSLFETSLNISHQPLSSDESFASGSHSSFGD--- 236 
 
H. s.  241  NSGCGNQERKLEGSINDIKSDVCISSLVLKANNIHSSPSFTHLDKSSPQKFLSNLSKEEI 300 
               CG+QERKL  S N++ +  C SS VL+A++ + S S  HL +  PQK   + SKE I 
M. m.  237  --SCGDQERKLGRSANEMTTVTCPSSPVLRASSFYGSASPNHLRQPRPQKAPDSPSKESI 294 
 
H. s.  301  NLQRNIAGKVVTPDQKQAAGMSQETFEEKYRLSPTLSSTKGHLLIHSRPRSSSVKRKRVS 360 
            N Q++  G V   ++KQAAG+SQ   +EK  LSPT+S  + H  +   P++SS KRKR + 
M. m.  295  NCQKDATGAVADSERKQAAGVSQGVPDEKLCLSPTMSIIEEHQ-VRLGPKNSSAKRKRAA 353 
 
H. s.  361  HGSHSPPKEKCKRKRSTRRSIMPRLQLCRSEDR----LQHVAG-PALEALSCGESSYDDY 415 
                SP   K K K+  +R     +QL +S+      ++ + G P +EA     SSY+DY 
M. m.  354  DLGSSP---KGKLKKRYKRKSALAIQLFKSDQSPPSTIRLIPGTPDVEA-----SSYEDY 405 
 
H. s.  416  FSPDNLKERYSENLPPESQLPSSPAQLSCRSLSKKERTSIFEMSDFSCVGKKTRTVDITN 475 
            FSPDNLKER SE LPPE+Q  +SP+   CR LSK ER ++ EM DF+C+G+K R++   + 
M. m.  406  FSPDNLKERNSERLPPEAQQLASPSLFHCRGLSKWERRNMLEMCDFTCIGEKHRSISSIS 465 
 
H. s.  476  FTAKT-ISSPRKTGNGEGRATSSC---VTSAPEEALRCCRQAG---KEDACPEGNGFSYT 528 
                   SS  K    E    S+C   V ++  ++   C Q G   ++D  PEG+    T 
M. m.  466  DLISKSASSLEKPVKEEVNTASTCLLLVETSANDSPGLCSQPGPQLRDDTGPEGSSHPDT 525 
 
H. s.  529  IEDPALPKGHDDDLTPLEGSLEEMKEAVGLKSTQNKGTTSKISNSSEGEAQSEHEPCFIV 588 
            +   A        +TPL+G+  E ++    K +  +G+T   S S E E       C +  
M. m.  526  LSSSA------HHITPLKGNSTETRDPGDGKGSPKEGSTPPASASPEDEVHI----CNLS 575 
 
H. s.  589  ---DCNMETSTEEKENLPGGYSGSVKNRPTRHDVLDDSCDGFKDLIKPHEELKKSGRGKK 645 
               DCN+E S EEKEN+  GYS SVKN P R D  D SC G   L++P ++ KKS + +K 
M. m.  576  LGEDCNVEKSVEEKENIATGYSESVKNGPGRPDPSDSSCTG---LVRPQQKPKKSEKEEK 632 
 
H. s.  646  PTRTLVMTSMPSEKQNVVIQVVDKLKGFSIAPDVCETTTHVLSGKPLRTLNVLLGIARGC 705 
            PTRTLVMTSMPSEKQ ++IQVV  LKGFS AP+VCETTTHVL GK  RTLNVL+GIARGC 
M. m.  633  PTRTLVMTSMPSEKQTLIIQVVSTLKGFSFAPEVCETTTHVLVGKSARTLNVLMGIARGC 692 
 
H. s.  706  WVLSYDWVLWSLELGHWISEEPFELSHHFPAAPLCRSECHLSAGPYRGTLFADQPAMFVS 765 
            W+LSY+WVL SLELGHWISEEPFELS  FPAAP+CR E HLS   Y+GTLFA+QP MF++ 
M. m.  693  WILSYEWVLLSLELGHWISEEPFELSETFPAAPICRLERHLSTQQYQGTLFANQPKMFIA 752 
 
H. s.  766  PASSPPVAKLCELVHLCGGRVSQVPRQASIVIGPYSGKKKATVKYLSEKWVLDSITQHKV 825 
            PASSPP AKLCELV LCGG+VS  P+ AS++IGPY GKKKA ++YLSEKWVLDSITQHK+ 
M. m.  753  PASSPPRAKLCELVLLCGGQVSPAPQLASLIIGPYKGKKKARIQYLSEKWVLDSITQHKI 812 
 
H. s.  826  CAPENYLLSQ  835 
            C   NY L Q 
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